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Abstract
Childhood respiratory disease is the leading cause of under-5 mortality in low and mid-
dle-income countries (LMIC) and a major reason for health care visits and hospitalisa-
tion.  Environmental exposures to indoor air pollution (IAP) or tobacco smoke are import-
ant risk factors for childhood respiratory disease. Despite increased electrification, many 
communities in LMIC rely on alternate fuel sources for household cooking or heating. 
The impact of antenatal or postnatal exposures on early childhood respiratory disease 
has not been comprehensively studied in LMIC especially in Africa.
The aim of this work was to investigate the impact of IAP and environmental tobacco 
smoke (ETS) exposure on child health and early-life respiratory disease in the Draken-
stein Child Health Study (DCHS), a South African birth cohort study. The DCHS investi-
gates the epidemiology and impact of early-life exposures on child health including lung 
disease. The study is set in a peri-urban poor community in the Western Cape, South 
Africa.  Pregnant women were enrolled from two public primary healthcare clinics, Mbe-
kweni (serving a predominantly black African population) and Newman (predominantly 
mixed-ancestry population) and 1000 mother-infant pairs longitudinally followed from 
birth through 1 year of life. The thesis chapters are presented as published manuscripts 
that describe IAP and ETS exposure in the 2 communities in the DCHS cohort from the 
antenatal period and the impact of these exposure on child health and lung diseases, 
LRTI and wheezing illness in the first year of life.
To measure exposures comprehensively, two home visits, one in the antenatal period 
(third trimester) and the second postnatally (between 4 and 6 months of the infant’s life), 
were conducted to assess the home environment and to measure the most common in-
door air pollutants and by-products of combustion. Devices placed in participants’ homes 
measured exposure to particulate matter (PM10), carbon monoxide (CO), nitrogen diox-
ide (NO2), sulphur dioxide (SO2) and volatile organic compounds (VOC). Maternal and 
infant urine cotinine measures were used to validate self-reported tobacco smoking and 
exposure. Study staff trained in recognition of LRTI or wheeze documented all episodes, 
which were categorised according to WHO case definition criteria. 
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Exposure to IAP was comprehensively assessed in over 800 homes antenatally and post-
natally providing important South African data on IAP and potential sources of exposure. 
Tobacco smoke exposure was assessed longitdunially by maternal self-report using vali-
dated scales and by measurement of urine cotinine in mothers and infants.  Tobacco smoke 
exposure was found to be highly prevalent  with a smoking prevalence of >50% in mixed-an-
cestry mothers. Alarmingly, 18% of infants were born with urine cotinine levels in keeping 
with active smoking, while a further 30% had levels indicating passive smoke exposure.
Key findings were despite 92% of homes reporting access to electricity, there was still a re-
liance on cheaper alternate fuels. Tobacco smoking prevalence amongst pregnant women 
was high (32%), as was household exposure to tobacco smoke (44%). ETS exposure was 
associated with low birth weight and antenatal IAP or ETS exposure was significantly as-
sociated with increased LRTI. ETS exposure was also associated with wheezing illnesses. 
A novel finding was that antenatal exposure to toluene, a volatile organic compound, was 
associated with severe LRTI and hospitalisation. 
The timing of environmental exposures on the subsequent development of LRTI in infan-
cy has not been well described. An important finding was that antenatal exposures were 
the main risk factors associated with LRTI, with maternal smoking in pregnancy or PM10 
exposure most strongly associated with LRTI. Wheezing illness was associated with both 
antenatal and postnatal maternal smoking and antenatal maternal smoke exposure and 
postnatal household member smoking.  Both IAP and ETS exposure impacted on both 
maternal and infant nasopharyngeal bacterial carriage which may be a precursor to the 
development of LRTI. 
Environmental exposures therefore had a substantial impact on child health and on LRTI 
and wheezing illness. The effect on LRTI of antenatal compared with postnatal exposure 
suggests an in utero developmental lung effect. This study highlights antenatal and ear-
ly life as a critical period for lung development. Urgent and effective smoking cessation 
programmes targeting women of child bearing age as well as public health interventions 
to reduce IAP are required. Woman of childbearing age, pregnant women and children in 
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Chapter 1
Indoor air pollution and environmental  




Childhood respiratory disease is the leading cause of under-5 mortality in low and middle 
income countries (LMIC) and a major reason for health care visits and hospitalisation.1, 2 
There are many risk factors for developing respiratory disease, which may interact with 
each other to affect disease incidence and severity. Respiratory disease is a broad term 
and studies focus on one aspect such as pneumonia or wheezing disease, when in fact 
it is often difficult to separate different forms of LRTI. Therefore, the effects on lower re-
spiratory tract infections (LRTI) in general should rather be considered. The Drakenstein 
Child Health Study (DCHS), a South African birth cohort study, was developed to inves-
tigate the early-life risk factors for child health including lung disease. The DCHS is set 
in a peri-urban, poor South African community in two suburbs, with a high prevalence of 
LRTI and many potentially deleterious exposures, which is typical of many LMIC settings 
and populations.  A key focus has been on longitudinal assessment of the aetiology, 
prevalence and sequelae of early-life LRTI  on child health.3  Despite a global effort to 
improve electrification to under-resourced areas, the use of alternate fuel sources for 
household activities continues in many LMIC. Indoor air pollution (IAP) generated from 
this and the effects on child health in an African setting have not been well described. 
Figure 1: Map of South Africa highlighting Cape Winelands area 
including Drakenstein  district.   
Figure 1:   Map of South Africa highlighting Cape Winelands area  including 
Drakenstein  district
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Further, tobacco smoking remains a global problem with an increasing prevalence of 
smokers particularly in LMIC.4 Atlhough the DCHS population is poor, electrification has 
occurred and there is increasing use of electricity as well as alternate fuels. This work 
explores the effects of these environmental exposures on child health and early-life re-
spiratory disease within the DCHS.
2 Background and Literature Review
2.1 Childhood Respiratory Diseases 
Respiratory diseases have long been recognised as the leading cause of childhood 
death or illness with infants and young children most vulnerable. Global efforts to ad-
dress this through widespread implementation of new vaccines; including pneumococcal 
conjugated vaccine, better nutrition, improved case-management algorhithms and better 
prevention and treatment of HIV as well as setting millennium development goal 4 (MDG 
4) as a two-thirds reduction in LRTI mortality by 2015, has resulted in much progress in 
the management of childhood LRTI as well as a substantial reduction in the number of 
LRTI deaths in the last two decades.5-7 However, despite these advances, LRTI including 
pneumonia and wheezing illnesses remain the leading cause of under-5  morbidity and 
mortality with almost 1 million deaths a year.5, 8-10
Infancy and early childhood are the most vulnerable period for the development of LRTI. 
Strategies to control both the morbidity and mortality in infancy and childhood associ-
ated with LRTI include providing a healthy environment, preventing the development of 
respiratory illnesses and appropriately treating children who become ill.6 Many of these 
strategies address well established risk factors for LRTI including the protective role of 
breastfeeding and appropriate nutrition in early life, immunisation against vaccine pre-
ventable illnesses, prevention and then appropriate management of conditions includ-
ing HIV and adequate treatment of co-morbid conditions.8, 11, 12 Through these sustained 
efforts, a notable reduction in LRTI mortality has occurred, however these interventions 
have not been enough to large portions of LMIC reaching MDG 4.
Environmental factors are increasingly recognised as risk factors for childhood respirato-
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ry diseases and for severe disease.2, 13, 14 The role of exposure to indoor air pollution (IAP) 
or exposure to tobacco smoke on the development of childhood respiratory disease in 
African children has not been well studied. Identification of environmental determinants 
is important to effect appropriate interventions and strengthen public health strategies 
to prevent such disease. Further, the timing of these environmental exposures on the 
development of respiratory diseases has not been well delineated. It is well-recognised 
that antenatal exposure to tobacco smoke impacts foetal lung growth, 5, 16 yet the long-
term consequences and cumulative effect of antental and postnatal exposure on the 
development of lung disease in infancy are less clear. 
2.2 Indoor Air Pollution (IAP)
2.2.1 Defining household indoor air pollution (IAP)
Household indoor air pollution is generated by the use of alternate fuel sources for cook-
ing and heating. Fuel sources can be categorised as solid fuels such as coal, biomass 
fuels including wood (unprocessed and charcoal), dung and crop residues and non–solid 
fuels like paraffin, liquefied petroleum gas, gas and electricity.17 As fuels become cleaner 
and more efficient, they also becomes more costly. The “energy ladder” is a model used 
to describe household fuel choices in which differences in the use of energy is ascribed 
to socioeconomic status.18 Fuels that require combustion result in numerous by-products 
which contribute to household indoor air pollution. There are over 200 by-products of 
combustion, the majority of which are of inhalable size. The more common measured in-
halable chemicals and compounds include, particulate matter (10um and smaller), nitro-
gen dioxide, sulphur dioxide, carbon monoxide and the volatile organic compounds.19-21
IAP may also be influenced by the levels of outdoor air pollution. Road traffic, pollution 
from industry and agricultural practices may lead to increased household levels of IAP. 22 
Other factors influencing IAP include environmental and household characteristics which 
impact on exposure levels. Single roomed homes, unventilated cooking and heating and 
overcrowding all contribute to higher levels of exposure.23-27
2.2.2 IAP – a global problem
Ambient air pollution is recognised as a major contributor to disease with household air pol-
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lution ranked tenth as a risk factor for increased mortality. 28 In 2015, diseases caused by 
pollution were responsible for 16% of premature deaths worldwide, triple that from tuber-
culosis, AIDS and malaria combined.22 Children are particularly susceptible to the effects 
of pollution, even at low doses, and are vulnerable during in-utero and early-life periods 
with potential lifelong effects.22 Globally it is estimated that a third of the world’s population 
rely on alternate fuel sources for domestic energy. 20, 29 Access to electricity is not univer-
sal especially in LMIC. Alternate fuels are often derived from local available sources that 
are dependent on geographical location.  In Africa and India wood and charcoal are more 
commonly used compared to China where coal is more available.29 In areas with limited 
fuel sources, there is often a reliance on household rubbish  and plant residues for fuel, 
however, in peri-urban areas fuel sources may include paraffin or charcoal. 
The use of alternate fuels is clearly linked to poverty.  Worldwide, areas that rely on alter-
nate fuels are also those with resource constraints, particularly in Africa and south-east 
Asia.17, 29
2.2.3 IAP – the South African context
In South Africa there has been a drive to increase electrification especially to rural areas. 
This has resulted in a national increase in households connected to the main electricity 
supply to 85% in 2012. However, despite this, on average 62% of homes reported inter-
ruptions to power supply in the preceding 6 months.30 Furthermore,  nationally a quarter 
of homes in spite of electricity being available still relied on alternate fuels for cooking 
and this was as high as 50% in certain areas.30, 31
Other environmental determinants that contribute to IAP include household factors such 
as dwelling type, access to basic amenities and socioeconomic status. Assessing pover-
ty relies on multiple factors. The multidimensional poverty index (MPI), an international 
measure of poverty,  can be used compare poverty between areas, using 3 broad dimen-
sions; health, education and living standard.31, 32 In South Africa, using this system, 8% 
of households were deemed to be poor. However, the intensity of deprivation based on 
weighted indicators was on average more than 40%.31
20 
While there is limited South African data on the effects of IAP on child lung health, a large 
study using reported alternate fuel use data from 1998 found nearly half of households 
surveyed used polluting fuels and was significantly associated with under 5 year-old 
mortality33 and another study  found that almost 20% of homes used solid fuels with an 
increase in mortality and resultant loss of healthy life years.34  These studies represent 
fuel use prior to the implementation of widespread electrification. However, more re-
cently the use of “non-electrical” fuels for cooking and heating was associated with with 
a significantly higher prevalence of respiratory symptoms in school children surveyed 
in two South African towns.35 Also children living within the Durban metropole, South 
Africa were found to have relatively high levels of PM10 within homes. Predictive models 
suggested that type of housing structure, household smokers or primary fuel used were 
the largest contributors to this.36 
2.2.4 Measuring IAP
Measuring household IAP is a challenge with most studies relying on reported exposure 
or extrapolating levels from sampling of a few homes.29, 37, 38 The lack of standardisation 
in assessing IAP makes it difficult to compare outcomes between studies.39-42 Studies 
that assess IAP broadly employ one the following methods; modelling studies, health 
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Figure 2: South African Households Connected to Electricity 
Supply by Province 2002 – 2017 *  
* Adapted from Statistics SA General Household Survey 2017 30 
Figure 2:  South African Households Connected to Electricity
21
come or intervention studies with improved combustion devices.40 However, the com-
plexity in assessing exposure in terms of direct measurement and other environmental 
factors with the potential to introduce bias is evident. 41
The numerous challenges involved in quantifying IAP include factors related to the home, 
the equipment used to measure pollution, the nature of the pollutants and duration of ex-
posure.39, 40 Outdoor air pollution may also influence IAP levels and this may be difficult 
to fully account for.43 The position and size of the home, type of kitchen and ventilation all 
play a role in household IAP.23, 29 
There are several barriers to measurement of IAP in resource-limited settings, Equip-
ment needs to cost-effective, robust and acceptable to the community in which it will be 
used.29, 44 Many of the commercially available equipment are dependent on a battery or 
power-source to work. This is a limiting factor in terms of duration of monitoring.44  This 
also leads to an average exposure calculated which may underestimate effects associ-
ated with peak exposure.29 Positioning of measuring devices in the home is important as 
this can lead to either over or under assessment of household pollution levels, depend-
ing on where the equipment is placed; such placement may be especially challenging in 
very small poor homes. 17, 23, 29
Direct measures of household IAP include devices that measure for common pollut-
ants. Carbon monoxide, nitrogen and sulphur dioxide, particles and volatile organic com-
pounds are the principle combustion pollutants.42 Particulate matter and carbon mon-
oxide are most commonly measured as they are considered the most health damaging 
and are produced with all forms of combustion.44 Particulate matter of size 2.5um (PM2.5) 
or 10um (PM10) are the sizes most commonly measured as these are of inhalable size. 
Other by-products of solid fuel burning include nitrogen dioxide and sulphur dioxide. 
Non-solid fuel sources such as paraffin are more likely to produce volatile organic com-
pounds including benzene, toluene and xylene.20, 45
The complex relationship between pollutant levels and human exposure make it difficult 
to define clear guidelines on acceptable IAP levels.  Various countries, including South 
Africa, have devised local ambient air quality standards, however, these are often vari-
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able, and increasingly lower standards have been recommended with recognition of the 
health effects associated with air pollution exposure.19, 45, 46
Owing to the difficulties of directly measuring IAP in households, a number of studies 
have relied on reports of alternate fuel used and correlated this to respiratory disease in 
children.47-51 These include case-control and large population based studies all showing 
significant associations between the use of alternate fuels and varying respiratory symp-
toms,47, 48 while other studies depended on inferring exposure using outdoor air quality 
monitors and modeling this to exposure in participants homes.52-55
2.3 Tobacco smoking and environmental tobacco smoke exposure (ETS)
2.3.1 Defining ETS exposure
While the direct harms of tobacco smoking are well known, the consequences of tobacco 
smoke exposure from second-hand smoking has gained recognition as a cause for mor-
bidity and premature mortality.56 Second-hand smoke is generated from the burning end 
of a tobacco product, including cigarettes and the smoke exhaled by the smoker, which 
contains thousands of chemicals and many carcinogenic and toxic compounds.57 Third-
hand smoke, refers to the residual tobacco smoke contamination that remains after the 
cigarette is extinguished58 and poses a further potential continued health risk.59 In-utero 
tobacco smoke exposure is usually the first point of ETS exposure to the developing foe-
tus. This may result directly from maternal smoking or from maternal smoke exposure.56, 
60 The level of foetal smoke exposure is dependent on a number of factors including the 
brand of cigarette smoked, the depth of inhalation and individual uptake and metabolism 
of the cigarette smoke components.61 
2.3.2 ETS exposure – a global problem
With an estimated 1.3 billion smokers world-wide and more than 80% living in LMIC56, 62 
the risk of tobacco smoke exposure is high, particularly for vulnerable groups including 
infants and children. While smoking prevalence is decreasing in high income countries 
(HIC), the converse is true of the LMIC where smoking rates are increasing.4, 62 Globally 
there are  very high childhood ETS exposures reported  ranging from over 60% in certain 
European regions to 12% in Africa with a worldwide average of 40% 4 Despite global ef-
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forts to regulate the tobacco industry including banning advertising of tobacco products 
and smoking in public areas in some countries,57, 62 these policies do not protect against 
household exposure to tobacco smoke. Children remain susceptible to this exposure 
from either mothers or other household contacts who smoke. Tobacco smoke expo-
sure in infants also may begin antenatally in pregnant women who smoke and continue 
through childhood. Underreporting of smoking and exposure, particularly in pregnant 
women is common. The pooled prevalence for tobacco use in pregnant women from 
LMIC was reported as 2.6% (95% CI 1.8-3.6), with current tobacco smoking in pregnant 
African women being 0.6% (95% CI 0.3-0.8) in the African region, however, this was 
based on self-reported data and tobacco smoke exposure was not assessed.63
2.3.3 ETS exposure – the South African context
South African prevalence data also confirmed that a large proportion (17.6% (95% CI 6.3 
- 18.9) of South African adults continue to use tobacco, with the highest current tobacco 
prevalence being in the Western Cape province (32.9%). Further, overall males had a 
four times high prevalence than females; 29.2% vs 7.3%.64 Smoking prevalence in South 
Africa has decreased from 24.6% in 1998 and may be attributable to tobacco control leg-
islation.65 South African government implemented tobacco control measures have led to 
a reduction in cigarette use amongst school learners over a 12-year survey period. How-
ever, of concern was the smaller reduction in smoking prevalence seen amongst girls.66 
Although The Global Youth Tobacco Survey has also reported a decrease in tobacco 
smoke exposure in South African school-going adolescents, 25.7% of students were still 
exposed to tobacco smoke within their homes and 34.2% outside their homes.67 
South Africa has adopted a number of tobacco control measures and is part of the World 
Health Organization’s (WHO) Framework Convention on Tobacco Control (FCTC).68-70 
Despite this, another large study of over 3000 South African adults assessed tobacco 
smoke exposure amongst non-smoking adults and found 55.9% reported smoke ex-
posure in the home, workplace or at a hospitality venue. This highlights the need for 
comprehensive smoke-free laws that prohibit smoking in all public indoor areas without 
exemptions.71
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2.3.4 Measuring ETS exposure
Maesuring exposure to ETS is difficult with prevalence data relying on self-reports of smok-
ing and exposure. This is often under-reported with the true magnitude of exposure re-
maining relatively unknown.4, 56, 67, 72 Biomarkers of tobacco smoke are useful in quantifying 
both smoking prevalence and exposure, however, the invasive nature of many of these 
tests makes the widespread use in epidemiological studies difficult.73, 74 While there are 
a number of emerging biomarkers of tobacco smoke, cotinine, a metabolite of nicotine, 
remains a reliable measure of both tobacco smoking and exposure.75 Cotinine can be test-
ed for in blood, urine, saliva or hair and has been found to be a very stable metabolite of 
nicotine with good correlation to nicotine levels. The ability to quantify cotinine levels also 
makes it a useful marker to differentiate between tobacco smoking and exposure.74, 76
2.4 Environmental exposures and childhood respiratory disease
Lung development commences in utero from the embryonic phase with maturation con-
tinuing into adolescence, thus making it highly susceptible to environmental exposures 
in this time. 77 Increasing evidence suggests  that alveolarisation continues into adoles-
cence and beyond, with the potential for recovery from early-life insults, however con-
versely environmental and other exposures may further affect lung growth in this time. 78, 79 
 ETS exposure and ambient air pollutants were found to impair both lung growth and 
architecture, leading to respiratory impairment after birth.77 A complex interplay of factors 
may contribute to the effect of environmental toxins on the foetus, including the direct 
effect of nanoparticles inhaled by the mother crossing the placenta, as well as the in-
duction of a systemic immune or inflammatory response in the mother causing oxidative 
stress and placental insufficiency. Nicotine is the major component of tobacco smoke 
found to affect lung growth and alveolarisation by interaction with nicotinic acetylcho-
line receptors (nAChR) leading to cell proliferation and dysanaptic lung growth and by 
reducing the surface complexity of the lung parenchyma, increasing collagen accumula-
tion, upregulating surfactant protein gene expression, and inducing neuro-endocrine cell 
hyperplasia in fetal lungs, all leading to altered pulmonary function.80, 81  Further, these 
insults may cause epigenetic changes all of which impact on post-natal lung health.82, 
83 Prenatal air pollution exposure was also found to alter immune competence with the 
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alteration of cord blood natural killer (NK) cells and T-lymphocytes which may play a role 
in long-term allergic conditions.84
Children’s susceptibility to air pollution is increased due to a number of factors including, 
vulnerability of the developing airways, an immature immune system, increased venti-
lation and greater proportion of time spent indoors compared to adults.85 Air pollution 
including tobacco smoke affects respiratory defence mechanisms at a number of levels 
with each level of the respiratory tract attempting to filter out the constituents of air pol-
lution.21 Ultrafine particles however, can rapidly pass into the systemic circulation and 
may induce a systemic response.86 IAP and ETS may also lead to epithelial inflammation 
allowing for organisms to breach the epithelial barrier more easily.87-89 Mice models have 
also shown an increase in proinflammatory cytokines with resultant computed tomogra-
phy (CT) scan changes in particulate matter exposed mice.90 Another animal study also 
found that nicotine induced epithelial-mesenchymal transition (EMT),  a process activat-
ed following lung injury, contributes to lung fibrosis.91
2.4.1 IAP and lower respiratory tract infections (LRTI)
In children under 5 years of age, household air pollution is the 7th leading risk factor for 
death due to its impact on acute lower respiratory infection.28 A large number of studies 
from both HIC and LMIC explored the associations between IAP and a number of child-
hood respiratory outcomes 52, 92 with 2 published meta-analyses. Dherani et al calculated 
a summary odds ratio of IAP and LRTI of  1.78 (95% confidence interval, CI: 1.45–2.18),38 
while Po and colleagues found an almost just over 2 times higher OR 3.53 (95% CI 1.94 
to 6.43).93  The differences found may be attributed to the definition of IAP used in each 
study and the outcomes (LRTI versus respiratory disease in general.) Similarly, another 
systematic review aimed at establishing a quantitative association between IAP, acute 
LRTI and low birth weight (LBW) in under-5 children, found that the risk of acute LRTI 
increased 2.51 times and that of LBW 1.45 times due to IAP exposure.94
Studies assessing IAP and respiratory disease in children are area specific and air pol-
lutants depend on the predominant fuel source used. However, the major by-products 
of combustion are generally the same. The effects of IAP are also dependent on other 
26 
factors including the home environment and the intensity and duration of exposure. In 
a large Indian rural cohort, children from households that used solid fuels were almost 
twice as likely to develop LRTI than those from households that did not [OR1.78 (95% 
CI: 1.05-2.99)]95 In a seperate case-control study, also from India, the use of biomass 
fuels for cooking, was associated with an almost five-fold risk of developing acute LRTI 
(adjusted OR 4.73, 95% CI 1.67–13.45).96 A case-control Nepalese study demonstrat-
ed an increased  risk of acute lower respiratory infections associated with any use of 
biomass stoves [odds ratio (OR) = 1.93; 95% CI: 1.24, 2.98], kerosene stoves (OR = 
1.87; 95% CI: 1.24, 2.83), and gas stoves (OR = 1.62; 95% CI: 1.05, 2.50) compared to 
electric stoves.97 Data from Africa also found an increased prevalence in acute respira-
tory infections in Ethiopian children exposed to biomass combustion, OR2.97 (95% CI: 
1.38-3.87) and kerosene, OR1.96 (95% CI: 0.78-4.89) fuels in their homes.98 Similarly, in 
Zimbabwean children under 5-years of age, household use of biomass fuels more than 
doubled the risk of acute respiratory infections (OR 2.20; 95% CI: 1.16 - 4.19) compared 
to children from homes that used cleaner fuel sources (e.g. kerosene).99 
Exposure to particulate matter, has also been associated with the development of LRTI 
in several studies. A systematic review and meta-analysis on the global burden of LRTI 
from particulate matter exposure, found most studies were from high income countries 
with low levels of particulate matter (PM2.5) exposure and that data from Africa was un-
derrepresented. The summary estimate of the meta-analysis, was a 1.12 (95% CI 1.03-
1.30) increased risk in LRTI occurrence per 10 micrograms per meter cubed (10 ug/
m3). increase in annual average PM2.5 concentration. 
100 However, a birth cohort study 
from Bangladesh, measured PM2.5 levels in the infants’ sleeping rooms and found an 
increased risk of developing LRTI in infants who were exposed to increased levels of 
PM2.5 (adjusted incidence rate ratio (IRR) 1.07, 95% CI 1.01-1.14).
101 Further, increased 
concentrations of PM2.5 (exceeding 100ug/m3) were associated with a 12% decrease 
in age to the child’s first acute LRTI.102 PM2.5(aOR 2.89, 95% CI 1.09-7.68), PM10 (aOR 
5.50 95% CI 1.69-17.91)  and CO (aOR 6.024, 95%CI 1.65-22.00) were also significantly 
associated with wheezing illness in Malaysian pre-school children103 and in a pilot study 
from India, in homes that had higher measured levels of PM2.5, increased respiratory ill-
ness was found in children. This was also noted in homes using biomass fuels and was 
27
associated with the number of family members in the household.104 Further, a study on 
the effect of particle size and concentration showed that smaller particles (mass con-
centration) (<1um) and the number concentration of particles (>5um) impacted on the 
development of respiratory symptoms and bronchitis.105 Interestingly, even prenatal ex-
posure to PM2.5, independent of postnatal IAP exposure, increased the risk of recurrent 
pulmonary infections (aOR  OR = 2.44, 95%CI: 1.12 – 5.36).106 However, even exposure 
to larger size particulate matter (PM10) was associated with increased frequency of LRTI 
in both children and adults.107
The impact of IAP on severe LRTI and  LRTI -associated mortality is also significant. A 
global estimate of annual childhood disease burden from IAP exposure suggests 455 
000 deaths and loss of 39 100 000 disability-adjusted life-years in under 5-year old chil-
dren.108 In a systematic review of IAP exposure on child survival, the pooled odds ratio 
for IAP exposure and childhood, including severe and fatal LRTI was 1.73 (95% CI=1.47, 
2.03). However, when considering only fatal LRTI, the pooled OR was  2.80 (1.81, 4.34) 
p<0.000.109 This was consistent with another systematic review looking at the risks for se-
vere childhood LRTI which also found  IAP exposure to be associated with this, OR1.57 
(95% CI1.06-2.31).110 Solid fuel use was also implicated in acute LRTI mortality in African 
children (adjusted hazards ratio 2.35 (95% CI 1.22 to 4.52) and the risk was increased in 
homes with poor ventilation (absent chimney or hood); adjusted hazard ratio 2.68 (95% 
CI 1.38-5.23).51
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2.4.2 Environmental Tobacco Smoke (ETS) exposure and child health
The impact of tobacco smoke exposure on child health is increasingly recognized with 
children remaining vulnerable to the effects from the antenatal period through child-
hood.111-113 Antenatal ETS exposure can affect somatic growth as well as have a devel-
opmental effect on lung growth.15, 114 As lung growth trajectories are set in early life, such 
exposure may predispose to development of adult respiratory illness.115 The timing of 
exposures may also influence outcomes. While the effects of antenatal tobacco smoke 
exposure on birth outcomes is well described,111 the effect of antenatal versus postnatal 
exposures on respiratory illness in children is less clear with differing evidence on which 
time period has the most significant effects on asthma or wheezing illness.116, 117 
In summary, there is an increased awareness that both indoor air pollution and environ-
mental tobacco smoke exposure may impact on child health and LRTI which remain a 
leading cause of childhood morbidity and mortality. However, there is limited data from 
LMIC and in particular Africa.
3 Aim 
The aim of this study was to investigate the impact of antenatal and early life exposure 
to indoor air pollution or environmental tobacco smoke on child health in the DCHS, a 
South African birth cohort study. 
3.1 Hypothesis
IAP  or ETS exposure is prevalent in pregnancy in this cohort , and is associated with 
impaired birth outcomes and LRTI or wheezing in infants and young children.  
3.2  Specific aims included:
i. To describe the home environments and measure IAP in the DCHS, a birth cohort 
study in the Western Cape.
ii. To measure antenatal and early-life tobacco smoke exposure and investigate the 
association with birth outcomes in the DCHS.
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iii. To longitudinally investigate the impact of antenatal and postnatal IAP or ETS expo-
sure on nasopharyngeal bacterial carriage in mothers and infants in the DCHS, from 
birth to one year of age.
iv. To longitudinally investigate antenatal and postnatal exposure to IAP or ETS and 
the association with LRTI or wheezing illness in the first year of life in children in the 
DCHS.
4 Research Setting
Drakenstein Child Health Study (DCHS)
The Drakenstein Child Health Study (DCHS), a South African birth cohort study of 1000 
mother-child pairs, longitudinally investigates the epidemiology, risk factors, aetiology, 
and long-term outcome of childhood diseases including respiratory illnesses.118 The study 
site is in a peri-urban, poor socio-economic community in the Drakenstein sub-district, 
50km from Cape Town. Pregnant women were enrolled from two public primary health 
care clinics, Mbekweni (serving a predominantly black African population) and Newman 
(predominantly mixed ancestry population) and all deliveries occurred at a single central 
hospital, Paarl hospital. Children are followed until at least 5 years of age. 
5 Ethical Considerations
The study was approved by the Human Research Ethics Committees of the Faculties of 
Health Sciences, University of Cape Town and Stellenbosch University, and by the West-
ern Cape Provincial Health Research committee (HREC 149/2013).  Mothers provided 
written informed consent at enrolment; renewed annually.
6 Chapters
The subsequent chapters address the following:
Chapter 2: presents a literature review on the epidemiology of ETS exposure and the 
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effect on acute respiratory infections, chronic respiratory conditions and lung function in 
children.
Chapter 3: describes the home environment of the participants’ and the methodology 
and process of measuring household indoor air pollution. It further expands on using 
urine cotinine as a quantitative measure of tobacco smoking and exposure.
Chapter 4: provides urine cotinine validated prevalence data on tobacco smoking and 
exposure in two disparate African communities. It also explores the association with birth 
outcomes in this birth cohort.
Chapter 5: focuses on antenatal and postnatal IAP and ETS exposure and nasopharyn-
geal bacteria carried in both mothers and infants.
Chapter 6:  explores the effect antenatal versus postnatal IAP and/or ETS exposure on 
LRTI and wheezing in the first year of life as well the effects on severity of LRTI.
Chapter 7: Summary and recommendations.
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Abstract
Introduction: Childhood respiratory illness is a major cause of morbidity and mortality 
particularly in low and middle-income countries. Environmental tobacco smoke (ETS) 
exposure is a recognised risk factor for both acute and chronic respiratory illness.
Areas covered: The aim of this paper was to review the epidemiology of ETS exposure 
and impact on respiratory health in children. We conducted a search of 3 electronic da-
tabases of publications on ETS and childhood respiratory illness from 1990-2015. Key 
findings were that up to 70% of children are exposed to ETS globally, but under-reporting 
may mask the true prevalence. Maternal smoking and ETS exposure influence infant 
lung development and are associated with childhood upper and lower respiratory tract 
infection, wheezing or asthma. Further, exposure to ETS is associated with more severe 
respiratory disease. ETS exposure reduces lung function early in life, establishing an 
increased lifelong risk of poor lung health. 
Expert commentary: Urgent and effective strategies are needed to decrease ETS ex-
posure in young children to improve child and long-term lung health in adults especially 
in low and middle income countries where ETS exposure is increasing. 
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1  Introduction
Childhood respiratory illness remains a major challenge for global health. Pneumonia is 
the leading cause of under-5 mortality outside the neonatal period in low and middle-in-
come countries (LMICs).1, 2 Asthma is the commonest chronic disease in children in high 
and LMIC settings.3 Environmental tobacco smoke (ETS) exposure is a well-recognised 
risk factor for acute and chronic respiratory illness;4 tobacco use is the leading global 
cause of preventable death.5 Despite worldwide initiatives to reduce tobacco smoking, it 
is estimated that up-to 40% of children are still exposed to tobacco smoke6 and approx-
imately 6 million deaths are tobacco related with half a trillion dollars in tobacco related 
economic damage.5 While the incidence of smoking is decreasing in certain regions,7 it 
is increasing in others, particularly in LMICs and especially amongst women.5, 8 Further, 
bans on tobacco smoking in public do not prevent smoking in homes where women and 
children may experience ETS exposure from household members,8 with the magnitude 
of exposure closely related to cohabitants smoking habits.9
ETS exposure often begins in utero with maternal smoking or exposure. Antenatal or 
early-life ETS exposure, from maternal, household or community contacts, may impact 
on the susceptibility of the infant to develop respiratory disease and impair lung devel-
opment.10, 11 However, the effects of postnatal tobacco smoke exposure may also be 
substantial, leading to poorer respiratory health.12
Potential mechanisms for ETS induced damage include impaired in utero lung growth 
from suppression of foetal breathing or direct genotoxicity.13 Tobacco smoke comprises 
a large number of chemicals and carcinogens, all of which may affect the developing 
respiratory system.14 Animal models suggest that nicotine is the component that has 
significant detrimental effects on lung growth and collagen deposition.15 Nicotine affects 
lung branching through stimulation of alpha- 7 nicotinic acetylcholine receptors during 
the pseudoglandular phase resulting in dysanaptic lung growth.16 Changes in conducting 
airway structure can lead to decreased airflow and increased resistance, decreasing 
pulmonary function.15, 16 Prenatal nicotine may also alter peripheral and central chemo-
reception.14 
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Further, there is evidence linking the effects of tobacco smoke exposure to impaired ear-
ly-life immune function resulting in an imbalance in Th1 and Th2 responses increasing 
the susceptibility to allergic diseases and childhood respiratory infections.14, 17
The aim of this paper was to review the current data on the epidemiology of ETS expo-
sure and the effects of this on lung health in children. Specific objectives were to inves-
tigate the effect of ETS exposure on acute respiratory infection, on chronic respiratory 
disease, and on lung function.  
2  Methods 
Searches were conducted of three electronic databases, PubMed, Scopus and Google 
Advanced Scholar. Keywords included, tobacco smoke or cigarette*, child*, respirato-
ry or lung*, exposure or illnesses. Searches were limited to English language articles 
to include publications from 1990 – 2016.  As this was not a formal meta-analysis, an 
adaption of the PRISMA guideline was used.18
 All papers including meta-analyses and systematic reviews were reviewed and included. 
Abstracts of identified documents were read and full texts of relevant documents were 
retrieved. Reference lists of retrieved documents were also searched to identify addi-
tional publications. Records were screened to identify the original articles, reviews and 
meta-analyses relating to: epidemiology, ETS exposure and respiratory tract infection 
in children; chronic lung diseases (asthma and chronic obstructive pulmonary disease 
(COPD); and lung function. The majority of these (n=4422) were excluded as they were 
either included in systematic reviews or meta-analyses, or assessed as being not rele-
vant to the above criteria. When multiple reports on the same area of knowledge were 
encountered the best quality article were selected for the review. From the 262 screened 
records, 123 were eligible for inclusion in the qualitative synthesis. (Fig 1).
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3  Results and Discussion
3.1  Results
The 123 articles included were chosen to review the available literature on ETS expo-
sure and childhood respiratory disease.  In order to comprehensively review this exten-
sive subject, literature pertaining to the epidemiology of ETS exposure, the acute and 
chronic sequelae and preventative strategies to limit exposure was then explored as 
described below.
3.2  Epidemiology of environmental tobacco smoke  (ETS) exposure in 
childhood
Recent global estimates report that worldwide 40% to 70% of children are exposed to 
tobacco smoke. [6, 19] Further, the burden of antenatal exposure may be underestimat-
ed as smoking during pregnancy is often under-reported.20, 21 There is large variability in 
smoking prevalence in different regions.20, 22 The reported overall pooled prevalence of 
smoking during pregnancy in LMICs is 1.3% (95% CI 0.9 – 1.8%) with Southeast Asia 
having the highest pooled regional prevalence of 2.7% (95% CI 1.1-4.8).20 However, this 
prevalence is based on self-reported smoking and may likely under estimate the true 
prevalence. (Table 1) Smoking in pregnancy may also depend on societal acceptance as 
demonstrated by very disparate smoking prevalence found in two closely located South 
African communities of different ethnicities; 51% in pregnant women from one commu-
nity compared to 14% in the other.23 Even in high-income countries the prevalence of 
smoking in various regions within the United States of America before, during and after 
pregnancy varied widely with smoking prevalence during pregnancy ranging from 2 - 
30%. Overall smoking prevalence was highest in the 3 months preceding pregnancy 
(almost 25%), decreasing during pregnancy (12.3%) and after pregnancy (17.2%), how-
ever tobacco-control efforts have achieved minimal reductions and much higher than 
national objectives of smoking within pregnancy (1.4%).21
3.3  ETS exposure and respiratory tract infection in children 
Respiratory tract infections (RTI) associated with ETS exposure include upper RTI (otitis 
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media, sinusitis, pharyngitis, tonsillitis) and lower respiratory tract infections (LRTI).24 
An increased risk of 1.2-1.6 of upper respiratory tract infection (URTI) or LRTI has been 
reported particularly in pre-school children exposed to parental smoking.25 When consid-
ering the impact of prenatal versus postnatal exposure on respiratory disease, postnatal 
paternal smoking is associated with increased otitis media while maternal smoking in 
pregnancy is associated with an increase in wheezing  (odds ratio (OR) 1.41, 95% CI 
0.99– 2.01) or chestiness (OR 1.46, 95% CI 1.03–2.01) in the first year of life.26 ETS is 
postulated to increase the risk of RTI by direct toxic effects on the mucosa, impaired 
ciliary function and impaired local immune defences resulting in prolonged inflammation, 
congestion or predisposition to infection.27, 28
3.3.1  Upper respiratory tract infection (URTI) (Table 2)
ETS exposure is associated with recurrent otitis media and the increased need for tym-
panostomy tube placement with parental smoking reported to double the risk of recurrent 
acute otitis media.29, 30 Maternal smoking increased the risk of middle ear disease and the 
need for surgery (OR 1.86, 95% CI 1.31-2.63).31 Exposure to ETS was more common 
in children undergoing tonsillectomy for recurrent tonsillitis compared to a control group 
who underwent hernia repair surgery.32 Children whose parents limited their exposure 
to ETS by enforcing smoke-free home environments experienced fewer URTIs and de-
creased health-care facility visits.30, 33 
3.3.2  Lower respiratory tract infection (LRTI) (Table 3)
ETS exposure is reported as an important risk factor for childhood LRTI in several stud-
ies.2 An updated systematic review found smoking by either parent  (OR 1.22, 95% CI 
1.10-1.35) both parents (OR 1.62, 95% CI 1.38-1.89) or a household member (OR 1.54, 
95% CI 1.40-1.69) significantly increased the risk of LRTI.34
In children hospitalised for community-acquired pneumonia, household ETS exposure 
was found to increase length of hospital stay and severity of pneumonia, particularly 
with more than two smokers in a household. 35 In a Canadian study, ETS exposure was 
also associated with severe LRTI in the first 2 years of life, predisposing to further respi-
ratory morbidity in pre-school years.36 Other studies, from LMICs have also shown this 
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association.37, 38, 39  A high incidence of pneumonia [0.27 episodes per child-year (95% 
CI 0.23-0.32)] was reported in infants in the Drakenstein Child Health study, an African 
birth cohort study; maternal smoking was strongly associated with pneumonia (RR 2.36, 
95% CI 1.45-3.82).37 Studies from Nepal and Indonesia confirm a similar  risk,38, 39 and 
in a large questionnaire based study from Taiwan, prenatal ETS exposure or maternal 
smoking were significant risk factors for infantile pneumonia.40 A Vietnamese study of 
almost 25 000 children less than 5 years of age, found that household ETS exposure to 
be independently associated with hospitalisation for pneumonia (adjusted OR 1.55, 95% 
CI 1.25-1.92). 41
Bronchiolitis is a major cause of respiratory morbidity in young children and while ETS 
exposure is a recognised risk factor, the source and timing of exposure varies.  A system-
atic review found that post-natal maternal smoking was strongly associated with bronchi-
olitis (OR 2.51, 95% CI 1.58 - 3.97).34 More recently prenatal ETS exposure and heavy 
postnatal maternal smoking were both associated with an increased risk of hospitaliza-
tion for bronchiolitis in the first year of life; however post-natal exposure increased the 
risk by 2 fold compared to prenatal ETS exposure.42 Further, both prenatal and postnatal 
maternal smoking were associated with an increased risk for admission to intensive care 
(ICU): OR = 1.51 (95% CI 1.14–2.00) for prenatal and OR = 1.95 (95% CI 1.13–3.37) for 
postnatal exposure. 43
3.3.3  Pathogen specific disease (Table 4)
Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory disease in chil-
dren and may cause severe disease. ETS has been found to increase the risk of severe 
RSV disease as measured by hospitalisation and hypoxia in both infants and children 
(adjusted OR 2.2 – 3.8).44 A recent systematic review and meta-analysis identifying risk 
factors for RSV-associated LRTI in children reported maternal smoking to be one of the 
most important risk factors (OR 1.36, 95% CI 1.24–1.50). 45
Severe influenza virus disease has also been associated with ETS exposure, with ETS 
exposure associated with a 20% increased need for ICU admission and 12% increased 
risk of intubation compared to children without ETS exposure.46
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Pneumococcal nasopharyngeal carriage has also been associated with smoke exposure 
in Australian children 47. However, in a systematic review of the association between ETS 
exposure and invasive bacterial disease, this association only occurred with meningo-
coccal disease. 48  Another systematic review on the health effects of passive smoking 
also reported an increased risk for invasive meningococcal disease, pneumococcal car-
riage and LRTI in children.49
Tuberculosis (TB) remains a global health problem with young children particularly vul-
nerable to developing disease especially those living in LMICs. Studies from high burden 
TB regions demonstrate an association between ETS exposure and development of TB 
disease in adults.50, 51 While the effects of tobacco smoking and exposure on TB have been 
well described in adults, there are fewer studies focusing on children. A systematic review 
and meta-analysis found that ETS exposure caused both an increase in TB infection (OR 
1.9, 95% CI 0.9–2.9) and disease (OR 2.8, 95% CI 0.9–4.8) in children. 52
3.4  ETS exposure and chronic lung disease in children 
3.4.1  Asthma 
Childhood asthma is the commonest non-communicable disease in children.53 Findings 
from the International Study of Asthma and Allergies in Childhood (ISAAC) have con-
firmed the association between maternal smoking, and symptoms of asthma or rhino-
conjuctivitis with an additive risk being paternal smoking.3 Increasing number of maternal 
cigarettes smoked was associated with a higher prevalence of asthma symptoms. Fur-
ther, maternal smoking in the first year of a child’s life was associated with a greater risk 
of all asthma symptoms at 13 to 14 years, highlighting the impact of early exposure on 
long-term respiratory outcome.3 ETS exposure has also been associated with more se-
vere asthma attacks; children with asthma and ETS exposure were twice as likely to be 
hospitalised for asthma and had more emergency unit visits (OR 1.66, 95% CI 1.02-2.69) 
than unexposed asthmatics.54 A 20% increased length of hospital stay was also found 
in ETS exposed asthmatic children.55 ETS exposure also impacts on asthma control 
with decreased response to inhaled corticosteroids and impaired histone deacetylase-2 
function, possibly contributing to steroid resistance in asthmatic children.56 In utero to-
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bacco smoke exposure increased age-related airway hyperresponsiveness and reduced 
the efficacy of inhaled corticosteroids in asthmatic children.57 Further, increased pas-
sive smoke exposure, as quantified by measuring urine cotinine, was also associated 
with more severe asthma exacerbations in Iranian children.58 ETS exposed children had 
increased co-morbid conditions with significantly higher body mass index percentiles 
(>75%, OR 1.64, 95% CI 1.22-2.2) and were more likely to have more severe asthma 
then non-exposed controls.59
In a recent meta-analysis, comparing antenatal and postnatal smoke exposure on the 
incidence of asthma and wheeze, children exposed to either antenatal or postnatal to-
bacco smoke exposure had a 30-80% increased risk of developing wheezing and a 21-
85% increased risk of developing asthma.60 However the strongest risk for the develop-
ment of wheezing was in children under 2 years with postnatal tobacco smoke exposure 
(OR 1.70, 95% CI 1.24–2.35) while the risk of developing asthma was associated with 
antenatal maternal smoking (OR 1.85, 95% CI 1.35–2.53).60 By contrast in a large pop-
ulation-based prospective cohort study, continued maternal smoking during pregnancy 
led to increased risk of early and persistent wheezing (OR 1.24, 95% CI 1.01-1.52; OR 
1.48, 95% CI 1.13-1.95) and asthma (OR 1.65, 95% CI 1.07-2.55).61 Post-natal paternal 
smoking was however not associated with an increased risk of wheezing.61
This was confirmed in a recent meta-analysis focusing on smoke exposure and the de-
velopment of wheezing and asthma in unselected birth cohorts. This analysis found a 
36% increased risk of wheezing in early-life of infants whose mothers’ smoked during 
pregnancy, while no clear exclusive post-natal effect could be demonstrated.62 While ma-
ternal smoking and exposure increase the risk of asthma development, in non-smoking 
mothers antenatal maternal ETS exposure also increased the risk of asthma develop-
ment in their children.63
3.4.2  Chronic obstructive pulmonary disease (COPD) 
One of the first studies to explore the association between ETS exposure in childhood and 
the development of COPD in adulthood found an almost 2-fold increased risk of women 
developing COPD following childhood ETS exposure. There was also an increased risk of 
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COPD symptoms in men exposed to ETS in childhood compared to those unexposed.64
Follow-up of participants from the Tucson Children’s Respiratory birth cohort study 
through first 26 years of life has demonstrated that ETS exposure in utero and during 
early-life increases the susceptibility to the harmful effects of active smoking in early 
adulthood and an accelerated decline in lung function.65
A number of studies have reported the impact of early-life smoke exposure on the “ge-
netic programming” that control life-long lung development and aging with consequent 
susceptibility to obstructive lung diseases.66 Studies investigating genetic determinants 
of obstructive lung disease and the effect of early life smoke exposure on gene expres-
sion, have found at least 3 COPD genes whose expression may be influenced by in 
utero tobacco smoke exposure.67, 68 Epigenetic changes may account for such gener-
ational effects.69 Mice models show alterations in DNA methylation and airway hyper-
reactivity in response to in utero ETS.70 Recent human studies have also found smoke 
exposure specific blood DNA methylation changes present in pre-school children, which 
were comparable to those found at birth.71 DNA methylation changes following in utero 
tobacco smoke exposure were also found in foetal lung and placental tissue suggesting 
a foetal origin for chronic diseases in later life.72
3.4.3  Bronchopulmonary Dysplasia (BPD)
While there is limited data on ETS exposure and BPD, the association between antena-
tal ETS exposure and preterm delivery is well recognized and there is a strong associ-
ation between preterm delivery and bronchopulmonary dysplasia (BPD).73 Gestational 
exposure of mice to cigarette smoke resulted in alveolar simplification and induction of 
a BPD-like condition in their offspring. This was mediated by down regulation of nico-
tinic receptors that in turn regulate other factors (hypoxia-inducible factor-1) involved in 
apoptosis control and angiogenesis in the developing foetal lung, which may explain the 
effects of ETS exposure on BPD.74 In very low birth weight infants, intrauterine smoke 
exposure was also found to be an independent risk factor for BPD (OR 2.21; 95% CI 
1.03-4.76).75 More recently a case-control study looking at the respiratory outcomes of 
preterm infants with and without BPD exposed to both in utero smoking (IUS) and post 
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natal ETS showed that infants with BPD on home oxygen had the highest exposure to 
both.76 Chronic tobacco smoke exposure as assessed by hair nicotine levels was com-
mon in children with BPD; relying on caregiver reported smoke exposure underestimated 
this by almost 50%. Further, in children who required respiratory support (home oxygen 
or ventilation) higher log hair nicotine levels were associated with increased hospitalisa-
tions and limitation of activities.77
3.4.4  Cystic Fibrosis (CF)
The deleterious effects of ETS exposure are likely to be more pronounced in children 
with chronic respiratory conditions including cystic fibrosis (CF).78 One of the few studies 
to look at the effects of ETS exposure in infants with CF found diminished growth as 
measured by length and weight/length at 4 and 12 months of age in smoke exposed CF 
infants as compared to unexposed CF infants. Exposed CF infants also had increased 
air trapping (measured on CT scan), bronchodilator responsiveness (4.2-fold increase) 
and a higher prevalence of methicillin resistant S. aureus and anaerobes on respiratory 
cultures.79 In utero tobacco smoke exposure was also found to precipitate earlier struc-
tural lung disease in young CF children with increased CT scan diagnosed bronchiecta-
sis (1.45 CF-CT score points [95% CI 0.35 – 2.56]) and air-trapping (1.39 CF-CT score 
points [95% CI 0.13 – 2.63]) as well as a shorter time to first infection. ETS exposed CF 
children also had decreased forced expiratory volumes (FEV1) at 6 years of age. These 
effects were strongest for maternal smoking; paternal smoking during gestation had a 
similar but milder effect.80 The significant effects of maternal smoking on lower lung func-
tion in young CF patients warrants smoking cessation strategies targeting parents of this 
vulnerable group of children. Telephonic counseling and trained nurse led interventions 
were found to be effective in enabling parents of children with CF to reduce or quit smok-
ing in 12.5% of participants.81
Both in-vitro and in-vivo studies have shown that cigarette smoke decreases the ex-
pression of cystic fibrosis transmembrane regulator (CFTR) gene, protein and function 
contributing to the pathophysiology of existing CFTR deficiencies.82
53
3.5  ETS exposure and lung function 
The detrimental effects of ETS exposure on lung function have been well documented.11, 83 
ETS exposure in children is associated with lower forced expiratory volume (FEV1) values 
compared to matched unexposed children.84 Antenatal maternal smoking has been asso-
ciated with a reduction in early-life lung function suggesting in utero smoke exposure may 
affect airway development and lung elasticity.85 Maternal smoking during pregnancy and in 
early life is the most significant source of exposure affecting infant lung function.83
Changes in infant lung function due to antenatal or early postnatal ETS can be detected 
very early in infants.  In a South African birth cohort, the Drakenstein child health study, 
maternal smoking in pregnancy or postnatally was associated with a 19% lower compli-
ance in exposed compared to unexposed infants at 6 weeks of age as measured by the 
forced oscillation technique.86 In a large Chinese study of ETS exposure in pre-school 
children, ETS exposure, as quantified by urine cotinine levels, was a significant risk fac-
tor for lung function impairment measured by spirometry.87 
Longitudinal cohort studies have shown that lung function trajectories are set in early 
life with a developmental window of susceptibility, which can be disrupted by both infec-
tious and environmental exposures.10, 88, 89 Maternal smoking reduces infant lung function 
which is associated with impaired lung volume in adulthood (both for FEV1 and forced 
vital capacity [FVC]), independent of smoking in adulthood, compounding the effect of 
smoking to reduce airflow limitation and increasing the risk of COPD.90 Parental smoking 
was also responsible for a rapid decline in FEV1:FVC ratio in young adulthood even 
more (3%) than that of smokers not exposed to parental smoke.65 The majority of studies 
focused on air flow limitation (FEV1 and FEV1:FVC) as a marker of ETS exposure relat-
ed airway obstruction.90
Even low levels of ETS exposure have been shown to affect lung function in pre-school 
asthmatic children.91 Further, ETS may increase airway inflammation in young children. 
ETS exposed steroid naïve pre-school wheezers were found to have higher levels of 
exhaled nitric oxide (FeNO) and higher respiratory resistance, as measured by impulse 
oscillometary, compared to unexposed children. 92 
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3.6  The additive effect of indoor air pollution (IAP) and ETS exposure on 
lung health in children 
The use of alternate fuel sources for cooking and heating is an important contributor to 
indoor air pollution (IAP) particularly in LMIC. 93 The multiplicative effects of air pollution, 
from both indoor and outdoor sources and ETS exposures are important particularly as 
these countries carry the highest burden of child respiratory diseases. 94 ETS combined 
with other IAP particularly antenatal exposure affects lung growth that persists through 
adulthood.95 There are numerous by-products of combustion; particulate matter (PM), 
carbon dioxide (CO2), sulphur dioxide (SO2), nitrogen dioxide (NO2) and volatile organic 
compounds (VOC) are the most commonly assessed by-products of both ETS and other 
combustions.93, 96  Recently it has been shown that sub- and nano-micron particles contrib-
ute to adverse effect of particulate matter on the lung health of children.97 A South African 
birth cohort study that evaluated the home environment and measured IAP in a peri-urban 
setting, reported high passive tobacco smoke exposure (44%) and benzene (VOC) levels 
(median 5.6 μg/m3 [IQR 2.6– 17.1]) exceeding acceptable ambient standards. Significant 
associations between fossil fuel use and increased benzene [OR 3.4 (95% CI 2.1–5.4)], 
carbon monoxide [OR 2.9 (95% CI 1.7–5.0)] and nitrogen dioxide [OR 18.6 (95% CI 3.9–
88.9)] levels were also found.98 In an Italian study that examined the association between 
household cohabitants’ smoking behaviours and urinary cotinine and benzene (a tobac-
co-related carcinogen) levels in children contacts, found the levels of urinary benzene par-
alleled that of urine cotinine and were related to smoking behaviours such as smoking in-
doors vs outside the home.99 Adverse respiratory outcomes are associated with a number 
of combustion by-products. A  Chinese study of over 3000 preschool children showed that 
gestational and early life exposure to NO2 from ambient air pollution was associated with 
asthma  (OR 1.77; 95% CI 1.29–2.43) or allergic rhinitis (OR 1.67; 95% CI: 1.07–2.61).100 
Indoor exposure to particulate matter (PM 2.5) above levels of 100ug/m
3 was independently 
associated with younger age of first LRTI [12% decrease (95% CI 2 – 21) in age] in Ban-
gladeshi children.101 Another African study assessing the effects of pollution from ETS, 
cooking and heating fuels and outdoor traffic found an increased risk of wheezing from 
both indoor and outdoor air pollution sources. ETS exposure at home was associated with 
current wheeze (OR 1.36 95% CI: 1.06 − 1.77);  use of gas for residential heating was 
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associated with wheeze ever (OR 1.68 95% CI: 1.23 − 2.28) or current wheeze (OR 1.61 
95% CI: 1.08 − 2.39); paraffin most frequently used for residential heating was associated 
with current severe wheeze (OR 1.85 95% CI: 1.04 − 3.28).102 The risk of LRTI mortality in 
LMIC is also increased by environmental exposures including ETS (OR1.52, 95% CI 1.20 
- 1.93) or IAP (OR 3.02, 95% CI 2.11‒4.31).103
3.7  Prevention of exposure to ETS 
The long term burden of ETS exposure on respiratory morbidity and mortality is sub-
stantial.  Public health programmes that highlight not only the acute effects of ETS but 
also the long-term consequences on child health are needed. In utero and early-life ETS 
exposure remains an important risk factor for respiratory disease in young children with 
consequent long-term effects on respiratory health. Increasing evidence indicates that 
the roots of adult COPD lie in antenatal and early life exposures including ETS.104 The 
generational effect of smoke exposure are important with evidence emerging of maternal 
smoking in pregnancy impacting on subsequent risk of asthma in grandchildren regard-
less of the mother’s smoking status or of long term COPD.105 
Global attempts to curb the tobacco epidemic include the World Health Organisation’s 
tobacco-free initiative, aimed at implementing smoke-free environments and legislation 
limiting tobacco advertising, particularly to prevent initiation of tobacco and nicotine ad-
diction among youth.5, 106, 107 While these measures aim to control tobacco smoke expo-
sure in public places, household exposure remains problematic. Public health interven-
tions require measures that target the tobacco industry through taxes on cigarette sales 
and warnings on cigarette packets but should also include local community involvement 
to ensure culturally acceptable interventions particularly in LMIC.108
Key preventative strategies to protect children from tobacco smoke and nicotine expo-
sure include a comprehensive ban on tobacco smoke, ban of smoking in multi-house 
units and the ban on the use of nicotine delivery systems (e-cigarettes).104
It is essential that counselling and smoking cessation programs are offered to parents to 
address parental dependency and to reduce the impact of early life exposures pre-con-
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ception, to promote child health and prevent long-term sequelae.104, 109 Effective smoking 
cessation programmes targeting vulnerable groups, especially women, pregnant women 
and adolescents, particularly in LMICs are required to stem the smoking pandemic. A 
combination of motivational counselling, therapy and pharmacological therapy is usually 
required.  Interesting, but yet unproven interventions might be using pharmacotherapy 
(bupropion and varenicline) and nicotine replacement therapy during pregnancy to re-
duce intra-uterine acquired lung disease.110, 111
However, the safety of pharmacological treatments in pregnant women is not established 
and alternative strategies including an individualised plan may be necessary.112, 113 Fur-
ther research is required in these preventative strategies in pregnant mothers.  
In low middle income countries, environmental tobacco smoke and indoor air pollution 
are often found in the same households necessitating interventions which would benefit 
both exposures. Interventions that have been implemented to reduce household ETS 
or IAP include a combination of counselling, the installation of clean chimneys and im-
proved ventilation in the homes of smokers. A systematic review and meta-analysis of 
the effectiveness of interventions to reduce ETS in homes as assessed by reduction 
in nicotine and PM levels, found that although some benefits were documented, at fol-
low-up exposure was still present.114 ETS exposure, as measured by cotinine levels, 
was consistently higher in children who lived in multiunit or attached housing compared 
to children living in detached homes, even if there were no smokers within the home.115 
Regulations to enforce smoke-free multiunit housing is a feasible intervention, particu-
larly for new developments 114, 116  that should be considered in LMIC regions especially 
where government subsidised housing may be provided. However, in LMIC these inter-
ventions might not always be possible. 
A novel strategy may be vitamin C supplementation to pregnant smokers who are unable 
to terminate smoking. A randomised double-blind trial showed that supplemental vitamin 
C improved newborn pulmonary function and decreased wheezing in the first year of life 
in infants of mothers who smoked.117 While prevention or avoidance of smoking should 
be the optimal strategy in pregnancy and postnatally, this intervention needs to be further 
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studied in pregnant mothers who are unable to refrain from smoking in pregnancy.
Electronic nicotine delivery systems (e-cigarettes) were designed to deliver nicotine with-
out tobacco combustion and are used in smoking cessation; however, until recently were 
unregulated by the Food and Drug Administration (FDA).118,119  While e-cigarettes are 
marketed as a safer alternative to tobacco smoking, they contain nicotine and flavou-
rants and the long-term effects are unknown.  Nicotine is a highly active chemical that 
affects many bodily cells and  pathways  and has both activating and desensitising ef-
fects on receptors with a high risk of lethal poisoning when accidentally consumed orally 
by young children.120 The attractive flavouring and active marketing of e-cigarettes also 
makes them appealing to the youth. Reducing tobacco use through campaigns that de-
pict cigarette smoking as undesirable and harmful have been implemented, however, the 
promotion of e-cigarettes threatens this with the risk of increasing nicotine addiction.120 
A recent systematic review also found no strong evidence for e-cigarettes as a smoking 
cessation tool.121 Urgent legislation and regulation of e-cigarettes is required to prevent 
another form of nicotine addiction targeted at vulnerable groups. 122
4  Conclusion  
Children and adolescents remain the most vulnerable groups for both ETS exposure and 
initiation of cigarette smoking. Parental and family education to provide a smoke free en-
vironment is vital to address this challenge.123 Failure to do so will allow the considerable 
morbidly of exposure to tobacco smoke in children and adults to continue.
5  Expert Commentary
Childhood ETS exposure is an often under-recognised and reported problem particularly 
in LMIC where the burden of respiratory diseases is highest. ETS is associated with upper 
and lower respiratory disease including infections, wheezing and chronic lung disease. 
Exposure antenatally may represent a particularly important period that affects lung devel-
opment, with intergenerational effects. The increase in the incidence of women smokers 
in LMIC is of concern. Effective intervention strategies to combat the increasing exposure 
to ETS in LMIC are urgently needed, particularly for vulnerable populations such as ad-
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olescents and women of child-bearing age. However, tobacco control measures may be 
influenced by lobbyists and tobacco companies making regulation or legislation required to 
effectively implement nation-wide smoking cessation interventions difficult.
Pneumonia remains the leading cause of childhood mortality outside the neonatal peri-
od, in LMIC. ETS exposure is strongly associated with an increased risk for pneumonia 
and of severe disease.  Further antenatal ETS is associated with childhood wheezing 
illness, asthma, more severe asthma attacks and reduced lung function. With lung health 
trajectories set in this critical development period, interventions that target smoking ces-
sation need to be broadened to include reducing not just maternal smoking but also ETS 
exposure from household contacts as differentiating prenatal from postnatal exposures 
as risk factors is difficult. 
Interventions to reduce tobacco smoke pollution within homes have shown that individ-
ual-level programmes are not effective enough to reduce contamination. Environmental 
risk factors from both ETS and other indoor air pollution (IAP) exposure are potentially 
modifiable. However, addressing these requires both population-wide smoking cessation 
programmes, as well as interventions to improve ventilation and decrease IAP, which 
may be difficult in LMIC where poverty results in poor infrastructure and high levels 
of air pollution within homes. In addition to the well-known exacerbating effect of poor 
ventilation on primary and second-hand smoking, impaired ventilation is a key factor in 
third-hand smoke exposure. Third-hand smoke describes pollutants than remain after 
the initial smoking event and react with other compounds to create secondary pollutants. 
These pollutants, such as carcinogenic nitrosamines, increase the risk of respiratory and 
non-respiratory diseases.
Electronic cigarettes provide a new risk for potential respiratory complications. This in-
consistently regulated industry poses a hazard both from the often unknown constituents 
of the inhaled aerosol to the long-term complications associated with the use of such 
devices. The regulation of electronic cigarettes varies widely across different countries 
– from those having no specific regulation, to those who legislate it under pharmaceu-
tical products, through to countries in which e-cigarettes are banned.  While electronic 
59
cigarettes eliminate the by-products of tobacco combustion, the nicotine inhaled may 
still lead to significant problems. Currently the effects of nicotine on the developing lung 
have mainly been studied in animal models with deleterious effects. Although passive 
vapour is considered safer than passive tobacco smoke exposure, the specific effects 
and safety levels are still being investigated. Systematic reviews on e-cigarettes have 
identified that some of the studies have methodological problems and / or are written by 
authors with conflicts of interest. Therefore, the effects of nicotine exposure on human 
developing lungs is a research field that requires further exploration, as the potential 
harm from this may be substantial.  
The early-life origins of adult chronic respiratory diseases are also increasingly rec-
ognised, however the evidence from LMIC, particularly African countries is lacking. Lon-
gitudinal studies, including birth cohort studies from these regions23, 86 may provide fur-
ther insights. Collaboration between paediatric and adult health care providers can only 
enhance patient care by early identification and monitoring of at-risk individuals.  
Certain interventions, such as antenatal vitamin C supplementation, parental enforce-
ment of smoke-free environments, and nurse-led or telephonic support in smoking ces-
sation, have shown positive results in reducing respiratory disease in children. These 
relatively simple, cost-effective interventions should therefore be widely implemented, 
with ongoing monitoring to confirm effectiveness. 
The body of evidence confirming the association between environmental tobacco smoke 
exposure and childhood respiratory disease is substantial and unequivocal. Further re-
search has the potential to identify specific underlying factors that contribute to ETS and 
IAP, as well as individual risk factors in children. The overall goal would be to develop 
targeted, cost-effective measures which would result in a tangible impact on both child-
hood and chronic adult respiratory diseases.
6  Five-year view
Effective anti-tobacco campaigns have to some extent reduced smoking prevalence in 
high income countries leaving LMIC more vulnerable to the tobacco industry.  The con-
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sequent health effects needs further exploration particularly as LMIC tend to face a mul-
titude of environmental challenges.
The long-term effects of electronic cigarettes both from use and exposure will become 
more evident. This may contribute to better regulation of both the manufacture and dis-
tribution of these products, and will hopefully result in more consistent legislation and 
enforcement across countries.
With the move towards personalised medicine, epigenetic factors may play a role in 
identifying tailored interventions for specific groups. Furthermore, the Genetic Test to 
Stop Smoking (GeTSS) trial has been developed to assess if the presence of a gene as-
sociated with lung cancer may be a motivating factor in smoking cessation. In the future, 
genetic factors are likely to play a role both in modifying risk factors and developing novel 
treatment approaches to ETS-related respiratory disease.
Further research into these factors may enhance our understanding of the association 
between ETS exposure and childhood respiratory disease.
7  Key issues
• Global estimates of childhood environmental tobacco smoke (ETS) exposure are 
high (between 40-70%).
• Early life ETS exposure affects both lung development and subsequent respiratory 
disease, with the origins of certain adult chronic respiratory conditions beginning in 
childhood.
• Lifelong lung function trajectories are influenced by both prenatal and postnatal ETS 
exposures.
• Prevention of ETS exposure in childhood requires effective interventions to improve 
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5 Abstract
Background: Household indoor air pollution (IAP) is a global health problem and a risk 
factor for childhood respiratory disease; the leading cause of mortality in African children. 
This study aimed to describe the home environment and measure IAP in the Drakenstein 
Child Health Study (DCHS), an African birth cohort.
Methods: An antenatal home visit to assess the home environment and measure IAP 
(particulate matter, sulphur dioxide, nitrogen dioxide, carbon monoxide and volatile or-
ganic compounds (VOCs)) was done on pregnant women enrolled to the DCHS, in a 
low-socioeconomic, peri-urban South African community. Urine cotinine measured ma-
ternal tobacco smoking and exposure. Dwellings were categorised according to 6 house-
hold dimensions. Univariate and multivariate analysis explored associations between 
home environment, seasons and IAP levels measured. 
Results: 633 home visits were completed, with IAP measured in 90% of homes. Almost a 
third of participants were of the lowest socio-economic status and the majority of homes 
(65%) lacked 2 or more of the dwelling category dimensions. Most households had elec-
tricity (92%), however, fossil fuels were still used for cooking (19%) and heating (15%) 
in homes. Antenatal maternal smoking prevalence was 31%; 44% had passive smoke 
exposure. Of IAP measured, benzene (VOC) was significantly above ambient standards 
with median 5.6ug/m3 (IQR 2.6-17.1). There were significant associations between the 
use of fossil fuels for cooking and increased benzene [OR 3.4 (95% CI 2.1-5.4)], carbon 
monoxide [OR2.9 (95% CI 1.7 - 5.0)] and nitrogen dioxide [OR 18.6 (95% CI 3.9 - 88.9)] 
levels. A significant seasonal association was found with higher IAP levels in winter.  
Conclusion:  In this low-socioeconomic African community, multiple environmental fac-
tors and pollutants, with the potential to affect child health, were identified. Measurement 
of IAP in a resource-limited setting is feasible. Recognising and quantifying these risk 
factors is important in effecting public health policy changes. 
83
1 Introduction
Household indoor air pollution (IAP) is a leading cause of morbidity and mortality glob-
ally1 and a major risk factor for childhood respiratory disease and for severe disease.2-4 
Childhood respiratory disease, particularly pneumonia, remains the leading cause of 
under-5 mortality and morbidity in low- and middle-income countries (LMICs) including 
South Africa.5-7 
The risk of exposure to IAP is particularly prevalent in LMICs where alternate fuels re-
main the main source of fuel for cooking and heating. Alternate fuel sources include solid 
fuels such as coal, biomass fuel such as wood, dung and crop residues and non–solid 
fuels like paraffin, liquefied petroleum gas. Combustion of these products produces nu-
merous by-products which contribute to household IAP.8 The risk of developing child-
hood pneumonia is almost doubled following exposure to indoor biomass fuels, as is the 
long-term risk of developing chronic lung disease in adulthood.9, 10  
In South Africa, despite increased electrification of areas, up to 40% of the population still 
use alternate fuel sources for household activities.11, 12 In rural areas, up to 90% of house-
holds use biomass fuels as an energy source.11, 13 Home environmental factors such as 
crowding, type of cook stove, ventilation and duration of exposure are also important 
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contributors to exposure levels.1, 11 The contribution of IAP exposure to the incidence and 
severity of childhood respiratory disease has not been well studied in an African setting. 
Quantifying indoor air pollution is difficult and there are few studies that measure IAP in 
individual homes on a large scale in this context.1, 9, 11
The aim of this study was to describe the home environments and measure IAP in the 
Drakenstein Child Health Study (DCHS), an African birth cohort study.14 Further, we 
aimed to investigate the feasibility of intensive sampling in individual homes in a LMIC 
setting and to explore associations between home environmental factors and pollutant 
exposure.
2  Methods
The DCHS is located in the Drakenstein sub-district of the Western Cape, South Africa, 
a peri-urban area 60km outside Cape Town.14 A prospective study to assess the home 
environment and household IAP exposure in participants was done from March 2011 
until May 2014. 
Study population and participants. This low socio-economic community accessed health 
care mainly in the public sector. Pregnant women were recruited from two primary health 
care clinics: Mbekweni (serving a predominately black African population) and Newman 
(serving a predominately mixed race population). Consenting pregnant women were en-
rolled between 20-28 weeks’ gestation. Mothers completed study questionnaires and 
provided urine for analysis of urine cotinine as a measure of smoking and smoke expo-
sure. Urine cotinine was measured using the IMMULITER 1000 Nicotine Metabolite Kit 
(Siemens Medical Solutions DiagnosticsR, Glyn Rhonwy, United Kingdom). This provides 
a quantitative test using a competitive chemiluminescent immunoassay, which contained 
solid-phase beads coated with polyclonal rabbit anti-cotinine antibody.15 Urine cotinine 
levels were classified as <10 ng/ml (non-smoker), 10-499 ng/ml, (passive smoker), or 
≥500 ng/ml (active smoker).
Assessment of home environment and indoor air pollution (IAP) exposures. Self-report-
ed questionnaires were administered at enrolment by trained staff.  A self-reported as-
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sessment of socioeconomic status (SES) adapted from the South African Stress and 
Health Study (SASH) was done.16 A composite SES score was developed based on cur-
rent employment status and standardised scores of educational level, household income 
and a composite asset index made up of access to household resources, amenities and 
market access categorising participants as being lowest SES, low-moderate SES, mod-
erate-high SES or high SES.
Home visits for assessment of the home environment and measurement of IAP were done 
antenatally within 4 weeks of enrolment. Both primary health care clinics, Mbekweni and 
Newman, had a dedicated team of two environmental fieldworkers trained to undertake 
home visits, administer questionnaires and set up equipment for IAP measurement. Field 
worker training was completed under the supervision of an accredited environmental lab-
oratory (SGS Environmental Services®). Each participant received an information leaflet 
reviewing the reasons for the home visit and the measures being conducted. Data were 
gathered on type of home, its position and size, number of inhabitants, access to basic 
amenities, fuels used for cooking and heating, ventilation within homes and pesticides/
cleaning materials used based on validated questionnaires.17-21 An implementation of the 
Alkire-Foster method, a flexible technique used to incorporate a number of dimensions 
of poverty or well-being, that can complement poverty assessment 22, 23 was applied to 
the dwelling characteristics. Six dwelling factors were used; type of home (formal versus 
informal), primary building material (brick or cement versus other materials), water supply 
(piped into dwelling or yard), toilet facilities (non communal flush), kitchen type (separate 
room in house) and ventilation in the kitchen area (pipe or duct to exterior). Dwellings were 
then categorised according to the number of dimensions lacking. This method defines a 
dwelling as a “poor structure” if it lacks one-third or more of the factors considered.  Size of 
the kitchen and main living room were measured using an ultrasonic measuring tool. The 
position of the home in relation to the road and passing traffic was also estimated.
The most common IAP were measured (Table 1). All measurements were done in the 
communal/main living room, away from windows and doors, approximately 1.5 meters 
from the ground. Devices were left in the home for 24 hours to 2 weeks depending on the 
measurement (Table 1, Image 1).
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Measurements processing and interpretation: Following collection, samples were stored 
in a refrigerator (under 8oC) to maintain a cold chain and transferred weekly to an ac-
credited environmental laboratory for analysis. Samples were batched and analyses 
were conducted monthly.  An average concentration based on the 2-week duration in the 
home was obtained for sulphur dioxide/nitrogen dioxide and volatile organic compounds; 
24-hour averages were obtained for particulate matter. Carbon monoxide data were 
downloaded to a computer and the frequency of exceedance above the hourly ambient 
standard was calculated. Based on the 10 minute readings, total hourly concentrations 
were computed using the trapezium rule.  Two consecutive ten minute CO readings were 
used to represent parallel sides of a trapezium and the 10 minute interval to represent 
the distance between the parallel sides (width). The trapezium formula; half the sum of 
the parallel sides multiplied by the width, was then applied. The sum of six consecutive 
trapezia areas to represent total CO concentration in an hour was then calculated. Using 
this approach hourly concentrations were then determined for the entire duration of the 
CO device in the household. 
Ethics. The study was approved by the Faculty of Health Sciences Human Research 
Ethics Committee of the University of Cape Town and of Stellenbosch University, and by 
the Western Cape Provincial Health Research committee. Written informed consent was 
obtained from participants at the time of enrolment.
2.1 Statistical Analysis
All data were entered into a relational database (Microsoft AccessR) and analysed using 
STATA version 12. Mann-Whitney tests were used to compare medians as well as their 
spread. Simple and multiple logistic regression were used to examine the associations 
between IAP measures and home environment characteristics. For each IAP measure 
exposure categories were determined following South African National Ambient Air Qual-
ity Standards.24 The 2015 ambient air quality standard values were used with the follow-





3, benzene: 5ug/m3. For CO, a household 
should not have more than 88 hours in which the CO concentration was 30mg/m3 or 
above.24 For each household, the number of hours that had an hourly CO concentration 
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above the ambient hourly threshold was counted and expressed as proportion of the 
total duration of the device in the household. A household was deemed to be exposed 
to CO if the actual proportion of hours with CO level of 30mg/m3 and above exceeded 
1%. Home environment and other characteristics considered for the model were based 
on factors that may influence IAP levels and included socioeconomic status, smoking 
status, dwelling categorisation, access to electricity, fossil fuel usage, number of people 
per sleeping room and dwelling proximity to passing traffic. Univariate analysis was done 
for each of the IAP measures in relation to the sociodemographic and household char-
acteristics in order to obtain a “crude” odds ratio, All these variables were then applied 
to a multiple logistic regression model to obtain the adjusted odds ratio. The variables 
included were guided by previous literature.1, 8, 25  Univariate analysis was used for sea-
sonal associations with IAP. Regression diagnostics followed standard procedures.26 All 
P-values and confidence intervals reported were two-sided at alpha 0.05.
3 Results
In this study period 633 mothers were enrolled, with 633 antenatal home visits complet-
ed. There was good acceptability of the placement of devices, with all mothers agreeing 
to placement; particulate matter (PM10) results were analysed for 592 homes (94%), sul-
phur dioxide (SO2) for 600 homes (95%), nitrogen dioxide (NO2) for 598 homes (95%), 
carbon monoxide for 505 homes (80%) and volatile organic compounds for 579 homes 
(91%). Where results included are fewer than total home visits completed, this was due 
to missing results or damaged devices.
Demographics and Home Environment. The population were predominantly of low so-
cioeconomic status with more than half (52%) in the lowest or low-moderate SES cate-
gory. Mbekweni had a higher proportion of participants in the lowest SES bracket (37%) 
compared to Newman (19%), p <0.001. The median household size was 5 (IQR 3-6) 
people; homes in Newman had significantly more people median 5 (IQR 4-7) compared 
to Mbekweni median 4 (IQR 3-6), p<0.001. A median of 3 (IQR 2-4) people per sleeping 
room was found across both sites. (Table 2)
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Most homes (65%) lacked 2 or more of the dwelling categorisation dimensions with 7% 
of homes lacking all 6 dimensions. This was significantly higher in Mbekweni dwellings 
(11%) compared to Newman (3%) homes, p<0.001. Most households (92%) had elec-
tricity, with significantly more in Newman (97%) compared to Mbekweni (88%), p <0.001. 
Conversely, more Mbekweni homes (28%) used fossil fuels for cooking or heating com-
pared to Newman homes in which 10% and 2% reported using fossil fuels for cooking 
and heating respectively. (Table 2) The majority of Mbekweni homes were estimated to 
be situated less that 50m away from continuously passing trucks. (Table 2) 
Thirty-one percent of mothers were active smokers, with significantly more smokers 
at Newman (52%) than Mbekweni (11%). A further 44% of participants were passive 
smokers and this was higher in the Mbekweni participants (51%) compared to Newman 
(37%). (Table 2)
Indoor Air Pollution. The IAP measures were not normally distributed and hence the 
median and inter-quartile ranges were reported. The median concentration of particulate 
matter (PM10) measured in the homes was 33.1 (IQR 13-62.2) ug/m
3, below the ambient 
standard of 40 ug/m3 with no significant difference between sites. Although the median for 
carbon monoxide (CO) based on the hourly average for the 24 hour period in the home 
was 0 ug/m3 (IQR 0 – 24.4 ug/m3 ), when measuring against ambient standards, 15% of 
homes had hourly CO values exceeding these. The distribution of nitrogen dioxide con-
centrations differed significantly between Mbekweni 8.6 ug/m3  (IQR 3.8 -15.3 ug/m3) and 
Newman 7.3 ug/m3 (IQR 3.6 – 11.4 ug/m3), p=0.004, however these were substantially 
below acceptable ambient standards (40ug/m3). Of the volatile organic compounds, the 
median benzene concentration was 5.6 ug/m3 (IQR 2.6-17.1 ug/m3) with a significant 
difference in the distribution of the concentrations between the sites: Mbekweni 6.0ug/
m3  (IQR 2.9 – 27 ug/m3) versus Newman 5.6ug/m3 (IQR 2.3 – 11.3 ug/m3), p=0.010, both 
were above the acceptable ambient standard of 5ug/m3 (Table 3).
Benzene: In the unadjusted model, the use of fossil fuels for cooking [OR 3.4 (95% CI 
2.1-5.4)] as well as the use of fossil fuels for heating [OR 3.2 (95% CI 1.9-5.5)] were 
significantly associated with an increased level of benzene.  Conversely, the presence of 
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electricity in the home was significantly associated with a decrease in levels of benzene 
[OR 0.2 (95% CI 0.1-0.4)]. (Table 4)
Carbon Monoxide: The unadjusted model also showed significant increase in carbon 
monoxide levels associated with fossil fuel cooking [OR 2.9 (95% CI 1.7 - 5.0)] and 
heating [OR 4.0 (95%CI 2.3 - 7.1)] and an associated decrease in these levels when 
electricity was present [OR 0.2 (0.1 - 0.4)]. (Table 4)
Particulate matter: Compared to households that had 2 people or less per sleeping room, 
households with 3 or more people per sleeping room were more likely to have increased 
particulate matter (PM10) levels [OR 2.12 (95% CI 1.22 - 3.69)].(Table 4)
Nitrogen dioxide: Having 2 or less of the dwelling category dimensions was significantly 
associated with increased nitrogen dioxide levels [OR 4.5 (95% CI 1.2 - 17.6)] in the un-
adjusted model.  There was also a significant association between the use of fossil fuels 
for cooking [OR 18.6 (95% CI 3.9 - 88.9) and heating [OR14.2 (95% CI 3.6 - 56.0)] and 
increased nitrogen dioxide levels. (Table 4)
Multivariate analysis: In the adjusted model, the presence of electricity in homes was 
significantly associated with a decrease in benzene [OR 0.2 (95% CI 0.1-0.6)] and CO 
levels [OR 0.3 (95% CI 0.1-0.7)].  The use of fossil fuels for heating was significantly 
associated with an increase in benzene [OR 2.0 (95% CI 1.0-4.0)] and CO levels [OR 
2.3 (95% CI 1.0-5.4)].  Only the use of fossil fuels for cooking maintained a significant 
association with increased levels of nitrogen dioxide [OR 8.6 (95% CI 1.1-67.4)] in the 
adjusted model. There was no significant association between household characteristics 
and PM10 levels when adjusted. (Table 4)
A significant seasonal association with benzene and carbon monoxide levels measured 
was found, with benzene [OR 35.9 (95%CI 10.3 - 125.5)] and carbon monoxide [OR 
2.7(95% CI 1.2 - 6.2)] levels significantly higher in winter.  There were an approximately 
equal number of home visits done in autumn, winter and spring, with fewer in the sum-
mer months. (Table 5)
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4 Discussion
In this study in a poor peri-urban, South African area, we identified a number of environ-
mental factors which may influence child health. Many  homes were lacking in dimen-
sions and basic amenities. Despite having access to electricity, fossil fuels were used as 
an alternate energy source in up to 20% of homes. There was a seasonal variation in IAP 
levels measured with higher levels associated with the winter months. The prevalance 
of maternal smoking was very high as was exposure to tobacco smoke in non-smoking 
mothers. 
Measuring IAP is difficult and most studies rely on reported exposure or extrapolation fol-
lowing sampling of selected homes1, 13 with few studies from LMICs and Africa in particu-
lar.27 However, we successfully measured IAP and by-products of combustion in the vast 
majority of homes (over 600) providing important data on household IAP in a peri-urban, 
LMIC setting. Suprisingly there was relatively little exposure to IAP with only benzene, 
a volatile organic compound, having a median concentration above acceptable ambient 
standards.24 However, ambient standards serve as a guide to acceptable levels of pollut-
ants with levels continually being lowered. It is therefore difficult to ascertain a clear level 
at which health effects are associated.1, 2, 28 The long term effects of exposure to IAP and 
association with childhood respiratory disease will be longitudinally studied in the DCHS.
In categorising dwellings, we found almost two-thirds of participants lived in homes that 
were of an inadequate structure.  Despite such poor housing and living conditions, IAP 
measurements were made in most homes, including measures that required devices to 
be left in situ for 2 weeks. The type of dwelling and home environment may impact on 
sources of pollutants and levels measured within the home. Factors such as a non-sep-
arate kitchen, with poor ventilation, the informal construct of the dwelling and crowding 
may also contribute to a higher exposure level to pollutants; as evidence of this higher 
exposure to PM was associated with more household members per sleeping toom.1, 29
Despite having access to electricity, fossil fuels were used for cooking or heating in 
almost a third of homes of black African mothers. The relatively high cost of electricity 
in South Africa30 and that it is purchased on a pre-paid basis may influence supply and 
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use. The predominant fossil fuels used included paraffin, wood, gas and coal, while oth-
er biomass fuels such as animal manure or crop residues were not commonly used.31 
Fossil fuel usage was significantly associated with measured benzene, carbon monox-
ide and nitrogen dioxide levels, contributing to household IAP.  The higher use of fossil 
fuels amongst black African households compared to mixed race populations may be 
explained by the relatively lower socio-economic status of the former.
Although we did not show any significant associations between tobacco smoke and 
measured IAP levels, environmental tobacco smoke remains an important contributor to 
IAP and a recognised source of benzene. The very high levels of maternal smoking and 
smoke exposure are of much concern, with potential fo several adverse health effects in 
mothers and children.32 Other sources of benzene include paraffin and outdoor traffic,28 
both potentially contributing to the significantly higher levels measured in the Mbekweni 
community.
A limitation of this study was the duration of sampling which ranged between 24 hours to 
2 weeks depending on the measure and the device used. Devices were also placed in 
one room and this might not fully account for IAP occurring in other areas of the home. 
The devices used to measure IAP (except for carbon monoxide) all gave an average 
concentration and therefore periods of peak exposure may have be underestimated. 
The sub-optimal housing, tobacco smoking and exposure, reliance on fossil fuels for 
energy and the associated pollutants as a result of their use are all important public 
health issues that need to be addressed on a policy level. IAP is often overlooked as a 
significant risk factor for a number of health problems1; recognising and quantifying these 
environmental risks are instrumental to effect change. 
To our knowledge, this is the first African study to comprehensively measure several pos-
sible pollutants and environmental exposures during pregnancy. This study has shown 
that measurement of IAP in a resource limited setting is feasible; combining this with a 
dwelling catergorisation may provide a novel measure for a household-exposure index. 
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Table 1 Measurements of IAP 
Pollutant/
Measure









24 hours Gravimetrically pre-weighed 
filter. 




Altair®  Carbon 
Monoxide single 
gas detection unit
24 hours Electrochemical sensor 
detection of gas at 10 min 









2 weeks Chemiadsorbed on to 
filter. Quantified by visible 












2 weeks Analysed for BTEX using the 
NIOSH 2549 method.(33) 
Image 1: Devices used to measure IAP
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Number of mothers 314 319 633  
SES quartiles     
   Lowest SES 115 (37) 62 (19) 177 (28)
*p<0.001
   Low-mod SES 82 (26) 73 (23) 155 (24)
   Mod-high SES 71 (23) 87 (27) 158 (25)
   High SES 46 (15) 97 (30) 143 (23)
Household Density (median, IQR)     
   Household size 4 (3-6) 5 (4-7) 5 (3-6) *p<0.001
   Persons per room 2 (1-3) 1 (1-2) 2 (1-3) *p<0.001
   Persons per sleeping room 3 (2-4) 3 (2-5) 3 (2-4) *p<0.001
Dwelling Category (Six Category variant)     
   Lacking 6 dimensions† 35  (11) 8  (3) 43  (7)
*p<0.001
   Lacking 5 dimensions† 34  (11) 43  (13) 77  (12)
   Lacking 4 dimensions† 63  (20) 34  (11) 97  (15)
   Lacking 3 dimensions† 8  (3) 20  (6) 28  (4)
   Lacking 2 dimensions† 102  (32) 68  (21) 170  (27)
   Lacking 1 dimensions† 55  (18) 146  (46) 201  (32)
   Lacking 0 dimensions† 17  (5) 0  (0) 17  (3)
Dwelling Category  
(Two Category variant)     
   Has ≤2 dimensions† 132 (42) 85 (27) 217 (34)
*p<0.001
   Has > 2 dimensions† 182 (58) 234 (73) 416 (66)
Electricity Access 277 (88) 308 (97) 585 (92) *p<0.001
Fossil Fuel (coal, wood, paraffin, gas) 
Used     
   Cooking 88 (28) 32 (10) 120 (19) *p<0.001
   Heating 87 (28) 7 (2) 94 (15) *p<0.001
Type of Stove     
   Electric 265 (84) 286 (90) 551 (87) p=0.049
   Paraffin 79 (25) 3 (1) 82 (13) *p<0.001
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   Gas 13 (4) 28 (9) 41 (6) *p=0.018
   Wood 2 (1) 1 (0) 3 (0) p=0.554
   Coal 2 (1) 0 (0) 2 (0) p=0.153
Smoking Exposure     
   Non smoker 107 (38) 30 (11) 137 (25)
*p<0.001   Passive Smoker 143 (51) 102 (37) 245 (44)
   Active Smoker 31 (11) 143 (52) 174 (31)
Distance of homes from continuously 
passing trucks     
   Less than 50 meters 200 (64) 24 (8) 224 (36)
*p<0.001
   50 - 100meters 67 (21) 27 (8) 94 (15)
   100 - 200 meters 42 (13) 34 (11) 76 (12)
   200 - 500 meters 3 (1) 92 (29) 95 (15)
   More than 500 meters 0 (0) 141 (44) 141 (22)
*Statistically significant results
†Dimensions comprise: type of home; building material; water supply; toilet facilities; kitchen type; ventilation 
in kitchen areas
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Table 3 Pollutants Measured
 Mbekweni 
m e d i a n 
(IQR)
Newman 
m e d i a n 
(IQR)
Total 


































Volatile Organic Compounds 







































Total n (%) N p value
Carbon Monoxide exceeding ambient standard
 Above Expected Frequency 37 (14) 40 (17) 77 (15) 505 p=0.399
* Statistically significant results




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Crude OR (95%CI) Crude OR (95%CI) Crude OR (95%CI)
Season
  Summer (n=103,16%) Reference Reference Reference
  Autumn (n=189,30%) 23.1 (6.6 - 80.9) 0.8 (0.3 - 2.0) 0.7 (0.4 - 1.5)
  Winter (n=172,27%) 35.9 (10.3 - 125.5) 2.6 (1.1 - 6.0) 1.3(0.7 - 2.4)
  Spring (n=169 27%) 8.3 (2.4 - 28.4) 2.7(1.2 - 6.2) 1 (0.5 – 2.0)
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Abstract
Background: Tobacco smoke exposure has not been well studied in African infants, 
despite the high burden of childhood respiratory disease in these communities.
Objective: To investigate the prevalence of antenatal and early life tobacco smoke ex-
posure and associations with infant birth outcomes in an African birth cohort, the Draken-
stein Child Health Study.
Methods: Self-report questionnaires assessing maternal and household smoking were 
administered. Maternal and infant urine cotinine testing was conducted antenatally, at 
birth and at 6-10 weeks of life to measure tobacco smoke exposure. Multivariate re-
gression models explored the associations between smoke exposure and infant birth 
outcomes.
Results: Of 789 pregnant women included, 250 (32%) were active smokers on cotinine 
testing. At birth and at 6-10 weeks of life, respectively, 135/241 (56%) and 154/291 (53%) 
infants had urine cotinine levels indicating tobacco smoke exposure. Household smoking 
was prevalent and was associated with positive infant cotinine tests. Antenatal maternal 
smoking was associated with decreased infant birthweight-for-age z-score (0.3 (95% CI: 
0.1 – 0.5). 
Conclusion: Antenatal and early life tobacco smoke exposure is highly prevalent in this 
community, and may impact on birth outcomes and subsequent child health.  Smoking 
cessation interventions are urgently needed to reduce tobacco smoke exposure in Afri-
can communities.  
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1 Introduction
Tobacco smoke exposure is an important risk factor for childhood respiratory disease 
1-3 and childhood morbidity and mortality worldwide.4, 5 Prenatal exposure is associated 
with an increased risk of pneumonia and of wheezing disorders 6-8 and may also lead 
to preterm delivery and decreased birthweight, predisposing infants to severe respira-
tory disease.9, 10 Similarly, other maternal socioeconomic and psychosocial risk factors, 
including depression and intimate partner violence (IPV), may impact on infant birth out-
comes. 11-13 
Tobacco smoke exposure often begins in utero with maternal active or passive smoking, 
and may continue postnatally. Both prenatal and postnatal exposure adversely affect 
infant health. Nicotine exposure may be directly toxic to the airways or may result in sec-
ondary impairment of lung growth due to decreased fetal breathing or cellular damage.14 
Further, adult smokers have a higher risk of respiratory infections with increased risk of 
pathogen transmission to child contacts.15
Cotinine, a biomarker of tobacco smoking and exposure, has been used to both confirm 
and quantify smoking and exposure in pregnant women.9, 16, 17 Infant exposure during 
the first year of life has been assessed using blood, urine or hair cotinine measures.16, 
18-20  However, no studies have used infant cotinine measurements at birth to assess in 
utero tobacco smoke exposure and few studies have used  infant measures to evaluate 
early life exposure. 16, 18 Documenting exposure is especially relevant in low-and-middle 
income country (LMIC) settings, which carry the highest burden of childhood respiratory 
illnesses. We thus measured antenatal and early postnatal tobacco smoke exposure; 
and investigated the association between antenatal exposure and infant birth outcomes 
in an African birth cohort study.   
2 Methods
A prospective study of smoke exposure was undertaken in pregnant women and infants 
enrolled in the Drakenstein Child Health Study.21 The study is located 60km outside Cape 
Town, South Africa in a semi-rural area with a low socioeconomic population.21 More than 
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90% of the population obtain health care in the public sector with a strong primary health 
care system.  
Study population, participants and procedure. Pregnant women were consecutively 
enrolled using convenience sampling, between 20 and 28 weeks’ gestation from one of 
two primary health care clinics serving different populations – Newman (predominantly 
mixed race) and Mbekweni (predominantly black African). A second antenatal study visit 
was completed at 28-32 weeks’ gestation. All births occurred at a single central public 
hospital, Paarl Hospital. Thereafter, mother-infant dyads attended follow-up visits includ-
ing at 6-10 weeks’ postpartum. 21
Self-reported measures. Sociodemographic data were collected at enrolment using a 
questionnaire adapted from the South African Stress and Health Study.22 A composite 
socioeconomic status (SES) score was developed as an internal comparison of SES for 
this sample, and participants were categorised as lowest, low-moderate, moderate-high 
or highest SES.13.
Maternal tobacco smoking and exposure were assessed using self-report questionnaires 
at enrolment. Maternal smoking was quantified as pack years, where one pack year was 
defined as 20 cigarettes smoked daily for one year. Maternal nicotine dependence was 
assessed using the Fagerström test, a well-validated questionnaire which scores tobac-
co dependence as low, low-moderate, moderate or high.23 
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was admin-
istered to assess substance use and substance-related risk.24 Participants were catego-
rized as being at low, moderate, or high risk of tobacco-related health problems, and any 
self-reported antenatal alcohol use was documented. 24 Women who reported antenatal 
substance use were counselled regarding cessation.
Comprehensive psychosocial data were collected antenatally, including an assessment 
for depression using the Beck Depression Inventory (BDI-II) and a questionnaire for any 
past-year IPV. 11, 13 
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Birth outcomes. All births were attended by a member of the study team. Birth out-
comes included birthweight, gestational age and presence of respiratory or other dis-
ease.  Gestational age at delivery (in completed weeks) was calculated from an antena-
tal ultrasound. If this was not available then fundal height at enrolment or maternal recall 
of last menstrual period was used. 
Urine cotinine testing. Maternal and infant urine cotinine tests were performed using 
the IMMULITER 1000 Nicotine Metabolite Kit (Siemens Medical Solutions DiagnosticsR, 
Glyn Rhonwy, United Kingdom) 25 This provided a quantitative test using a competitive 
chemiluminescent immunoassay, which contained solid-phase beads coated with poly-
clonal rabbit anti-cotinine antibody. The test had a calibration range of 10-500 ng/ml, with 
an analytical sensitivity of 2 ng/ml.25 Urine cotinine levels were classified as <10 ng/ml 
(non-smoker), 10-499 ng/ml, (passive smoker/exposed), or ≥500 ng/ml (active smoker) 
according to the manufacturer’s directions.
Maternal urine was collected at the second antenatal study visit and at birth, with the 
higher result used to classify smoking levels. Infant urine was collected at birth and at 
6-10 weeks, either via a urine bag or by placing a cotton-wool ball in the diaper from 
which urine could then be squeezed. Urine samples were transferred to a clean, pre-
servative-free, plastic container and transported at temperatures between 2-8 0 C to the 
accredited medical laboratory for testing.
Ethics. The study was approved by the Faculty of Health Sciences Human Research 
Ethics Committees of the University of Cape Town and of Stellenbosch University, and 
by the Western Cape Provincial Health Research committee. Written informed consent 
was obtained from mothers at enrolment.  
Statistical analysis. Tobacco smoking and exposure were compared across recruit-
ment site using x2 or Fisher exact tests for categorical variables and Wilcoxon rank sum 
tests (Mann-Whitney tests) for non-normally distributed continuous variables. The sen-
sitivity and specificity of self-reported maternal smoking was calculated, using maternal 
urine cotinine as the “gold standard” measure. The associations between household and 
maternal smoking (self-reported and based on urine cotinine) and infant urine cotinine 
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were assessed using x2 tests, with cotinine levels of ≥10 used to categorize infants as 
exposed to tobacco smoke. Risk ratios (RR) with 95% confidence intervals (CI) were 
calculated to determine the strength of these associations. Infant weight-for-age (WfA) 
z-scores were calculated using the revised Fenton preterm growth charts and infants 
with a WfA z-score <10th percentile were classified as small for gestational age (SGA). 
26, 27 The associations between each of maternal and infant cotinine levels, potential 
confounders, and infant birth outcomes were explored in regression models. Data were 
analyzed using Stata 12 (StataCorp Inc, College Station, Texas, USA). 
3 Results
Data from 789 mothers, enrolled between March 2012 and October 2014, were included; 
792 infants (including 3 sets of twins) were born, and data from 720 mother-infant dyads 
at 6-10 weeks’ postpartum were included.
The median age of mothers at enrolment was 25.7 (IQR 21.8 – 30.8) years. A high 
prevalence of unemployment (74%) was observed, and most participants had not com-
pleted secondary education. Although this is a low socioeconomic population overall, the 
mixed race community (Newman) were of comparatively higher SES than the black Afri-
can community (Mbekweni). Twenty-one percent of mothers screened above threshold 
for antenatal depression and almost one-third reported having experienced recent IPV. 
Self-reported antenatal alcohol use was significantly higher amongst mixed race (28%) 
compared to black African (8%) participants. (Table 1). 
Maternal Smoking. Overall, 24% of mothers reported smoking antenatally. Most (94%) 
reported smoking daily with a median of 1.2 pack-years (IQR 0.4 -2.5). Nicotine depen-
dence was classified as low or low-moderate in 77% of smokers. However, there was a 
moderate to high risk of tobacco-related problems in 97% of smoking mothers (Table 2).
Using urine cotinine, 250 (32%) mothers were classified as active smokers and 366 
(46%) as having passive smoke exposure. The prevalence of both self-reported smoking 
and active smoking based on urine cotinine was higher among mixed race compared to 
black African mothers. (Table 2). The sensitivity of self-reported smoking compared to 
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urine cotinine was much lower for black African (26%) compared to mixed race (85%) 
participants. However, specificity was high in both groups. 
Infant birth outcomes. Only 2 (0.2%) stillbirths occurred. The median gestational age 
at delivery was 39 (IQR 38 – 40) weeks overall, with 16% (mostly late) preterm births. 
Median birthweight was significantly higher in black African [3130 (IQR 2800 – 3440) 
grams] compared to mixed race infants [2980 (IQR 2590-3350) grams]. The median WfA 
z-score at birth was -0.6 (IQR -1.3 – 0.1) overall, and was substantially lower in mixed 
race infants. Low birth weight (LBW; <2500g) was observed in 15% of infants, and more 
than one-quarter were SGA. Only 45 (6%) infants had documented respiratory distress 
at birth (Table 1). Most (83%) mother-infant pairs were discharged from hospital within 
48 hours of delivery.
Infant smoke exposure. Household smokers (including mothers) were reported in al-
most two-thirds of homes. The prevalence of household smoking was significantly higher 
in mixed race families where one or more household members reportedly smoked in 
83% of homes (Table 2). Excluding maternal smokers, the reported number of other 
family and household smokers was high at both sites, with 142 (38%) black African and 
264 (77%) mixed race participants reporting other smokers.
Urine cotinine measures were obtained in 241 infants at birth and 291 infants at 6-10 
weeks. At birth, 56% of infants had urine cotinine indicating exposure with 18% having 
levels comparable with active smoking, significantly higher in mixed race (33%) com-
pared to black African (4%) infants (Table 2). The prevalence of passive smoke exposure 
was similar across site. 
At 6-10 weeks, half (50%) of infants had cotinine levels indicative of passive smoke expo-
sure, with a much higher prevalence in mixed race (69%) compared to black African (28%) 
infants. There were few infants (3%) with levels indicative of active smoking (Table 2).
Higher infant urine cotinine levels at birth were associated with maternal smoking (both 
self-reported and based on cotinine measurements); infants born to mothers classified 
as active smokers had an almost 15-fold increased risk of testing positive for smoke 
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exposure. At 6-10 weeks, infant urine cotinine levels were associated with increasing 
number of household smokers, with infants exposed to 3 or more household smokers 
having a 4-fold increased risk of testing positive for smoke exposure (Table 3). 
Tobacco smoke exposure and birth outcomes. Associations were observed between 
maternal urine cotinine and a number of adverse birth outcomes in crude analysis. Ma-
ternal smoking was significantly associated with a reduction in infant WfA z-score, and 
with an increased risk of LBW and SGA. (Table 4). 
Although associations between maternal urine cotinine and LBW and SGA were no lon-
ger significant in adjusted analyses, active smoking remained significantly associated with 
decreased WfA. Infants born to mothers who were active smokers during pregnancy had, 
on average, a 0.3 [0.1 - 0.5] z-score decrease in WfA at birth compared to infants born to 
non-smoking mothers, independent of recruitment site, maternal age, SES, and antenatal 
alcohol use. In addition, antenatal alcohol use remained an independent predictor of de-
creased WfA, and was associated with a 0.3 [0.1 – 0.4] z-score decrease in WfA. (Table 5).
Similar results were observed when comparing birth outcomes across categories of in-
fant urine cotinine measured at birth. No associations were observed between infant co-
tinine and any of gestational age at delivery, pre-term birth, LBW, or respiratory distress 
at birth. In crude analysis, however, infant cotinine was significantly associated with both 
a reduction in WfA z-score and an increased likelihood of SGA. Notably, the association 
between infant cotinine and decreased WfA persisted in adjusted analyses. Infants in the 
active smoker category had, on average, a 0.6 [0.2 - 1.1] z-score decrease in WfA at birth 
compared to infants in the non-smoker category, independent of recruitment site, SES, 
maternal age, and maternal antenatal alcohol use (results not shown). 
4  Discussion 
This study has shown an alarmingly high prevalence of objectively assessed antenatal 
and early-life tobacco smoke exposure in infants in this low socioeconomic population. 
Almost two-thirds of infants had evidence of smoke exposure at birth, while more than 
50% were exposed at 6-10 weeks of age. Further the degree of smoke exposure is 
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concerning, with 18% of infants having birth urine cotinine values in the ‘active smoker’ 
range. This prevalence of smoke exposure is much higher than those previously report-
ed globally.2 Notably, smoke exposure was associated with lower birth weight, a risk 
factor for respiratory disease and other long-term health effects. 9, 10, 28
Mothers were a major source of smoke exposure, especially in the mixed race popula-
tion, with 46% of mixed race women reporting antenatal smoking. This is as much as 
10 times the global estimate for pregnant women in LMICs particularly in Africa. 2, 29, 30 
Further, the psychosocial stressors affecting participants were considerable with a high 
prevalence of antenatal depression and recent IPV.
The high prevalence of self-reported smoking was confirmed with maternal urine cotinine 
testing, with surprisingly high sensitivity of self-report, especially in the mixed race com-
munity (85%).  The lower sensitivity and lower prevalence of smoking in the black African 
population may reflect cultural differences in acceptability of cigarette smoking, perhaps 
contributing to under-reporting. 31 
Although nicotine dependence was low or low-moderate in most mothers, this may be 
explained by patterns of cigarette use in these impoverished communities, where cost 
often results in fewer cigarettes smoked. In contrast, scores on the ASSIST indicated 
that the majority were at moderate to high risk of tobacco-related health problems and 
could benefit from tobacco cessation programmes. While the most effective smoking 
cessation programmes rely on a combination of counselling and medication interven-
tions, given the potentially low rates of physical dependency (based on Fagerström test 
findings), brief behavioural interventions (that include building readiness and motivation 
to change) may be useful for facilitating reductions in tobacco-related health problems; 
however, medication-assisted therapy may be necessary in those showing higher rates 
of dependency.32, 33
Household smokers were another major source of on-going smoke exposure, with 
household smoking again more prevalent in the mixed race (84%) compared to black Af-
rican community (43%). Increasing number of household smokers was associated with 
positive urine cotinine measurements in infants, confirming more exposure. 
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Such intense, early smoke exposure may have profound effects on child health. In this 
study, smoke exposure was associated with decreased birthweight, a well-described 
association in both middle and high income countries. 9, 10, 34 Notably, this association 
persisted even when adjusted for potential confounders. Smoke-exposed children have 
a higher risk of developing pneumonia, wheezing disorders and chronic respiratory dis-
eases.6, 7, 15, 35 The cumulative and long-term effects of early and ongoing exposure on 
child health are currently being longitudinally studied in this cohort. 
Several limitations of these findings must be noted, including the fairly small sample size. 
In addition, although maternal urine cotinine was obtained in all mothers, urine collection 
was somewhat less successful in infants. As the half-life of cotinine is 17 hours, the prev-
alence of active smoking or smoke exposure may have been under-estimated if a urine 
sample was obtained after this time period. These data therefore provide a minimum 
estimate of smoking and exposure. This analysis was limited to tobacco smoke exposure 
in the antenatal and early postnatal period; further study of ongoing smoke exposure is 
underway. 
To our knowledge, this is the first study to quantify such exposure at birth, using a com-
bination of maternal and infant measures as well as subjective and objective assess-
ments and highlights the urgent need to develop and implement effective interventions 
for smoking cessation in pregnant women.15, 32, 33 In addition, public health interventions 
and educational initiatives that highlight the risk of household tobacco smoking to adult 
and child health are urgently needed among vulnerable groups in poor communities. 
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– n (%) P-value
Maternal baseline demographic characteristics
Number of mothers 412 (52) 377 (48) 789 (100)










   Black








Married/cohabiting 145 (35) 159 (42) 304 (39) 0.044
HIV-infected 154 (37) 11 (3) 165 (21) <0.001
Educational attainment
   Primary
   Some secondary
   Completed secondary














Unemployed 321 (78) 262 (70) 583 (74) 0.007
Average household income
   <R1000/month
   R1000-R5000/month












   Lowest SES
   Low-moderate SES
   Moderate-high SES















   Informal housing








Median number of household 
members (IQR)
4 (3 - 6) 5 (4 - 7) 4 (3 - 6) <0.001
Antenatal depression – 
above threshold
87 (21) 76 (20) 163 (21) 0.740
Recent intimate partner 
violence – above threshold 107 (26) 148 (39) 255 (32) <0.001
Any self-reported antenatal 
alcohol use








– n (%) P-value
Infant birth outcomes
Number of infants; sets of 
twins
415 (52); 3 377 (48); 0 792 (100); 3
Sex – Female 205 (49) 165 (44) 370 (47) 0.113
Median gestation at delivery 
[IQR]
39 [38, 40] 39 [37, 40] 39 [38, 40] 0.271
Pre-term birth  
(<37 weeks gestation)
65 (16) 58 (15) 123 (16) 0.914









Median WfA z-score [IQR] -0.4 [-1.2, 0.2] -0.7 [-1.4, -0.1] -0.6 [-1.3, 0.1] <0.001
Low birthweight  
(LBW; <2500 grams)
48 (12) 74 (20) 122 (15) 0.002
Small for gestational age 96(23) 110(29) 206(26) 0.053
Respiratory distress at birth 23 (6) 20 (5) 43 (5) 0.883
Table 2 Antenatal and early postpartum tobacco smoke exposure
Mbekweni 
– n (%)
TC Newman – 
n (%)
Total
 – n (%)
P-value
Maternal antenatal tobacco 
smoking, n (%)
412 (52) 377 (48) 789 (100)
Self-reported current 
smoking 
17 (4) 174 (46) 191 (24) <0.001
Frequency of smoking 
(n=191)
      Daily










      10 or less
      11-20
      21-30














Years smoked – median 
[IQR; n=191]




TC Newman – 
n (%)
Total
 – n (%)
P-value
Pack-years smoked – 
median [IQR; n=191]
0.1 [0.1, 0.3] 1.4 [0.5, 2.7] 1.2 [0.4, 2.5] <0.001
Nicotine dependence 
(Fagerström Test; n=191)
      Low
      Low-moderate
      Moderate














Risk of tobacco-related 
problems (ASSIST; n=183)
      Lower risk
      Moderate risk












   <10 ng/ml (Non-smoker)
    10-499 ng/ml (Passive/
exposed)











Early postpartum tobacco 
smoke exposure
Number of family/household 
smokers (n=720)
   0
   1
   2














Infant urine cotinine 
Urine cotinine at birth 
(n=241)
   <10 ng/ml
   10-499 ng/ml











Urine cotinine at 6-10 weeks 
(n=291)
   <10 ng/ml
   10-499 ng/ml











1 Antenatal and birth combined, i.e. “Active smoker” if cotinine ≥500 ng/ml for either timepoint
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Associations with infant urine cotinine at birth (n=241)
Self-reported maternal an-tenatal 
smoking
   Non-smoker






2.3 [1.9, 2.7] <0.001
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)












Associations with infant urine cotinine at 6-10 weeks (n=291) 
Number of family/household smokers
   0
   1
   2
















1 Antenatal and birth combined, i.e. “Active smoker” if cotinine ≥500 ng/ml for either timepoint
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Table 4  Unadjusted associations between tobacco smoke exposure and infant birth out-
comes
(A) Association with gestation at delivery
Variable Gestation at delivery – median (IQR) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)
   Active smoker (≥500 ng/ml)
39 (38 – 40)
39 (38 – 40)
39 (37 – 40)
0.135
(B) Association with pre-term birth
Variable Full term – n (%) Pre-term – n (%) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)








(C) Association with infant WfA z-score
Variable Infant WfA z-score – median (IQR) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)
   Active smoker (≥500 ng/ml)
-0.4 (-1.2 – 0.3)
-0.5 (-1.1 – 0.2)
-0.9 (-1.5 – -0.2)
<0.001
(D) Association with infant LBW (<2500g)
Variable ≥2500g – n (%) <2500g – n (%) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)








(E) Association with infant SGA at birth
Variable AGA/LGA – n (%) SGA – n (%) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)








(F) Association with infant respiratory distress at birth
Variable No distress – n (%)
Respiratory 
distress – n (%) P-value
Maternal antenatal urine cotinine1
   Non-smoker (<10 ng/ml)
   Passive/exposed (10-499 ng/ml)
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Chapter 5
Indoor air pollution and tobacco smoke  
exposure: impact on nasopharyngeal  
bacterial carriage in mothers and infants in 
an african birth cohort study.
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Take home message:
Indoor air pollution and tobacco smoke exposure impacts on nasopharyngeal bacterial 
carriage in mothers and infants.
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Abstract 
Background: Indoor air pollution (IAP) or environmental tobacco smoke (ETS) expo-
sure may influence nasopharyngeal (NP) carriage of bacterial species and development 
of lower respiratory tract infection (LRTI). Antenatal or postnatal IAP/ETS exposure on 
NP bacteria in mothers and infants was longitudinally investigated.
Methods: A South African cohort study followed mother-infant pairs from birth through 
the first year. NP swabs were taken at birth, 6 and 12 months for bacterial culture. Multi-
variable and multivariate logistic regression investigated associations between NP bac-
terial species and IAP/ETS. IAP exposures (particulate matter; carbon monoxide; nitro-
gen dioxide; volatile organic compounds) were measured at home visits. ETS exposure 
was measured through maternal and infant urine cotinine. Infants received the 13-valent 
pneumococcal and Haemophilus influenzae B conjugate vaccines. 
Results: There were 881 maternal and 2605 infant NP swabs. Antenatal ETS exposure 
was associated with Streptococcus pneumoniae carriage in mothers (aOR1.9 (95%CI 
1.0-3.5)). Postnatal ETS exposure was associated with carriage in infants (aOR1.5 
(95%CI1.0-2.2)). Postnatal carbon monoxide exposure was associated with NP carriage 
of Staphylococcus aureus (aOR2.7 (95%CI 1.0-6.9)), S. pneumoniae (aOR2.4 (95%CI 
1.1–5.4)) or gram-negative bacilli (aOR4.1 (95% CI 1.0–16.7)) in infants. 
Conclusion: Early-life environmental exposures are associated with increased preva-
lence of specific NP bacteria during infancy, which may predispose to developing  LRTI.
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1 Background
Nasopharyngeal (NP) microbiota, comprised of a myriad of microorganisms is rapidly 
acquired after birth and established in infancy.1, 2 NP carriage of potentially pathogenic 
bacteria in early life precedes the development of lower respiratory tract infections (LRTI) 
including pneumonia and bronchiolitis.3 Understanding the factors that impact on NP car-
riage may therefore be important in developing strengthened strategies to prevent LRTI, 
a major cause of death in children in low and middle-income countries (LMIC). 
NP carriage may be influenced by several environmental factors including exposure to 
environmental tobacco smoke (ETS) or indoor air pollution (IAP).4 Rapid urbanization 
particularly in LMIC, has resulted in increased use of alternate fuel sources for house-
hold energy, with numerous by-products of combustion (including particulate matter, car-
bon monoxide, nitrogen dioxide and volatile organic compounds) contributing to IAP.5 
Antenatal and early-life exposure to ETS has many potentially detrimental effects on 
child health including an increased incidence and severity of LRTI.6, 7 
While studies have assessed the effect of household air pollution on the lung micro-
biome, 8 no studies have investigated the effects of IAP on NP carriage particularly in 
infants. However, recently mouse models  have shown black carbon (a component of 
particulate matter)  induced structural, compositional and functional changes in bacterial 
biofilms and their responses to antibiotics as well as facilitated the microaspiration of 
Streptococcus spp. from the nasopharynx to the lung.9  Further, ETS exposure increases 
NP carriage of Streptococcus pneumoniae10, alters innate immune mechanisms in the 
nasal mucosa and disrupts epithelial barriers.11
This study longitudinally investigated the impact of antenatal and postnatal IAP and ETS 
exposure on NP carriage in mothers and infants enrolled in an African birth cohort study, 
from birth to one year of age.
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2 Methods
2.1  Study population and procedures
This study was nested within the Drakenstein Child Health Study (DCHS), a birth cohort 
in  a peri-urban area of South Africa.12 Consenting pregnant women were enrolled at 20 
– 28 weeks’ gestation at two public primary health clinics: Mbekweni (serving a predom-
inantly black African population) and Newman (serving a predominantly mixed ancestry 
population) from March 2012 – July 2015.
All births occurred at a single, central hospital, Paarl hospital. Thereafter, mother-infant 
pairs were followed at 6, 10 and 14 weeks, 6, 9 and 12 months, for health care and im-
munisations including the 13-valent pneumococcal conjugate vaccine (PCV-13) given 
at 6, 14 weeks and 9 months and Haemophilus influenzae type b conjugate vaccine at 
6, 10, 14 weeks according to the South African Expanded Programme on Immunisation 
(EPI) schedule.13 Study questionnaires and clinical data were collected at enrollment 
and follow-up visits. A validated socio-economic score (SES) was used to categorise 
participants into quartiles as lowest, low-moderate, moderate-high or highest SES.5 Clin-
ical data collected at each follow-up visit included details on recent respiratory tract in-
fections, including respiratory symptoms, otitis media, wheeze or LRTI in the preceding 
month and any antibiotic use in the prior 6 months.
2.2  Assessing environmental exposures
2.2.1 Measuring IAP exposure
The participant’s home environment was assessed and dwellings categorized based on 
having 2 or more defined household dimensions (type of home; building material; water 
supply; toilet facilities; kitchen type; ventilation in kitchen areas).5   IAP was measured 
at home visits conducted antenatally (within 4 weeks of enrollment) and postnatally (be-
tween 4-6 months of the infant’s life).5 Home visits were conducted over 3 years with 
sampling occurring throughout the year covering all seasons and weather conditions. 
Particulate matter (PM10) and carbon monoxide (CO) were measured by separate mon-
itors (AirChek 52; SKC, Eighty Four, PA, USA for PM10 and Altair; Troy, MI, USA for CO) 
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left in homes over 24 hours. Nitrogen dioxide (NO2) and volatile organic compounds 
(VOC), benzene and toluene, were measured using diffusion tubes (Radiello absorbent 
filters in polyethylene diffusive body; Sigma-Aldrich, St Louis, MO, USA) and (Markes 
thermal desorption tubes; Llantrisant, UK) left in homes for 2 weeks.5 These monitors 
were internally calibrated for temperature and humidity as per manufacturer information 
and whereas diffusion tubes were corrected for humidity during laboratory analysis.5, 14 
The South African National Ambient Air Quality Standards were used to define expect-
ed exposure levels for each pollutant based on an averaging period of 1 year for each 
measure.15, 16
2.2.2 Measuring ETS exposure
Maternal, paternal and household tobacco smoking and exposure were assessed us-
ing questionnaires administered at enrolment, and antenatal and postnatal visits. These 
were validated using maternal and infant urine cotinine measures. Maternal cotinine was 
measured antenatally and at birth, and infant cotinine at birth and 6-10 week with the 
highest result used to assign smoking status and exposure. Cotinine levels were classi-
fied as <10 ng/ml (non-smoker), 10-499 ng/ml, (passive smoker/exposed), or ≥500 ng/
ml (active smoker).7
2.3  Assessing nasopharyngeal (NP) carriage of bacteria
NP swabs were obtained from mothers (at the time of delivery) and infants at birth, 6 
and 12 months by trained study staff according to WHO recommendations17. The swabs 
were immediately stored in 1 ml of skim-milk, tryptone, glucose and glycerol transport 
medium (STGG), transported on ice to the laboratory and frozen at -80 oC for later batch 
processing.  After thawing at room temperature (22 oC), samples were vortexed for 15 
seconds before plating out a 10uL aliquot onto four different solid media (National Health 
Laboratory Services, Green Point Media Laboratory Cape Town, South Africa). Standard 
laboratory protocols were used for the phenotypic and biochemical identification of com-
mon bacterial species that asymptomatically colonise the upper respiratory tract. For S. 
pneumoniae culture,  Columbia blood agar base with 2% agar, 5% horse blood and 4 
mg/mL gentamicin (CAG) was incubated at 37oC in 5% CO2 overnight. Presumptive S. 
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pneumoniae isolates were identified by colony morphology, α-hemolysis, optochin disk 
susceptibility (Oxoid, Basingstoke, UK) and confirmed using lytA PCR.18 For H. influen-
zae, bacitracin heated blood (BHB) agar plates were incubated at 37°C with 5% carbon 
dioxide (CO2). Suspected H. influenzae colonies were inoculated onto Columbia agar 
and identified using Factors X, V and XV discs and by observing growth in the hemolytic 
zone of Staphylococcus aureus on Blood Agar plates. S. aureus isolates were identified 
by culturing on Mannitol Salt Agar (MSA), and DNase testing whereas Moraxella ca-
tarrhalis isolates were identified by culturing on 2% blood agar, incubated overnight at 
37°C. Isolates were presumptively identified by push test and confirmed by copB PCR.19 
Gram-negative bacteria were subcultured onto MacConkey agar and identified on Vitek 
2® (bioMérieux, Marcy I’Etoile, France).
2.4   Ethics
The study was approved by the Human Research Ethics Committees of the Faculties of 
Health Sciences, University of Cape Town and Stellenbosch University, and by the West-
ern Cape Provincial Health Research committee (HREC 149/2013).  Mothers provided 
written informed consent at enrolment.
2.5   Statistical analysis
Study data were captured in a relational Microsoft Access® database or collected and 
managed using REDCap electronic data capture tools hosted at the University of Cape 
Town .20 Statistical analyses were conducted in Stata version 14.2 for Windows (Stata 
Corp, College Station, TX). Statistical tests were considered significant if p value <0.05. 
Categorical variables were summarised using frequency counts and percentages, n (%). 
Normally and non-normally distributed continuous variables were described using Mean 
(SD) and median (IQR) values, respectively. Mann–Whitney or Wilcoxon signed-rank 
tests, as appropriate, were used to compare medians as well as their spread. Cross 
tabulations with Fishers’ exact or Chi-square tests were used to describe and compare 
the prevalence of pathogen carriage between the infants (at all time points) and their 
mothers or between different time points for infants.  
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Multivariable logistic regression analyses were performed to estimate adjusted odds ra-
tios between each bacterial pathogen and IAP measures (individually or together). The 
association between antenatal exposures or maternal cotinine and maternal carriage 
was explored as was the association between postnatal exposures or infant cotinine 
and infant carriage. The multivariable logistic regressions adjusted for demographic and 
clinical factors (weight for age z-score at birth, pre-term, ethnicity, sex, HIV exposure, 
time on exclusive breastfeeding, average number of people per sleeping room, dwelling 
category, recent respiratory infection, day care attendance, vaccination, number of other 
children under 5 years in the household, antibiotic use) that have been associated with 
pathogen acquisition. 21, 22 Further, we explored the possible confounding effects of bac-
terial co-carriage by including indicator variables for each pathogen. 
3 Results
During the study period there were 1137 women enrolled with 1143 live births (4 sets of 
twins and 1 of triplets), of which 986 infants had at least 1 IAP home measurement and 
1 NP swab collected and were included in this analysis.  (Fig 1).
3.1  Maternal characteristics
Five hundred and thirty (54%) mothers were enrolled from Mbekweni and 452 /982 (46%) 
from Newman. The  median age of mothers enrolled was 25.8, IQR[22.0, 30.6] years. 
Significantly more Mbekweni mothers were HIV infected; 193 (36%) compared to New-
man, 13 (3%), p <0.001. However, with an effective prevention of mother to child trans-
mission (PMTCT) programme only 2 infants  (<1%) were HIV-infected. Unemployment 
was high in both communities (74%)  with more Mbekweni participants in the lowest SES 
(30%) compared to Newman (18%). (Table 1).
3.2  Infant characteristics
Of the 986 infants included, 484 (49%) were female; the median gestational age was 39 
[IQR 38,40] weeks. Most [ 585 (59%)] infants were not breastfed at 6 months and  duration of 
exclusive breastfeeding was short at 1.4 [IQR 0.7, 3.0] months. Significantly more Newman 
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infants attended day care at both 6 months (6%)  and 12 months(20%) of age compared to 
Mbekweni infants; 6 month (3%) and 12 months (5%). In 851 (86%) of households there 
was at least one other child younger than 5-years. Seventy-seven (8%) children reported 
a recent respiratory infection at  6 months and 51 (5%) at 12 months of age.  Antibiotic 
use was infrequent, (Table 1), while  vaccine coverage was high in infants. (Supplemental 
Table 1)                                                                                                                                               
3.3  Home environment and exposures
Almost 40% of homes were informal and one-third of homes had less than 2 of the 
defined household dimensions. Electricity access was high (95%), however nearly one-
third of Mbekweni homes used alternate fuels for cooking and heating. The median Mbe-
kweni household size was 4 [IQR 3-6] people, smaller than Newman , 5 [IQR 4-7] peo-
ple. (Table 2)
Of the pollutants measured antenatally, significantly more Mbekweni homes had NO2 
levels above ambient standard compared to Newman [16 (4%) vs. 3(1%)]; overall 45% 
of homes had measured benzene levels above ambient standards. However, none of 
the median levels were above ambient standards. For pollutants measured postnatally, 
there were significant differences across sites in prevalence of above ambient standards 
for NO2 (p=0.041) and CO (p= 0.026). (Table 2)
Using maternal cotinine measures, 316 (33%) of mother’s were active smokers, signifi-
cantly higher for Newman, 241 (55%) compared to Mbekweni, 76 (15%) and a further 
423 (44%) were exposed to tobacco smoke. For infant ETS exposure, 524 (69% ) had 
cotinine levels indicative of tobacco smoke exposure, of which 104 (14%) were that of a 
level of active smokers. (Table 2)
3.4  NP bacterial carriage
At delivery, 167/881 (19%; 95%CI 16-22) mothers carried S. aureus, 114/881 (13%; 
95%CI 11-15) S.pneumoniae, 57/881 (6%; 95%CI 5-8) H.Influenzae, 59/881 (7%; 95%CI 
5-9) Moraxella catarrhalis  and 18/881 (2%; 95% CI 1-3) other gram-negative bacilli. 
(Table 3)
133
At birth, 15/910 (2%; 95%CI 1-4)  infants had S.aureus while 40/910 (4%; 95%CI 3-6) 
had gram-negative bacilli on NP samples. By 6 months, 584/887 (66%; 95%CI 63-69) 
infants carried S.pneumoniae, which remained the predominant organism at 1 year of 
age, carried by 547/800 (68%;95%CI 65-72). However, carriage of S. aureus 53/800 
(7%; 95%CI 6-9) or gram-negative bacilli 18/800 (2%; 95%CI 1-4) decreased between 6 
and 12 months (p<0.001).  The median number of bacteria carried was 2 (IQR 1-3) and 
2 (IQR 1-2) at 6 and 12 months respectively.  (Table 3) 
Of the infants who carried H. influenzae at 6 months, 160 (50%) continued to carry this at 
12 months. Likewise, 376 (74%) of infants who carried S. pneumoniae at 6 months also 
carried  S.pneumoniae at 12 months, (Supplemental Table 2)
3.5  Associations between environmental exposures and NP carriage
3.5.1 Antenatal exposures and maternal NP carriage
Antenatal exposure to nitrogen dioxide (NO2) above ambient standards was associated 
with increased maternal NP carriage of M. catarrhalis when adjusted for all clinical co-
variates (Adjusted), aOR 4.6 (95% CI 1.4- 15.1) and when adjusted for clinical covariates 
as well as the other pollutants (Adjusted 2), aOR 5.1 ( 95%CI 1.1 - 23.6).
Benzene exposure was associated with maternal H. influenzae carriage when adjusted 
for clinical covariates (Adjusted);  aOR 2.213 95%CI(1.202 - 4.077) and tobacco smoke 
exposure almost doubled the risk of S. pneumoniae carriage in mothers; aOR 1.9 (95% 
CI 1.0 - 3.4). (Table 4)
3.6  Postnatal exposures and infant NP carriage
ETS exposure was associated with S. pneumoniae carriage in infants at 6 months of age 
[aOR 1.5 (95%CI1.0 - 2.2) (adjusted)] and doubled the risk of carriage of H. influenzae; 
[aOR 2.4 (95%CI 1.1 – 5.6) (adjusted 2)] at 12 months. (Table 5) The association be-
tween smoke exposure and S. pneumoniae was also noted when adjusting for the other 
bacterial organisms co-carried (Adjusted); [OR 1.6 (95% CI 1.1 - 2.4)] at 6 months and 
this association was also seen with gram negative bacilli [ aOR 8.5 (95% CI1.0 – 70.9)] 
at 12 months. (Supplemental Table 3)
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Of the IAP measures, only NO2 was associated with increased gram negative bacilli car-
riage at 12 months aOR 23.5 (95% CI 1.5 - 364.5). (Table 5) However, when adjusting for 
co-carriage, clinical covariates and all the other pollutants (Adjusted 2), CO was associ-
ated with increased NP carriage of S. aureus; OR 2.7 (95%CI 1.0 – 6.9), S. pneumoniae; 
OR 2.4 (95% CI 1.1 – 5.4) or gram negative bacilli; OR 4.1 (95% CI 1.0 – 16.7) in infants 
at 6 months of age. (Supplemental Table 3)
4 Discussion
In this large peri-urban birth cohort study, we have shown an association between an-
tenatal IAP exposure and maternal NP carriage of bacteria and the impact of tobacco 
smoke exposure on both maternal and infant bacterial carriage, particularly S. pneu-
moniae. We also report an association between exposure to other indoor air pollutants 
including carbon monoxide (CO) and nitrogen dioxide(NO2) on infant bacterial nasopha-
ryngeal carriage.
While it is recognized that several factors including age, season, day care, number of 
siblings, acute respiratory illness, HIV infection, diet and vaccination may influence the 
acquisition of NP carriage in infants,4, 21 the effect of indoor air pollution on NP carriage 
has not been well described particularly in LMIC.23 In this study, significant associations 
between exposure to several indoor air pollutants and maternal and infant NP carriage 
occurred even after adjusting for such clinical factors associated with carriage and for 
co-carriage. The associations noted between CO exposure and both S. aureus and S. 
pneumoniae are also significant as the carriage of these microbes are usually inversely 
correlated.24 In more detailed studies of the NP flora, S. aureus carriage peaks at around 
3 months, considerably earlier than S. pneumoniae which occurs at around 6 months. 
As the current study only included infant NP swabs at 6 and 12 months, the relationship 
between S. aureus carriage and S. pneumoniae could not be determined.  However, giv-
en the prevalence S. aureus (20% and 7%) and S. pneumoniae (66% and 68%) and rel-
atively low co-colonisation with S. aureus and S. pneumoniae (11% and 4% co-carriage 
at 6 and 12 months, respectively), it would seem to suggest that there is a negative cor-
relation between S. aureus and S. pneumoniae colonisation. Nevertheless, postnatal CO 
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exposure was independently associated with each of these microbes, suggesting that 
this exposure predisposes to bacterial colonisation with either of these. Although there 
were no consistent associations between postnatal IAP exposure and infant carriage at 
both 6 and 12 months, this may reflect both the dynamic nature of bacterial carriage and 
the complex interplay of a number of factors that influence this and highlights the impor-
tance of IAP and ETS exposure in influencing NP bacterial carriage.   
In this cohort, maternal smoking and infant in utero and postnatal tobacco exposure was 
very high as indicated by urine cotinine in both mothers and infants. The high rates of 
maternal smoking especially amongst mixed race mothers is concerning, as is the very 
high exposure to household smoke.7  ETS exposure was associated with increased car-
riage of several microbes in mothers and infants including S. pneumoniae, H. influenzae 
and M. catarrhalis. NP carriage is recognized as a precursor to LRTI and a source of 
person-to-person transmission  among individuals.3, 25  Mice models have shown ciga-
rette smoke suppressed nasal inflammatory mediator expression, in particular neutrophil 
recruiting chemokines normally activated by S. pneumoniae carriage, thereby predispos-
ing to invasive S. pneumoniae infection. Further, smoking cessation reversed this and 
prevented invasive pneumococcal disease.26 Other animal studies have also shown an 
increased neutrophil response to H.influenzae in cigarette exposed mice, with interleu-
kin 1 alpha produced by alveolar macrophages driving this process. This exaggerated 
response may underlie accelerated lung pathology seen when there is cigarette smoke 
and bacterial infection.27 Tobacco smoke also has significant effects on the generation 
of adaptive immune responses to H. influenzae which may predispose to recurrent in-
fections and exacerbations particularly in chronic lung diseases.28 The host’s ability to 
control bacterial colonisation of the upper airway is also impacted by cigarette smoke 
with increased inflammatory mediators and reduced blood granulocyte and monocyte 
phagocytosis activity.29 These mechanisms may therefore increase the risk of developing 
LRTI and warrant further investigation. 
The association between S. pneumoniae NP carriage and the development of subse-
quent S. pneumoniae disease including lower respiratory tract infection (LRTI) is well 
recognized.3, 25, 30 Increased S.pneumoniae carriage in infants associated with both car-
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bon monoxide and ETS exposure suggests that reducing exposure to these pollutants 
could play a role in the prevention of childhood LRTI. Further, tobacco smoke exposure 
also doubled maternal NP pneumococcal carriage, providing a source for increased 
transmission between individuals. While we found no association between preceding 
respiratory tract infection (either upper or lower respiratory tract infection), on nasopha-
ryngeal bacterial carriage, the association between NP pneumococcal carriage and the 
development of LRTI (as an outcome) was not explored, as for this study infant NP 
carriage was assessed at two time points (6 and 12 months) and the majority of LRTI 
cases occurred early, before 6 months.31 Similarly, we were unable to assess the effect 
of pneumococcal conjugate vaccine (PCV) (administered at 6, 14 weeks and 9 months) 
on S.pneumoniae carriage due to the very high vaccination rates and the infrequent 
sampling period in this study. We have however, previously described the association 
between IAP and ETS exposure and LRTI in this cohort,31 highlighting the role of IAP and 
ETS as potential risk factors for childhood respiratory illness. 
The patterns of infant carriage seen in this cohort are consistent with those previously 
described, with S. aureus predominating in the first months, followed by S. pneumoniae 
which persisted till 12 months of age21, 32. The predominant maternal bacteria carried was 
S. aureus, however the prevalence is lower than other studies which have reported ma-
ternal S. aureus carriage of up to 50%.33-35 The high rates of infant S. pneumoniae car-
riage are also consistent with those reported in low and low-middle income settings30, 36. 
The study extends this knowledge by identifying factors associated with acquisition which 
have not previously been described in infants. A limitation of this study is reliance on bac-
terial culture to identify organisms, which may underestimate bacterial prevalence and 
the inability to sub-type organisms. However, the four most common bacterial species 
identified are the major contributors to bacterial LRTI in infants. In addition to these spe-
cies, we also identified a range of gram-negative enteric bacterial species in the naso-
pharynx, but at a considerably lower frequency, and with insufficient statistical power to 
draw conclusions. Although standard bacterial culture is likely to miss key components of 
the bacterial microbiota of the nasopharynx, one of the major advantages of culture over 
16S- amplicon sequencing based microbiome studies, is the ability to identify bacteria 
at the species level.37 This is highly relevant for nasopharyngeal bacteria, where there is 
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substantial difference in potential for pathogenicity within a genus. Further, a range of viral 
infections are likely to impact carriage of bacteria in the nasopharynx, 38 with viral infec-
tions playing a mediator role.  IAP or ETS exposure may also impact on viral infections,39 
which in turn may influence bacterial carriage. However, a limitation of this study is that 
comprehensive assessment of viral infections at a range of time points, including time 
points preceding our analysis of bacterial carriage was beyond the scope of this analy-
sis. Further, we considered multiple hypothesis at once through multiple statistical tests 
with the consequence that some of the significant associations might be due to chance. 
Strengths of this study were the large sample size, longitudinal measurements of NP 
carriage, direct measurements of indoor air pollutants both antenatally and postnatally, 
testing of maternal and infant samples and comprehensive analysis which considered 
numerous co-variates. 
The association between both IAP and ETS exposure on maternal and infant nasopha-
ryngeal bacterial carriage has not been well described, particularly in LMIC, peri-urban 
communities who may rely on alternate fuel sources . This study highlights the need for 
effective, preventative measures to reduce such exposures.  The population in this study 
represent a particularly vulnerable group of poor pregnant women and children in a low 
and middle-income country setting, where there is a high burden of respiratory disease. 
Effective strategies to reduce smoking in pregnant women and to minimize household 
IAP exposure are needed to improve child and maternal health particularly in LMICs.
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Figure 1: Cohort description and samples collected
1143 live births 
986 with any IAP 
measure (604 with 
both, 259 with ante 
only and 123 with post 
only)
157 with no IAP 




886 - 6 month 
samples
802  - 12 month 
samples





Total, n (%) P-value
Maternal characteristics
Number of mothers 530 (54) 452 (46) 982 (100)
Ethnicity
   Black













HIV-infected 193 (36) 13 (3) 206 (21) <0.001
Unemployed 400 (75) 325 (72) 724 (74) 0.205
SES quartile
   Lowest SES
   Low-moderate SES
   Moderate-high SES














Median number of household 






Total, n (%) P-value
Married / cohabiting 188 (35) 194 (43) 382 (39) 0.017
Infant characteristics and birth outcomes
Number of infants; sets of twins 534 (54); 4 452 (46); 0 986 (100); 4
Female 280 (52) 204 (45) 484 (49) 0.022
Median gestation at delivery [IQR] 39 [38, 40] 39 [37, 40] 39 [38, 40] 0.032














Low birthweight (<2500 grams) 55 (10) 83 (18) 138 (14) <0.001
Pre-term birth (<37 weeks gesta-
tion) 16 (3) 19 (4) 35 (4) 0.314
Feeding at 6 months 
   Exclusive breastfeeding
   Mixed











Duration of exclusive breastfeed-





Day care attendance 
      6 months of age









Additional child under 5 years in 
household 455 (85) 396 (88) 851 (86) 0.274
Respiratory infection in prior 
month
     6 months of age









Antibiotic use (prior 6 months) 
      6 months of age















Total, n (%) P-value
Home environment
Household dimensions §
   Has ≤2 dimensions








Alternate fuel used (coal, wood, 
paraffin, gas)
   Cooking










   Household size









Pollutants measured – antenatal
Particulate matter (PM10) g/m





































































Pollutants measured - postnatal
Particulate matter (PM10) g/m















































Total, n (%) P-value
























Maternal antenatal tobacco smoking, n (%)
Number of mothers 530 451 981
Maternal Urine cotinine (n=954) 512 442
   <10 ng/ml (Non-smoker) 181 (35) 47 (11) 228 (24) <0.001
   10-499 ng/ml (Passive/exposed) 255 (50) 155 (35) 410 (43)
   ≥500 ng/ml (Active smoker)  76 (15) 240 (54) 316 (33)
Infant urine cotinine
Urine cotinine at birth or 6-10 
weeks (n=763)
415 348
   <10 ng/ml 184 (44) 55 (16) 239 (31) <0.001
   10-499 ng/ml 212 (51) 208 (60) 420 (55)
   ≥500 ng/ml 19 (5) 85 (24) 104 (14)
§ Dimensions comprise: type of home; building material; water supply; toilet facilities; kitchen type; ventilation 
in kitchen areas
Table 3: Nasopharyngeal bacterial carriage at birth, 6 months and 1 year of life
Maternal Infants
At time of birth, 
n (%) (95% CI)
n= 881
At birth, n (%) 
(95%CI)
n= 911
At 6 months, 
n (%) (95%CI) 
n= 887
At 1 year, n (%) 
(95%CI)
n= 800
S. aureus 167 (19)(16-22) 15 (2)(1-4) 172 (19)(17-22) 53 (7)(6-9)
S. pneumoniae 114 (13)(11-15) 2 (0)(0-1) 584 (66)(63-69) 547 (68)(65-72)
H. influenzae 57 (6)(5-8) 2 (0)(0-1) 371 (42)(39-45) 335 (42)(38-45)
M. catarrhalis 59 (7)(5-9) 8 (1)(0-2) 452 (51)(48-54) 435 (54)(51-58)
Gram negative 
bacilli
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Research in context
Evidence before this study
Environmental exposures from indoor air pollution (IAP) or environmental tobacco 
smoke are important risk factors for childhood lower respiratory tract illness (LRTI) or 
wheezing, but there are few data on the impact of antenatal compared to postnatal ex-
posures and from low or middle income country (LMIC) and African settings, which have 
a high burden of illness.  Further there is a paucity of data on the impact of exposure to 
new alternate sources of fuel, including volatile organic compounds (VOCs), increasingly 
used globally.  We searched PubMed, Scopus and Google Advanced Scholar using the 
search terms “child”, “ indoor air pollution (IAP)”, “tobacco smoke”, “pneumonia”, “re-
spiratory tract infection”, “wheezing” for English articles from 1990 – 2017. We focused 
on studies particularly from LMICs that studied the effects of environmental exposures 
(either IAP or tobacco smoke) with paediatric respiratory health as an outcome. These 
studies reported an association between environmental exposures and childhood LRTI 
or wheezing with IAP associated with an almost double risk of developing LRTI in a sys-
tematic review. A similar increase was reported in a systematic review of ETS exposure 
and LRTI or wheezing, which found that both parental and household smokers signifi-
cantly increased the risk of LRTI. However, the strongest effect was on bronchiolitis with 
household smokers more than doubling this risk.
Highlighting a critical gap, we found little data differentiating timing of exposures i.e. 
antenatal vs postnatal and no longitudinal African data. Further, most studies relied on 
reported environmental exposures or modelled data, rather than direct measurement of 
exposures and none measured new exposures like VOCs. 
Added value of this study
In this African birth cohort study, in which exposures were objectively and longitudinally 
measured antenatally and postnatally, LRTI or wheezing was common and associated 
with antenatal rather than postnatal exposure to ETS or to IAP.  Antenatal exposure to 
toluene, a VOC, was identified as a novel exposure associated with LRTI, hospitalisation 
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and severe disease. Both antenatal and postnatal maternal smoking were associated 
with wheezing. This study provides novel data on new exposures such as VOCs which 
are increasingly used as alternate fuel sources globally.  Further the study highlights the 
importance of exposures in the antenatal rather than the postnatal period in determining 
child respiratory health. 
Implications of all the available evidence
Preventive strategies should focus on women of child bearing age in the prenatal peri-
od to reduce ETS and IAP exposure.  Alternate sources of fuel may not be as safe as 
currently regarded; further study of these is needed. Effective public health interventions 




Background Indoor air pollution (IAP) and environmental tobacco smoke (ETS) are 
associated with lower respiratory tract illness (LRTI) or wheezing in children. However, 
the effect of the timing of these exposures, specifically antenatal versus postnatal, and 
of alternate fuel sources such as the increasingly used volatile organic compounds have 
not been well studied. We longitudinally investigated the effect of antenatal or postnatal 
IAP and ETS on LRTI or wheezing prevalence and severity in African infants.
Methods Mother and infant pairs enrolled over a 3-year period in a birth cohort study 
in two centres in Paarl, South Africa, were followed for the first year of life for LRTI or 
wheezing illness. We measured exposure to IAP (particulate matter, nitrogen dioxide, 
sulphur dioxide, carbon monoxide, and volatile organic compounds benzene and tol-
uene) using devices placed in homes, antenatally and postnatally. We measured ETS 
longitudinally by maternal self-report and by urine cotinine measures. Study staff trained 
in recognition of LRTI or wheeze documented all episodes, which were categorised ac-
cording to WHO case definition criteria. We used multivariate logistic and Poisson regres-
sions to explore associations.
Findings Between March 1, 2012, and March 31, 2015, we enrolled 1137 mothers with 
1143 livebirths. Of 1065 infants who attended at least one study visit, 524 episodes of 
LRTI occurred after discharge with a wheezing prevalence of 0·23 (95% CI 0·21–0·26) 
episodes per child year. Exposures associated with LRTI were antenatal maternal smok-
ing (incidence rate ratio 1·62, 95% CI 1·14–2·30; p=0·004) or particulate matter (1·43, 
1·06–1·95; p=0·008). Subanalyses of LRTI requiring hospitalisation (n=137) and supple-
mental oxygen (n=69) found antenatal toluene significantly increased the risk of LRTI-as-
sociated hospitalisation (odds ratio 5·13, 95% CI 1·43–18·36; p=0·012) and need for 
supplemental oxygen (13·21, 1·96–89·16; p=0·008). Wheezing illness was associated 
with both antenatal (incidence rate ratio 2·09, 95% CI 1·54–2·84; p<0·0001) and postna-
tal (1·27, 95% CI 1·03–1·56; p=0·024) maternal smoking.
Antenatally, wheezing was associated with maternal passive smoke exposure (1·70, 
1·25–2·31; p=0·001) and, postnatally, with any household member smoking (1·55, 1·17 
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–2·06; p=0·002).
Interpretation Antenatal exposures were the predominant risk factors associated with 
LRTI or wheezing illness. Toluene was a novel exposure associated with severe LRTI. 
Urgent and effective interventions focusing on antenatal environmental factors are re-
quired, including smoking cessation programmes targeting women of childbearing age 
pre-conception and pregnant women.
Funding Bill & Melinda Gates Foundation, Discovery Foundation, South African Thoracic 
Society AstraZeneca Respiratory Fellowship, Medical Research Council South Africa, 
National Research Foundation South Africa, and CIDRI Clinical Fellowship.
1  Introduction
Lower respiratory tract illness (LRTI), principally pneumonia remains the leading cause 
of under-5 mortality in low and middle-income countries (LMIC), with a very high burden 
of disease in low and middle income country settings including Africa.1  Wheezing illness 
is common in young children and asthma is the commonest non-communicable disease 
(NCD) in African children.2 Indoor air pollution (IAP) or environmental tobacco smoke 
(ETS) exposure have been strongly associated with the development of childhood re-
spiratory illness but there are little data on the impact of the timing of exposures on child 
respiratory health.3,4
Antenatally, in utero tobacco smoke exposure has been shown to affect lung growth 
and predispose to development of LRTI or wheezing disorders.5 Potential mechanisms 
include the toxic effects of the numerous chemicals found in tobacco smoke on the 
developing respiratory system,6 suppression of foetal breathing or direct genotoxicity,7 
the effects of nicotine on lung collagen deposition6 and impaired immune function from 
imbalances in Th1 and Th2 responses.8  While less clear, antenatal IAP exposure is pos-
tulated to impact lung development through an interplay of maternal and placenta-foe-
tal factors including oxidative stress resulting in placental insufficiency with decreased 
transport of oxygen and nutrients to the developing foetus.9 Postnatal IAP and/or ETS 
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exposure may disrupt pulmonary defences leading to epithelial inflammation, affect mi-
crobial colonisation and systemic inflammation, particularly if the alveolar capillary mem-
brane is breached.3  Most studies have focused on the association of postnatal IAP ex-
posure on child respiratory health;10 separating the impact of antenatal versus postnatal 
exposure is difficult with few studies able to delineate this.9,11 
Many peri-urban communities, particularly in LMIC including South Africa are undergo-
ing rapid urbanization. This has led to a shift in the type of IAP exposure with less use 
of open fires, but increasing use of cheap fuels such as paraffin, which produce volatile 
organic compounds (VOC) on combustion.12   The impact of these on child respiratory 
health have not been well studied. Further there is a paucity of longitudinal African data, 
despite the high incidence of LRTI or wheezing illness,13,14 large childhood populations 
and exposure to different forms of IAP and ETS.15 The prevalence of ETS exposure 
is also underreported particularly in LMIC,4 with most studies reporting cross sectional 
associations without objective measures of exposure and the extent and impact of expo-
sures on child respiratory health has not been well studied especially in infants.
The aim of this study was to longitudinally investigate antenatal and postnatal exposure 
to IAP and/or ETS, using objective measurements, and the association with LRTI or 
wheezing illness in a South African birth cohort study.
2 Methods
2.1 Study population and procedures 
A longitudinal study of children enrolled in the Drakenstein Child Health Study (DCHS), a 
birth cohort study,16 in a peri-urban area of South Africa was done that included follow-up 
through the first year of life.  Consecutive consenting pregnant women were enrolled 
at 20 – 28 weeks gestation at two public primary health clinics: Mbekweni (serving a 
predominantly black African population) and Newman (serving a predominantly mixed 
race population) from 1 March 2012 to 31 March 2015, a 3 year period so as to ensure 
constant enrolment over different seasons and time periods with more than 90% of the 
studied population attending the public health service17 (Supplemental Table 1). Exclu-
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sion criteria were individuals who were younger than 18 years, who did not attend study 
clinics for postnatal care (and thus could not be readily followed up), or those who were 
intending to move out of the district within 2 years after the infant’s birth.17 Study ques-
tionnaires and clinical data were collected at enrolment, and at follow up.  All children 
were born at a central single hospital, Paarl hospital. Thereafter, mother-infant pairs 
were followed at 6-10 and 14 weeks, 6, 9 and 12 months. A composite socioeconomic 
status (SES) score was applied and participants categorized into quartiles as lowest, 
low-moderate, moderate-high or highest SES (Supplemental Table 1).12,17,18
2.2 Measuring exposure to IAP 
An antenatal (within 4 weeks of enrolment) and postnatal (between 4-6 months of the 
infant’s life) home visit was undertaken to assess the home environment and measure 
IAP. Dwellings were categorized12 and the most common pollutants and by-products of 
combustion measured. Particulate matter (PM10) was measured using a personal air 
sampling pump [SKC AirChek 52®] and carbon monoxide (CO) with  an Altair® carbon 
monoxide single gas detection unit, left in homes for 24 hours. Diffusion tubes placed 
in homes for 2 weeks measured nitrogen dioxide (NO2)/ sulphur dioxide (Radiello
® ad-
sorbent filters in polyethylene diffusive body) and volatile organic compounds (VOC), 
benzene and toluene, (Markes® thermal desorption tubes). As described previously an 
average concentration based on the 2-week duration in the home was obtained for ni-
trogen dioxide/sulphur dioxide and volatile organic compounds; 24-hour averages were 
obtained for particulate matter. Carbon monoxide data was downloaded to a computer 
and the frequency of exceedance above the hourly ambient standard was calculated. 
(Supplemental Table 1).12 The South African National Ambient Air Quality Standards19 
were used to define expected exposure levels for each pollutant based on an averaging 
period of 1 year for each measure; PM10: 40ug/m
3, NO2: 40ug/m
3, benzene: 5ug/m3, 
toluene: 240ug/m3, CO: >30mg/m3 (not more than 88 hours). (Supplemental Table 1).19 
During the postnatal home visit, these same measurements were repeated.
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2.3 Measuring exposure to ETS 
Questionnaires of maternal and paternal smoking and household exposure to tobacco 
smoke were administered at enrolment and at each follow-up visit during the antenatal 
and postnatal follow-up period.20 Maternal exposure to ETS was also measured using 
urine cotinine, at the second antenatal visit (28-32 weeks gestation) and at birth with 
the highest result used to assign the mother’s smoking status (Supplemental Table 1).20 
Urine cotinine levels were classified as <10 ng/ml (non-smoker), 10-499 ng/ml, (passive 
smoker/exposed), or ≥500 ng/ml (active smoker).20
2.4 Assessing lower respiratory tract disease
Respiratory disease was characterized as an episode of LRTI and/or wheeze. Study staff 
trained in the recognition of LRTI or wheezing illness documented all episodes either 
ambulatory or hospitalized. LRTI and severe LRTI were defined using World Health Or-
ganization (WHO) case definition criteria (Supplemental Table1).13,21  Active surveillance 
for LRTI in the cohort was established (Supplemental Table1).13 LRTI which occurred at 
or shortly after birth prior to discharge was defined seperately. Episodes of wheeze were 
self-reported by a caregiver at a study visit or diagnosed on auscultation by trained study 
staff at a study visit or inter-current illness. Study staff were trained in the recognition 
and auscultation of wheezing; caregivers were also trained in clinical recognition (Sup-
plemental Table1). Recurrent wheezing was defined as 2 or more episodes of wheezing.
2.5 Ethics
The study was approved by the Faculty of Health Sciences Human Research Ethics 
Committees of the University of Cape Town and of Stellenbosch University, and by the 
Western Cape Provincial Health Research committee. 
2.6  Statistical analysis 
Data were analyzed using STATA 13·0 (STATA Corporation, College Station, TX USA). 
Simple descriptive statistics were used to characterize the study population, continuous 
data were summarized as median and interquartile range and categorical data were 
summarized as proportions with 95% confidence intervals (CI)s. Wilcoxon rank-sum test 
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was used to compare medians, and proportions were compared using the chi-squared 
test. Mixed effects Poisson regression clustered around the infant was used for mul-
tivariate analysis of LRTI incidence and multivariable Poisson regression for wheez-
ing, results are presented as incidence rate ratios and 95% CIs. Univariate mixed ef-
fects logistic regression clustered around the infant was used to explore associations 
between demographic, household, socio-economic characteristics, indoor air pollutants 
and smoke exposure between severe vs non-severe LRTI, hospitalized vs ambulatory, 
LRTI requiring oxygen vs not requiring oxygen and wheeze at LRTI vs no wheeze in the 
subset of infants that had an LRTI; results are presented as odds ratios and 95% CIs. 
Univariate analysis tested the association between environmental and socio-economic 
factors and respiratory disease. (Supplemental Table1). Variables that were associated 
with these outcomes and those of clinical relevance were included in multivariate (mixed 
effects) logistic regression models to determine the effect of severity of disease. Wilcox-
on signed-rank test was used to compare differences in the median pollutants measured 
antenatally to postnatally. Confounding variables (birth weight, gender, ethnicity (site), 
SES status, weight for age Z (WAZ) score,22 maternal HIV status, crowding, household 
characteristics, fossil fuel usage, vaccination status, nutritional status and feeding in the 
first 6 months status) that showed an effect were included in the final analysis models 
(Supplemental Table1). All statistical tests were two-sided at α = 0·05.
2.7 Role of the funding source 
The sponsors of the study had no role in the study design, data collection, data analysis, 
data interpretation, or writing of the report. All authors had full access to all the data and 
had final responsibility for the decision to submit for publication.
3 Results
Amongst 1137 mothers (median age 25.9 [IQR 22.1-30.8] years) enrolled with 1143 live 
births (4 sets of twins and 1 triplet), a total of 4521 visits were completed; 1065 children 
attended at least one of the study visits between birth and 12 months of age. Attendance 
varied at each time point with 1030 having attended the 6-10 week visit, 933 the 14 week 
visit, 936 the 6 month visit, 844 the 9 month visit and 778 the 12 month visit. A minority [119 
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(10%)] of children were lost to follow-up before the first full year of follow-up (Figure 1). 
3.1 Demographics and home environment
There were notable differences between the Mbekweni (black African) and Newman 
(mixed ancestry) populations (Table 1).  More black African participants were in the low-
est SES quartile compared to mixed race participants; the median household size was 
lower 4 (IQR 3-6) versus 5 (IQR 4-7) for mixed race participants (Table 1). One-third of 
homes had less than two of the household dimensions, however, 94% of homes had ac-
cess to electricity. Despite this 30% of black African homes used fossil fuels for cooking 
and heating (Table 1), with paraffin being used in 22% of homes. Twenty-two percent of 
infants were born to HIV-infected mothers and therefore HIV exposed, significantly more 
in black African infants (37% vs 3%), but only 2 infants were HIV infected. There were no 
differences between the maternal, household or birth characteristics of those included in 
the analysis or those lost to follow up except  in the dwelling catergory where 244/1065 
(38.8%) of homes had less than two household dimension compared to 37/119 (45.1%) 
in the LTFU group (p=0.018).
Birth weight for age Z-scores (WAZ) differed significantly with black African babies [medi-
an WAZ -0·41 (-1·22; 0·24)] heavier compared to mixed race babies [median WAZ -0·73 
(IQR-1·36; -0·06)] (Table 1).  Approximately 17% of all births were preterm, predominant-
ly late preterm. Eighty-six percent of mother initiated breastfeeding, however, the median 
duration of exclusive breastfeeding was 2 (IQR 1-4) months. There was a high rate of 
infant vaccination including 13-valent pneumococcal conjugate vaccine, with above 80% 
coverage for the first 3 doses (Table 1). 
3.2 IAP or tobacco smoke exposure
The median level of each of the pollutants measured did not exceed ambient stan-
dards.19 The median PM10 level measured antenatally combining both sites was 33·12 
(IQR 12·22 – 64·17) ug/m3 significantly higher than the postnatal measurement of 29·29 
(IQR 12·59 – 52·46), p=0·011. Of the VOC’s, the median benzene concentration was 
significantly higher antenatally [4.29 (IQR 1·70 – 11·53) ug/m3] compared to postnatal 
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[3·12 (IQR 1·09 – 9·46) ug/m3] when both sites were combined, p=0·014. The median 
toluene concentration was 16·94 (IQR 7·05 – 44·85) ug/m3 antenatally and 15·52 (IQR 
5·93 – 49·95) ug/m3 postnatally (Table 2).  Use of paraffin for cooking was significantly 
associated with higher toluene values (p=0·04).  When measures were compared be-
tween sites, at both antenatal and postnatal time points, only SO2 (antenatally) and CO 
(postnatally) were significantly different (Supplemental Table 2).
Using antenatal maternal urine cotinine levels, 343/1058 (32%) mothers were active 
smokers and 464/1058 (44%) were exposed to tobacco smoke (Table 3). Smoking prev-
alence was significantly higher in mixed race (53%) compared to black African (15%) 
mothers p<0·001 (Table 3).  Self-reported smoking correlated well with urine cotinine 
measurements, especially in mixed race women (Supplemental Table 3). There were 
high levels of reported smoke exposure to infants throughout the first year, with 41% of 
fathers, 22% of mothers and 37% of other household members reported to be smokers. 
In 74% of homes, at least one household member was reported as a smoker (Table 3). 
3.3 Lower respiratory illness
3.3.1 LRTI
There were 569 cases of LRTI of which 45 (8%) occurred at or shortly after birth prior to 
discharge and analysed separately. Of 524 LRTI cases, more occurred amongst Black 
African (321, 61%) than mixed race (203, 39%) infants (p < 0·001). The median age at 
LRTI was 4·6 (IQR 2·8 – 7·4) months. The highest number of cases 178 (37%) occurred 
in winter. 105 (20%) were severe, and 137 (26%) required hospitalization. There were 5 
(0.8%) LRTI-related deaths.
3.3.2 Wheeze
The overall prevalence rate for wheeze was 0·23 (95%CI 0·21 - 0·26) per child year, 
higher amongst mixed race [0·32 (95%CI 0·27-0·37)] compared to black African infants 
[0·16 (95%CI 0·13-0·20)], p<0·001.  Recurrent wheeze occurred in 47 (4%) infants. 
Amongst LRTI cases, 227/524 (43%) had associated wheeze on auscultation (Table 4). 
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3.4 Association between antenatal environmental exposures and lower 
respiratory illness
3.4.1 LRTI: Antenatal exposures
Antenatal maternal smoking was associated with an increased risk of LRTI [IR 1·62 
(95%CI 1·14-2·30)] as was male gender [IR 1·69 (95%CI 1·33 -2·13)].  Increasing in-
fant age was associated with a decreased risk of LRTI (Table 5). Antenatal PM10 above 
ambient standards (>40ug/m3) was significantly associated with LRTI [IR 1·43 (95% 
CI 1·06- 1·95)] (Table 5). In those children with LRTI, antenatal exposure to toluene 
above ambient standards (>240ug/m3),  was further associated with an almost five-fold 
increase in hospitalization, OR 5·13 (95% CI 1·43-18·36) (Supplemental Table 4) or with 
an increased requirement for oxygen; OR 13·21 (95% CI 1·96-89·16) (Supplemental 
Table 5). There were however, no significant exposures associated with WHO-defined 
severe LRTI, but the number of severe cases (n=44) meant the model was not sufficient-
ly powered. There were no associations found between antenatal exposures and cases 
of congenital LRTI. 
3.4.2 Wheezing illness: antenatal exposures 
Antenatal maternal smoking increased the risk of infant wheezing, [IR 2·09 (95% CI 1·54-
2·84)] as did passive smoke exposure [IR 1·70 (95% CI 1·25-2·31)] (Table 6). None of the 
IAP exposures were associated with an increased the risk of wheezing (Table 6). When 
correcting for both smoke exposure and IAP, a moderate-high SES [IR 1·53 (95% CI 1·17-
2·00)] was associated with an increased risk of wheezing (Supplemental Table 9). 
3.5 Association between postnatal environmental exposures and lower 
respiratory illness 
3.5.1 LRTI: postnatal exposures
Neither postnatal self-reported maternal or household smoking nor PM10 exposure was 
associated with an increased risk of LRTI or of LRTI-associated hospitalization (Supple-
mental Tables 4 & 6).
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3.5.2 Wheezing illness: postnatal exposures 
None of the postnatal IAP measured were associated with wheeze but postnatal mater-
nal smoking IR 1·27 (95% CI 1·03 –1·56) and any household member smoking IR 1·55 
(95% CI 1·17 –2·06)  was associated with an increased risk of infant wheezing; (Supple-
mental Table 7).
3.6 Combined antenatal and postnatal exposures
Although combined antenatal and postnatal ETS exposure increased the risk of wheez-
ing [IR 1·79 (95% CI 1·34 -2·38)], this was similar to the risk associated with antenatal 
exposure alone (Supplemental Table 8). Further, combined ETS and IAP exposure in-
creased the risk of wheezing [IR 1·96 (95% CI 1·32-2·92)], however this was also similar 
to the risk associated with either ETS or IAP exposure (Supplemental Table 9).
Combining antenatal and postnatal ETS exposure or combined IAP exposure was not 
associated with a risk of LRTI (Supplemental Tables 8 & 9).
4 Discussion 
A high incidence of LRTI or wheezing illness was found in infants in this poor peri-urban 
community, associated with very high rates of exposure to tobacco smoke and IAP. An-
tenatal exposures were much more strongly associated with respiratory disease in the 
first year of life with maternal smoking, ETS exposure, PM10 or toluene exposure asso-
ciated with LRTI, wheezing or hospitalization for respiratory illness. Amongst postnatal 
exposures, only maternal smoking was associated with an increased risk of wheezing in 
infants. Recurrent wheezing was unusual, as might be expected in the first year of life.
The effect of antenatal ETS exposure may relate to high levels of in utero exposure with 
higher levels than those occurring postnatally.  This is consistent with our findings in this 
cohort, in which infant urine cotinine levels at birth attain levels equivalent to an active 
smoker in babies born to mothers who smoke, but reduce at 6-10 weeks of age to levels 
indicative of passive exposure associated with maternal smoking.20  Further, antenatal 
exposure may occur at a crucial time of lung development, impairing lung growth.7 In vi-
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tro studies have shown that nicotine impairs lung growth and increases collagen deposi-
tion in airways.6 The very high prevalence of maternal smoking in pregnancy, particularly 
in the mixed race population (53%), which was up to 10 times higher than the reported 
African pooled prevalence,23 and high exposure to tobacco smoke in utero are concern-
ing. The results may not be generalizable to settings with lower levels of smoke expo-
sure; however, maternal smoking prevalence is rising in Africa and amongst pregnant 
women23 .  Further self-reported smoking is under reported by pregnant women; however 
in our study self-reported smoking and urine cotinine measurements correlated closely 
especially in the mixed race, high prevalence smoking community. 
A few studies have tried to differentiate timing of exposure on the development of child-
hood respiratory illness24,25 with difficulty in measuring the impact of antenatal compared 
to postnatal exposure.  In this study antenatal exposure was the most important risk 
associated with the development of respiratory illness in infants.
The differences between antenatal and postnatal measurements of particulate matter 
(PM10) were due to a combination of seasons and sites. Antenatal exposure to particu-
late matter (PM10) was associated with an increased risk of LRTI, as has been previously 
reported.10,26,27 This may be due to impaired lung growth and increased risk of infection 
associated with exposure.28  Further, innate immune responses may be compromised 
due to impairment of alveolar macrophage function and upregulation of inflammatory 
responses.29-31  Particulate matter inhaled during pregnancy may therefore act directly on 
the developing fetus or induce a systemic immune or inflammatory response resulting in 
placental insufficiency leading to reduced fetal oxygen and nutrients.9,32 By comparison 
postnatal exposure relies on direct inhalation of PM that results in increased number of 
macrophages, neutrophils and T lymphocytes in the lungs.30 The antenatal developmen-
tal factors increased the susceptibility to LRTI more than postnatal exposure, particularly 
in in the first months of life.  
A novel finding was the association between antenatal toluene exposure and severe 
LRTI, with exposure increasing the risk of hospitalization almost five-fold and the need 
for supplemental oxygen more than thirteen-fold. Toluene, a VOC, has numerous sourc-
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es including ETS, paraffin, solvents, emissions and household products,33 reflective of 
the sources of IAP in many poor peri-urban communities. Although toluene exposure has 
been reported to play a role in wheezing illnesses and asthma development or exacer-
bations, no studies have described the association of antenatal toluene exposure with 
LRTI in children.34,35 Consistent with the findings for other IAP exposures, postnatal ex-
posure was not associated with LRTI incidence or severity.  In vitro studies, have shown 
an effect on immune cells including suppression of cytokine secretion and lymphocyte 
activity, so potentially increasing susceptibility to severe LRTI.36 Further, antenatal mater-
nal exposure to IAP may affect the developing fetal innate immune system in particular 
toll-like receptor and nucleotide-binding oligomerization domain–like receptor involved 
in pathogen-induced immune responses,37 which may  contribute to the severity of LRTI 
as occurred in infants with antenatal toluene exposure.  Mice models have also shown a 
shift in balance from Th1/Th2 to predominantly Th2 responses with toluene exposure.38 
While the small number of severe cases of LRTI may be a limitation of this observation, 
this association requires further investigation, particularly as VOC exposures are ubiqui-
tous, increasing globally and often under-recognized.
The incidence of LRTI and prevalence of wheezing was high, with important differences 
in the two communities. While LRTI was more common in black African infants, wheez-
ing was more prevalent in mixed race infants, even though more than 40% of LRTI was 
associated with wheezing. The higher prevalence of wheezing in mixed race infants may 
be explained by high exposure to ETS from antenatal maternal smoking and household 
smoking. The higher prevalence of LRTI in black African infants may be explained by 
their poorer socioeconomic status, with more homes lacking basic household dimen-
sions, higher HIV exposure and associated household exposure to potential pathogens 
or greater use of fossil fuels for cooking and heating.12  The effects of other recognized 
risk factors associated with LRTI including crowding, nutritional status and immunization 
were explored but no significant associations were found. However, immunization rates 
in both communities was high and nutrition was generally good.
Strengths of this study include the longitudinal follow up, prospective collection of data, 
high cohort retention and repeated objective measures of IAP and ETS through the 
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antenatal period and through infancy.  Few studies, particularly from LMIC have directly 
measured household IAP exposures in large numbers.39 The strong association between 
antenatal exposures and LRTI including severe LRTI, which did not occur with postnatal 
exposures, suggests that in utero exposures may be important in determining suscepti-
bility to LRTI in infancy.  This may be mediated through effects on lung function, as we 
have previously shown that antenatal smoke exposure is associated with lower lung 
function and lower respiratory system compliance in these infants shortly after birth.40,41 
Limitations of this study include the broad clinical definition of LRTI used, however the 
WHO definitions are widely used for maximum sensitivity and to reflect the broad spec-
trum of LRTI.  A further limitation was reliance on caregiver report of wheezing episodes; 
however, physician diagnosed wheezing also occurred at follow-up or sick visits and at 
the time of LRTI.  Further, large epidemiological studies such as the International Study 
of Asthma and Allergies in Childhood have relied on report of wheeze as a standard 
method.2 Other limitations were the use of maternal rather than infant birth urine cotinine 
measures to assess ETS exposure, given that not all infants had urine collected at birth 
and a lack of validated post-natal measures of ETS exposure. However, maternal self 
report and urine cotinine levels were highly correlated as was the sensitivity of self-re-
ported household smokers compared to cotinine results.20 
Antenatal exposures were the most significant exposures associated with LRTI in in-
fancy suggesting a developmental lung effect. This study highlights the need for ur-
gent and effective smoking cessation programmes targeting women of child bearing 
age pre-conception and of pregnant women.  The study also highlights the importance 
of other sources of IAP including toluene exposure, which has not been previously de-
scribed to be associated with severe LRTI, and which are increasingly used as rapid 
urbanisation in LMICs occurs. Limiting IAP exposure, by identifying household sources 
of IAP and providing safe alternative fuels, and improving household ventilation39,42 may 
be important strategies to optimize child health. The study underscores the importance 
of the antenatal period as a time of exposure, in contrast to the postnatal period, which 
has been the focus of most studies.  Further study of this cohort will provide important 
information on the long-term effects of these exposures on respiratory health in a  LMIC 
population.  
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Figure 1:  Trial profile 
The trial profile shows the number of eligible infants assessed at each visit, excluding 
those who did not attend that specific visit. Eligibility at each visit is defined as all infants 
minus the total number of infants lost to follow-up by that visit. All infants who attended at 
least one study visit were assessed, including those lost to follow-up who had attended 
at least one visit
1143 infants born to 1137 women
1030 of 1115 eligible infants  
attended the 6–10 week study visit
28 lost to follow-up 
85 did not attend the 6–10-week 
study visit
18 lost to follow-up 
164 did not attend the 14-week 
study visit
933 of 1097 eligible infants 
attended the week 14 study visit
27 lost to follow-up 
134 did not attend the 6-month 
study visit
936 of 1070 eligible infants  
attended the 6-month study visit
19 lost to follow-up 
207 did not attend the 9-month 
study visit
844 of 1051 eligible infants  
attended the 9-month study visit
27 lost to follow-up  
246 did not attend the 12-month 
study visit
778 of 1024 eligible infants  
attended the 12-month study visit
119 lost to follow-up in 12 months 
78 did not attend any study visits
1065 attended at least one study 
visit
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Number of mothers 583 (55%) 477 (45%) 1060







Number of infants 588 (55%) 477 (45%) 1065
Male 288 (49%) 260 (55%) 548 (51%) 0·073
Preterm *
(Gestation median 35 (IQR 
32-36) weeks)










HIV exposure 219 (37%) 16 (3%) 235 (22%) <0·001
Initiated breast feeding 430 (78%) 448 (96%) 878 (86%) <0·001











Black 581 (99%) 6 (1%) 587 (55%) <0·001
Mixed / other 7 (1%) 471 (99%) 478 (45%)
Vaccinations Received
1st dose (EPI at 6 weeks)







        Received 2 weeks late 32/529 (6%) 32/438 (7%) 64/967 (7%)
2nd dose (EPI at 10 weeks)













3rd dose (EPI at 14 weeks)
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        Received 2 weeks late 2/512 (0·4%) 0/422 (0) 2/934 (0·4%)
4th dose (EPI at 9 months)















Lowest SES 176 (30%) 85 (18%) 261 (25%) <0·001
Low-mod SES 164 (28%) 117 (25%) 281 (26%)
Mod-high SES 137 (23%) 134 (28%) 271 (25%)
High SES 111 (19%) 141 (30%) 252 (24%)
Household Density
Median (IQR)
Household size 4·0 (3·0, 6·0) 5·0 (4·0, 7·0) 4·0 (3·0, 6·0) <0·001
Persons per room 2·0 (1·0, 2·0) 1·0 (1·0, 2·0) 2·0 (1·0, 2·0) 0·004
Persons per sleeping room 3·0 (2·0, 4·0) 3·0 (2·0, 5·0) 3·0 (2·0, 4·0) <0·001
Dwelling category †‡
N (%)
Has ≤2 dimensions 164 (39%) 98 (26%) 262 (33%) <0·001
Has ≥2 dimensions 257 (61%) 277 (74%) 534 (67%)
Electricity Access 535 (91%) 3465 (98%) 1000 (94%) <0·001
Fossil fuel (coal, wood, paraffin, gas) used†
N (%)
Cooking 133 (32%) 35 (9%) 168 (21%) <0·001
Heating 129 (31%) 6 (2%) 135 (17%) <0·001
IQR, inter-quartile range; WAZ, weight-for-age z-score; HAZ, height-for-age z-score; HIV, human immuno-
deficiency virus; EPI, Expanded Programme on Immunisation; SES, socio-economic status.
*Median gestation for preterm infants in the study was 35 weeks (IQR 32–36). 
†Home assessments of dimensions and fossil fuel use were successfully completed for 796 of the 1060 
homes. 
‡The six dwelling dimensions were type of home (formal vs informal), primary building material (brick or 
cement vs other materials), water supply (piped into dwelling or yard), toilet facilities (noncommunal flush), 
kitchen type (separate room in house), and ventilation in the kitchen area (pipe or duct to exterior).
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Particulate Matter (PM10) (ug/m
3) 33·12 (12·22 - 
64·17)
29·29 (12·59 - 
52·46)
0·011
Nitrogen Dioxide (ug/m3) 7·08 (3·32 - 12·70) 5·83 (2·58 - 12·55) 0·812
Sulphur Dioxide (ug/m3) 0·00 (0·00 - 0·28) 0·00 (0·00 - 0·00) 0·058
Benzene (ug/m3) 4·29 (1·70 - 11·53) 3·12 (1·09 - 9·46) 0·014
Toluene (ug/m3) 16·94 (7·05 - 
44·85)
15·52 (5·93 - 
49·95)
0·869
Average Carbon Monoxide Per 
Hour (mg/m3)
0·00 (0·00 - 7·65) 0·00 (0·00 - 0·00) 0·923
Note:    Calculated based on matched pairs. (Based on Wilcoxon signed rank test)
174 











Antenatal tobacco smoke exposure (urine cotinine)
Number of mothers 574 484 1058
Urine cotinine <10 ng/ml 
(Non-smoker)
195 (34·0%) 56 (11·6%) 251 (23·7%) < 0·001
Urine cotinine 10-499 ng/ml 
(Passive / exposed)
291 (50·7%) 173 (35·7%) 464 (43·9%)
Urine cotinine ≥500 ng/ml 
(Active smoker)
88 (15·3%) 255 (52·7%) 343 (32·4%)
Self-reported smoking during infancy
Number of participants 583 477 1060
Mother 43 (8·7%) 280 (29.2%) 323 (22.2%) < 0·001
Father 271 (54·7%) 320 (33.4%) 591 (40.7%)
Other household members 181 (36·6%) 358 (37.4%) 539 (37.1%)
Total number of household smokers
Number of participants 583 477 1060
None 239 (41·0%) 41 (8·6%) 280 (26·4%) <0·001
One 208 (35·7%) 87 (18·2%) 295 (27·8%)
Two 121 (20·8%) 176 (36·9%) 297 (28·0%)





















































































































































































































































































































































































































































































































   






















IRR (95% CI) P value
Site
Mbekweni 1·43 (1·07 - 1·90) 0·009
Maternal smoke status
Active smoker 1·62 (1·14 -2·30) 0·004
Passive smoker 1·04 (0·76 - 1·41) 0·483
Infant characteristics 
Male 1·69 (1·33 - 2·13) <0·001
WAZ at birth 0·96 (0·86 - 1·06) 0·239
Maternal HIV exposure 1·12 (0·83 - 1·50) 0·488
Age in months 0·90 (0·88 - 0·92) <0·001
SES quartiles
Lowest SES 1·12 (0·79 - 1·59) 0·485
Low-mod SES 1·42 (1·02 - 1·97) 0·042
Mod-high SES 0·98 (0·70 - 1·39) 0·918
Indoor Air Pollutant Exposure
(N = 763)
IRR (95% CI) P value
Site
Mbekweni 1·02 (0·76 - 1·36) 0·872
Indoor air pollutant exposure
PM10 above ambient standard 1·43 (1·06 - 1·95) 0·008
Infant characteristics 
Male 1·76 (1·34 - 2·31) <0·001
WAZ at birth 0·89 (0·79 - 1·00) 0·063
Maternal HIV exposure 1·02 (0·72 - 1·46) 0·833
Age in months 0·91 (0·89 - 0·94) <0·001
SES Quartiles
Lowest SES 1·15 (0·78 - 1·69) 0·324
Low-mod SES 1·46 (1.01 - 2·12) 0·039
Mod-high SES 0·99 (0·67 - 1·47) 0·885
WAZ, weight-for-age z-score; HIV, human immunodeficiency virus; SES, socio-economic status; PM10, par-
ticulate matter
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IRR (95% CI) P value
Maternal smoke status
Active smoker 2·09 (1·54 – 2·84) <0·001
Passive smoker 1·70 (1·25 – 2·31) 0·001
Infant characteristics
Male 1·41 (1·16 - 1·72) 0·001
WAZ at birth 0·98 (0·89 – 1·07) 0·614
Maternal HIV exposure 0·49 (0·33 - 0·72) <0·001
SES quartiles 
Lowest SES 0·95 (0·70 - 1·30) 0·760
Low-mod SES 1·23 (0·93 - 1·63) 0·151
Mod-high SES 1·51 (1·15 – 1·98) 0·003
Infant feeding
Duration exclusively breast fed in months 0·98 (0·93 - 1·03) 0·435
Indoor Air Pollutant Exposure
(N = 585)
IRR (95% CI) P value
Indoor air pollution
Toluene above ambient standard 1·29 (0·88 – 1·89) 0·197
Particulate Matter (PM10)  above ambient standard 0·93 (0·70 - 1·25) 0·643
Benzene  above ambient standard 1·08 (0·85 - 1·38) 0·539
Infant characteristics
Male 1·50 (1·19 – 1·91) 0·001
WAZ at birth 0·95 (0·85 - 1·06) 0·327
Maternal HIV exposure 0·55 (0·34 – 0·90) 0·018
SES quartiles 
Lowest SES 0·99 (0·67 – 1·45) 0·942
Low-mod SES 1·51 (1·07 – 2·13) 0·019
178 
Mod-high SES 1·62 (1·15 – 2·27) 0·006
Infant feeding
Duration exclusively breast fed in months 0·99 (0·93 - 1·05) 0·740
WAZ, weight-for-age z-score; HIV, human immunodeficiency virus; SES, socio-economic status
*Site excluded as significant confounder
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This study comprises, 1137 mothers enrolled in the Drakenstein Child Health Study 
(DCHS), with 1143 live births, who were longitudinally followed through the first year of 
life. The impact of indoor air pollution (IAP) and/or environmental tobacco smoke (ETS) 
exposure on birth outcomes and on respiratory illness in infants was comprehensively 
investigated using objective measures of exposures antenatally and postnatally. These 
included comprehensive measurements of the home environment, and of indoor air pol-
lution exposure in the antenatal and postnatal period, in over 800 homes. (Figure 1) 
Further, longitudinal quantitative measurements of tobacco smoking and exposure in 
mothers and infants using urine cotinine were done. The impact of these exposures on 
child health and lower respiratory tract infections (LRTI) and wheezing in infancy was 
investigated. 
Figure 1: Summary of Home Environment Assessment
1 Summary of results
1.1  Home environment and household exposures
Home visits highlighted the poor living conditions, with one third of homes having 2 or 
204 
less pre-defined household dimensions.  Despite 92% of homes reporting access to 
electricity, alternate fuels were still used, particularly in the black African (Mbekweni) 
community in which 28% of homes used these for cooking and heating. Further, 36% of 
homes were positioned less than 50m away from road traffic and trucks passing contin-
uously. Using a composite socio-economic score (SES),1 more than half  the participants 
were in the lowest or low-moderate SES bracket, with the black African population hav-
ing more people in the lowest SES quartile.  Lack of adequate ventilation, poor sanitation 
and crowding compound the effects of IAP.2
Image 1 – Multipurpose single-room dwelling
1.2  IAP exposure
Of the IAP pollutants measured, only benzene (median 5.6ug/m3, IQR 2.6–17.1ug/
m3) was significantly above ambient standards.3  There were significant associations 
between alternate fuels used for cooking and increased benzene [OR 3.4 (95% CI 2.1–
5.4)], carbon monoxide [OR 2.9 (95% CI 1.7–5.0)] or nitrogen dioxide [OR 18.6 (95% CI 
3.9–88.9)] levels. IAP levels were higher in winter than in other seasons.
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Types of alternate fuels used included paraffin, wood, gas and coal, while other biomass 
fuels such as animal manure or crop residues were uncommon. These are important 
findings in the context of societies in transition whereby people are not so poor as to rely 
on biomass fuels but not sufficiently wealthy to afford available electricity.
1.3  ETS exposure
By using urine cotinine measures, this study reported validated prevalence data on 
maternal smoking and passive smoke exposure including household tobacco smoke 
exposure.  There  were significant differences found in the black African compared to 
the mixed ancestry communities. Overall, the prevalence of tobacco smoking and ETS 
exposure was very high. One-third of mothers smoked during pregnancy; significantly 
higher in the mixed ancestry community with over 50% of mothers smoking. A further 
45% of pregnant women were exposed to tobacco smoke. Tobacco smoking in preg-
nancy is often under-reported and there is limited valid data from LMIC and Africa, espe-
cially as self-reports are usually used.4-6  Also of concern, was that almost 20% infants 
had birth cotinine measures indicative of “active” smoking, and a further 38% that of 
passive exposure to tobacco smoke. Over 70% of infants lived in a home with a smoker 
and in 18% of households there were 3 or more smokers. Also, of note at 6-10 weeks 
of age infants exposed to more than 3 household smokers had a four-fold increased 
risk of testing positive for smoke exposure, highlighting that postnatally, environmental 
ETS exposure was also significant. This study emphasizes that self-reported smoking 
and exposure under-estimates the true magnitude of ETS exposure and that while ma-
ternal smoking prevalence varied between the two communities, exposure from other 
household members was high. The prevalence of smoking and of passive exposure are 
substantially higher that those reported from other African regions, where the pooled 
smoking prevalence in pregnant women was reported as 2.0%, (95%CI 1.2-2.9) the 
lowest of all LMIC with an overall pooled prevalence of 2.6% (95% CI 1.8-3.6).4 These 
are likely to be substantial under-estimates. The findings of this study provide important 
valid African prevalence data on maternal smoking during pregnancy and ETS exposure 
to both mothers and infants.
206 
1.4  IAP and ETS exposure: impact on child health
1.4.1.  ETS and birth outcomes 
Antenatal maternal smoking was associated with decreased infant birth weight-for-age 
z-score (0.3, 95%CI 0.1–0.5). As birth weight is an important predictor of life-long health 
outcomes, low birth weight infants are at increased risk for growth, illness or neurodevel-
opmental problems.7 Further, low birth weight is a risk factor for LRTI both from respira-
tory syncytial virus (RSV) and other infectious agents.8, 9
1.4.2 IAP or ETS exposure and nasopharyngeal bacterial carriage.
Nasopharyngeal bacterial carriage may be a precursor to the development of LRTI.10 
While it is recognised that ETS exposure impacts on nasopharyngeal bacterial carriage, 
11 the impact of IAP exposure on infant nasopharyngeal bacterial carriage has not been 
well described, particularly in LMIC. In this study, both antenatal and postnatal ETS expo-
sure was associated with Streptococcus pneumoniae carriage in mothers and in infants. 
Other IAP, including carbon monoxide, benzene and nitrogen dioxide also influenced 
nasopharyngeal bacterial carriage in both mothers and infants. We found that the effect 
of IAP on carriage was still present even after correcting for other recognised risk factors 
(weight for age z-score at birth, pre-term, ethnicity, sex, HIV exposure, time on exclusive 
breastfeeding, average number of people per sleeping room, dwelling category, recent 
respiratory infection, day care attendance, vaccination, number of other children under 5 
years in the household and antibiotic use).12, 13 Further study of the effect of carriage on 
the subsequent development of LRTI is planned. 
1.4.3 Exposures and lower respiratory tract infection and wheezing
Lower respiratory tract infections (LRTI) were common with 524 episodes of LRTI in the 
first year of life, incidence 0.49 (95% CI 0.45-0.53) episodes per child year. More epi-
sodes of LRTI occurred in the black African infants compared to those of mixed ancestry 
(61% versus 39%). The wheezing incidence was 0.23 (95% CI 0.21–0.26) episodes per 
child year. Amongst infants with LRTI, 43% had medically ascertained wheeze, though 
recurrent wheeze was uncommon (4%). 
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1.4.3.1. IAP and LRTI
Antenatal particulate matter (PM10) exposure was associated with LRTI (IR 1.43, 95%CI 
1.06–1.95) and antenatal toluene (a volatile organic compound) was identified as a nov-
el exposure associated with LRTI-associated  hospitalisation (OR 5.13, 95% CI 1.43–
18.36) and need for supplemental oxygen (OR 13.21, 95%CI 1.96–89.16). This high-
lights that alternate cheaper fuels may be associated with severe LRTI and the potential 
emergence of previously unrecognised compounds impacting on child health. 
1.4.3.2 ETS and LRTI
Only antenatal maternal smoking was associated with LRTI in infancy (IR1.62, 95% CI 
1.14–2.30). 
1.4.3.3 IAP, ETS and wheezing
Both antenatal (IR2.09, 95% CI 1.54–2.84) and postnatal (IR1.27, 95% CI 1.03–1.56) 
maternal smoking was associated with wheezing, as was antenatal maternal smoke 
exposure and postnatal household smoke exposure.
1.4.4 Timing of exposures
Antenatal exposures were the predominant risk factor associated with LRTI in the first 
year of life. This suggests an effect on lung  development or immunity, that increases the 
susceptibility of an infant to developing LRTI.  The results highlight the importance of the 
antenatal period as a key  risk time for exposures. Further, there is increasing evidence 
that lung growth trajectories are set in early life14, 15 and that adult chronic obstructive re-
spiratory disease risk is set in childhood16, 17 The consequences of early-life  exposures 
are far reaching with  life-long implications including reduced lung function,18 increased 
risk of chronic obstructive pulmonary disease, even in non-smokers19 and genetic and 
epigenetic changes that may result in generational effects.20 While a number of studies 
have compared the effects of antenatal to postnatal ETS exposure on respiratory ill-
nesses,21-23 there are few studies that have specifically explored the impact of antenatal 
versus postnatal IAP exposure.24  The pathophysiologic mechanisms also differ, with 
antenatal exposures having a direct effect on foetal development and growth through 
the maternal-foetal circulation 24 and post-natal exposures impacting directly on host 
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immune defences or directly damaging the lungs. 2 
2 Strengths and limitations
The DCHS provided a unique platform to explore the impact of early-life environmental 
exposures on child lung health. Strengths of this cohort were  the high vaccination rates 
achieved, timely, free access to care  and an effective HIV prevention of mother to child 
transmission (PMTCT) programme. Prospective data collection, careful LRTI surveil-
lance, longitudinal follow-up, the inclusion of 2 communities with different risk factors and 
high retention rates were further strengths. 
In this study thorough assessment of antenatal and early-life personal exposure to IAP 
using validated and quantitative measures was done. Successful measurement of IAP 
in most  homes and careful assessment of the home environment further allowed for 
associations between environmental exposures and LRTI and wheezing to be explored. 
Each of these associations were tested  individually and the associations reported were 
based on multivariate and multivariable analysis. Urine cotinine measures in mothers 
and infants provided objective measurement of ETS and served to validate self-reported 
data on smoking and exposure. 
Limitations included the broad definition of LRTI and reliance on care-giver reported ac-
counts of wheezing to characterise respiratory disease. However, the definition of LRTI 
is consistent with that used in large epidemiological studies and with the WHO revised 
definitions. Further, large scale epidemiological studies of asthma and wheezing such as 
International Study of Asthma and Allergies in Childhood (ISAAC) rely on self-reported or 
parental reported wheeze. In addition, medically ascertained wheeze was also obtained 
in children who developed LRTI. 
A further limitation was that although measures were placed within the homes, the influ-
ence of outdoor pollutants could not be excluded. The distinct differences between the 
two communities in this study who live in close geographical proximity, suggests that 
exposures may be very population and household specific, however, measured pollutant 
levels did not differ significantly between the two sites. Further, the very high ETS ex-
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posure and the effects associated  with this may have led to an underestimation of  the 
effects of IAP.
2.1  Generalisability of results
This community is representative of many peri-urban informal communities and commu-
nities living in sub-optimal housing across Southern Africa and in other LMIC settings 
with a number of environmental factors (air pollution both indoor and outdoor, tobacco 
smoke, HIV exposure, poor ventilation and crowding) and high incidence of childhood 
LRTI. However, the notable differences between the black African and mixed ancestry 
communities within  the same area indicates that despite their close physical proximity 
there is often much inhomogeneity, highlighting the need for any planned intervention to 
be directed appropriately for the setting. 
3 Recommendations
3.1  Future research
This study has identified a number of early life environmental exposures including IAP and 
ETS that impact on child health in the first year of life. The focus of this study was exposure 
to indoor air pollution antenatally and in early-life. However, as the child becomes more 
mobile the external environment, beyond the home, also may be a source of exposures. 
Evaluating outdoor air pollution and other areas where the child may be exposed to IAP 
(eg crèche, school) and the combined effect of this with household IAP is required and will 
provide further insights on the impact of these environmental exposures on child health.
The effect of continued exposure and the impact on recurrent and childhood respiratory 
illnesses through the childhood years requires longitudinal assessment and follow-up. 
Retention and longitudinal monitoring of this cohort will also allow for further understand-
ing of the impact of these early life exposures on long term lung health including, growth, 
development and lung health including lung function. 
The impact of IAP on bacterial nasopharyngeal colonisation in both mothers and infants 
is novel. While an association between environmental exposures and bacterial naso-
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pharyngeal carriage was found,  further investigation of the impact of carriage on the 
subsequent development of disease including LRTI and on wheezing illness is required. 
Electronic nicotine delivery systems (e-cigarettes), designed to deliver nicotine without 
tobacco combustion are an emerging threat. Marketed as a safer alternative to conven-
tional cigarettes and as a smoking cessation tool, this poorly regulated industry is gain-
ing popularity amongst young people. Increasing evidence points to nicotine as having 
significant detrimental effects on lung growth and development as well as being highly 
addictive.25 The long-term effects of e-cigarette use are yet to be evaluated and require 
close monitoring, but given that e-cigarettes contain nicotine the use of these will pro-
mote another form of nicotine dependence.  Further, evidence suggests that use of e-cig-
arettes is likely to lead to tobacco smoking in time.26
The impact of these exposures on genetic, epigenetic and immunological changes re-
quires further investigation. Studies from high income countries have reported the impact 
of early-life smoke exposure on the genetic programming that control life-long lung de-
velopment, aging and susceptibility to obstructive lung diseases27-29 and on the transgen-
erational effects of tobacco smoking.20
 3.2  Interventions and policies
Strategies to reduce household IAP through universal access to affordable electricity 
or clean fuel must be a primary goal. Where alternate fuel sources are unavoidable, a 
multi-pronged approach addressing technologies such as improved stoves and combus-
tion design, access to cleaner fuels, improved household ventilation and behaviours that 
minimise childhood exposure is required.2
3.2.1  Regulatory changes
• National housing policies need to ensure IAP exposure is minimised especially when 
planning and developing new houses.30 Policies to protect children from adverse 
exposures and prevent long-term adverse lung health should be standard practice. 
This may require a multidisciplinary approach with contributions from health, housing 
and social development sectors to address the socioeconomic issues linked to this
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• Ambient air quality standards need to be geographic location specific and acceptable 
standards require on-going review which may include reducing current standards as 
health effects may still occur with exposure levels below ambient standards.31
• Urgent public health interventions addressing tobacco smoking and household expo-
sure are needed32 including accessible and effective smoking cessation programmes. 
A combination of motivational counselling / cognitive behavioural therapy and drug 
therapies are usually required and currently are the most effective strategy.33 Such 
programmes need to be widely available at a primary health care level.  In addi-
tion, targeted programs aimed at women of child bearing age and pregnant women 
should be a priority.  Smoking cessation and counselling should be incorporated into 
antenatal programs.
• National policies to regulate and prevent smoking should aim for a tobacco-free so-
ciety through measures including increased taxation on tobacco products, bans on 
advertising including marketing tobacco products to youth through sponsored parties 
and events and enforcing legislation that bans smoking in public places.
Novel approaches to protect children from tobacco smoke may require behavioural 
changes, air filters, smoking cessation tools and child appropriate aids such as story 
books. A systematic  review and meta-analysis of studies from HIC, found that while 
these interventions have decreased tobacco smoking pollution in homes, contamination, 
as measured by air nicotine and PM, still remained. This highlights that despite intensive 
interventions, exposures  in households and personal space are very difficult to control 
and remain problematic 34.
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4 Conclusion
Environmental exposures from IAP and tobacco smoke exposure impact negatively on 
child health, especially in this LMIC context. The predominant effect of antenatal com-
pared with postnatal exposure on infant LRTI and wheezing suggests an in utero devel-
opmental lung effect. This study highlights the antenatal period and early life as a critical 
period for lung development, and identified novel exposures as impacting negatively on 
child health. This work provides novel South African epidemiological data which is rele-
vant to other LMIC particularly in Africa. Addressing antenatal and early-life environmen-
tal exposures is crucial to improving child health. Further longitudinal study of this cohort 
will provide important information on the long-term respiratory outcomes.
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The purpose of this SOP is to describe the Home Visits to be performed and the pro-
cedures surrounding the devices to be used for measuring indoor air pollution from bio-
mass fuels and tobacco smoke.
2 Background
Two home visits are planned for all participants enrolled on DCLHS. These home visits 
will occur during the antenatal period following enrolment of the mother. A subsequent 
home visit will take place within the first 4-6 months of the infant’s life. 
During these home visits, a questionnaire will be administered by the environmental 
fieldworker, measurements of the home will be taken and four devices to measure indoor 
air pollution from Biomass fuels and tobacco smoke will be placed in the home. 
3 Scope
This SOP will be used by DCLHS staff involved in performing or assisting with home vis-
its; as delegated by the Project Management Office and indicated by staff job description. 
Equipment
1. Questionnaire
2. Laser measuring device
3. Sulphur dioxide (SO2) / Nitrogen dioxide (NO2) passive sampler.
4. Volatile organic compound (VOC) passive sampler
5. Gillian Pump and filter
6. CO Monitor
4 Procedure
a. Pre-arrange a suitable date and time to perform the home visit. 
b. Ask permission to visit the home, administer questionnaires and leave devices for 
measuring indoor air pollution.   Explain the purpose of the home visit and what you 
will be doing while in the home as well as the schedule for picking up devices.  Any 
questions about the home visit should be answered prior to beginning.  
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c. Identify the main person who will be available to answer questions regarding the 
home environment.
d. Check each room as per questionnaire and fill in appropriate information before 
leaving the home.  Verify the answers to the question by observing it in the home. 
(For example, if the answer to how many rooms is 5, the fieldworker should walk 
around the home and verify that this information is correct).
e. During the antenatal visit, the main living room, the bathroom, the kitchen and 
mother’s bedroom will be measured.  Measure each room using laser measure. 
At the post-natal visit, these living areas will be measured once more as well as 
the child’s room (where the child sleeps).  NB: If the main living room/kitchen/
child’s room are the same room, field worker only needs to measure once and 
identify by main purpose of room as well as indicate on the CRF that they were 
“the same room”.  (See Home Visit Questionnaire.)  Additionally, if the bathroom 
is external to the home or communal i.e. shared by multiple families, does not 
need to be measured, fieldworker should note this in the CRF. 
f. Find a suitable space in main living room (where majority of people spend ma-
jority of time in the home) to leave the 4 devices to measure indoor air pollution.
g. Place the nitrogen dioxide (NO2) / sulphur dioxide (SO2) and volatile organic 
compound (VOC) passive samplers out of reach of children.  These measures 
should be placed at 1.5 meters height and in the same location, where possible. 
If not, this should be indicated on the CRF. 
h. Explain to household members that these devices will be left in the home for 2 
weeks and should not be moved. Record the date and time. (See separate SOP 
for more details).  
i. Place Gillian Pump  and the CO monitor in the home in a place high enough to 
not be in the way.  Where possible, it should be placed near the VOC and NO2/
SO2 (radiello) measures; it should be in the same room.  Record time and date 
of leaving device.  (see separate SOP for more details)
j. The CO monitor must be turned off between homes.  This should be done once 
inside home and before exiting the home so that measurements are only taken 
for the interior of a home.  The CO monitor must be downloaded at least every 3 
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days, or more often.  When downloading the CO measurements, data for each 
home should be clearly labeled with PID indicated for first and last reading with-
in each home.  This information must be retreived from the CRF at the time of 
downloading.  
k. Retrieval of the Gillian pumps & CO monitor should be done the day after placing 
them in the home, or as close to 24 hours later as possible. When retrieving the 
devices, fieldworker must take the CRF with them and fill in the reference num-
bers as well as the time of pick up before leaving the home. 
l. For the dust samplers, two will be placed in the home at both the antenatal visit 
and then again at the 4-6 month visit (see Dust Sampler SOP for more details). 
One will be placed in the main living area and one will be placed in the child’s 
room or where the child’s room will be after birth.  If this is the same space as 
the main living area, please note this on the Environmental Measures CRF and 
place only one.  
m. Retrieval of the passive devices should be done approximately 2 weeks after 
placement.  When retrieving the devices, fieldworker must take the CRF with 
them and fill in the reference numbers as well as the time of pick up before leav-
ing the home. 
6 Documentation
Home visits will be documented on the completed questionnaires (CRFs).  These should 
be completed at the time of placement and pick up.  In addition, tracking forms for all 
measurement devices sent to the lab should be completed and filed at the respective 
sites. 
7 Training 
Training in this SOP will be documented per the DCLH Study Training Plan.
8 Reference
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The purpose of this SOP is to describe the assembly, placement and pick up of the 
Radiello (in home) measure, which will be used to measuring indoor sulfur dioxide and 
nitrogen dioxide pollution within the home.
2 Background
During each of the two scheduled home visits, which will take place antenatally and with-
in the first 6 months of the infant’s life, the radiello measure will be placed in the home 
for a period of two weeks. 
3 Scope
This SOP will be used by DCLH staff involved in performing or assisting with home visits, 
in particular the fieldworker who will conduct home visits and place as well as pick up air 
pollution measures.
4 Equipment
Sulphur dioxide (SO2) / Nitrogen dioxide (NO2) passive sampler (radiello measure).
5 Procedure
The procedure for setting up and dropping off the radiello measure will take place after 
completion of questionnaire and room measurement.  
a. Placement
Find the most appropriate room and space to leave the radiello measure.  It is im-
portant to consider the following criteria: the device should be placed 1) at breathing 
level 2) where the majority of persons living in home spend the majority of their time 
3) out of the reach of children 4) affixed to stationary object to avoid disturbance 5) 
where the air is able to flowing over device. 
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Explain to household members that this device will be left in the home for 2 weeks 
and should not be moved. Record the date, time and location. (See separate SOP 
for more details).  Leave the information sheet for devices with person who has been 
answering questions.   
Schedule a date/time for pick up of radiello measure, when someone will be at home 
to allow the fieldworker to collect.  This should be two weeks after drop off.  Please 
make a note of the best time for collection on the CRF for environmental measures. 
b. Exposing the (SO2/NO2) samplE
i. Assemble the supporting plate
• Insert the plastic clip through the slot at the top of the triangular base plate
• Bend the plastic over and clip closed
• Stick the plastic label holder onto the base plate just below the plastic clip
ii. Expose the cartridge & start sampling
• Remove the sample cartridge from its plastic casing
• Open tube
• Get the blue diffusive body ready, being careful not to touch the blue spongy 
layer (only touch the black plastic components)
• Tip the sample cartridge into the blue diffusive body so that it falls all the way into 
the holder
• Gently twist blue diffusive body into the blue triangular base plate – make sure 
this is done upright so that the sample does not fall out of the diffusive body
• No not twist the diffusive body too tightly as this could cause the plastic to break
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iii. Label the sample & record sampling data
• Fill in the sample start date and time (hour and minute is necessary) onto the 
label but do not remove the backing paper
• Record the samples reference number and start date and time on a separate 
logsheet
• Slide the label into the plastic label holder on the blue triangular base plate
• Close the empty sample cartridge holder (test-tube) and store in a safe place 
until the sample is ready to be collected.
iv. Clip the sampler in the required location
 The final sample should look like this:
C. Collecting the (SO2/NO2) sample after 2 weeks of sampling
Once the sample has been exposed for 2 weeks it will need to be collected, labelled and 
sent to the lab for analysis, following the steps outlined below.  Once collected, complete 
the device measures form regarding pick up details.  
i Remove the sampling cartridge
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• Unclip the sampler
• Make sure the empty cartridge holder is open and ready for the exposed sample
• Gently unscrew the diffusive body from the triangular base plate whilst keeping 
the diffusive body upright to prevent the sample from falling out
• Tip the sample cartridge into the original plastic holder and close the lid
ii. Label the sample & record sampling data
• Remove the label from the triangular base plate
• Record the end date and time (in hours and minutes)
• Stick the label onto the plastic cartridge holder
• Make sure all the necessary data is recorded on the sample logsheet (start date 
& time, end date & time, location & unique reference number)
iii. Sample storage & analysis
• Please store samples in a plastic ziplock bag in a cool place (preferably the 
fridge) until they are delivered to SGS for analysis
6 Documentation
The device measures form must be initially filled in when leaving the samples in the 
home and then completed when all the devices have been collected.  This information 
must be completed in real time.  This form includes a checklist of where to leave devices, 
how to set up devices and documentation for drop-off and pick-up.  
7 Training 
Training in device use to be undertaken by SGS – Aneesa Vanker, Whitney Barnett 
and Masande Mbovu (fieldworker) and Barnita van Staveld (fieldworker) to be trained. 
January 2012
• Each Staff member receives or has direct access to the SOP
• Staff members involved in home visits reviews the applicable SOP’s on a three 
monthly basis
• New staff involved in administration of in home environmental measures is trained on 
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home visit SOP within 14 days of employment.
• Staff members whose duties fall within this SOP scope are retrained within 14 days 
of the approval of each SOP revision.
APPENDIX A: Radiello Sampler Parts (SO2/NO2)
The Radiello samplers consists of 5 parts:
Name Image Use
Radiello base plate A supporting structure 
for the sample
Radiello base plate clip Allows the base plate 
to be hung





(actual sample which is 
sent for analysis)
Label Provides a unique 
reference number for 
each sample & for the 
lab.
General Info and considerations:
• Please be careful not to touch the blue spongy part of the blue diffusive body as this 
allows air to flow over the sample and any dirt will affect the flow.
• If the diffusive bodies get dirty, please return them to SGS and they can be washed 
(usually every 3 months)
• Do not touch the sampling cartridge (white tube inside plastic case) as this will affect 
the sample results
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• Please keep exposed samples in their original tubes so they can be sent to the lab 
for analysis
• Ensure that the unique reference number, start & end dates and times are recorded 
for each sample
• Please ensure that each sample is labelled on the outside of the plastic tube with the 
official label before sending it to the lab and that duplicate data is kept on a separate 
logsheet
• A blank cartridge should be sent with each batch of samples sent for analysis.
APPENDIX B: TRAINING RECORD
THE PERSON WHO SIGNS THIS FORM HAS READ AND UNDERSTOOD THIS SOP
SOP Number:          
Title:           
SOP Version:           
NAME SIGNATURE DATE: dd/mm/yy Comments
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1 Purpose
The purpose of this SOP is to describe the assembly, placement and pick up of the VOC 
sampler, which will be used to measuring indoor organic compounds.
2 Background
During each of the two scheduled home visits, which will take place antenatally and with-
in the first 6 months of the infant’s life, the VOC sampler will be placed in the home for a 
period of two weeks. 
3 Scope
This SOP will be used by DCLH staff involved in performing or assisting with home visits, 
in particular the fieldworker who will conduct home visits and place as well as pick up air 
pollution measures.
4 Equipment
      Volatile organic compound (VOC) passive sampler.  
5 Procedure
The procedure for setting up and dropping off the VOC sampler will take place after com-
pletion of questionnaire and room measurement.  
a. Placement
Find the most appropriate room and space to leave the VOC sampler.  It is import-
ant to consider the following criteria: the device should be placed 1) at breathing 
level 2) where the majority of persons living in home spend the majority of their 
time 3) out of the reach of children 4) affixed to stationary object to avoid distur-
bance 5) where the air is able to flowing over device. 
Explain to household members that this device will be left in the home for 2 
weeks and should not be moved. Record the date, time and location. (See sepa-
rate SOP for more details).  Leave the information sheet for devices with person 
who has been answering questions.   
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Schedule a date/time for pick up of VOC sampler, when someone will be at 
home to allow the fieldworker to collect.  This should be two weeks after drop off. 
Please make a note of the best time for collection on the CRF for environmental 
measures. 
b.  Exposing the VOC sample
1. Record the sample details including sample reference number, location and 
start date & time (hours and minutes are necessary).
2. Identify the correct side to open the sample tube. The correct side is the 
same side as the letter “M” at the start of the reference number (i.e. if you are 
reading the reference number it will be the left-hand cap assembly).
3. Using one spanner hold the base nut of the cap steady whilst loosening the 
cap with the second spanner (the cap can be untwisted by hand once it has 
been loosened).
4. Slide the cap and nut off the sample tube.
5. Press the diffusive cap onto the open end of the sample tube until secure.
6. Clip the sampler into the holder/shelter and ensure it is firmly fixed in place.
7. Store the nut and cap assembly in a safe place until the sample is collected.
c. Collecting the VOC sample after 2 weeks of sampling
Once the sample has been exposed for 2 weeks it will need to be collected and 
sent to the lab for analysis:
1. Record the sample details including sample reference number, location and 
end date & time (hours and minutes are necessary). Be sure to check that 
the tube number is the same as what was recorded initially.
2. Unclip the sampler from the holder/shelter.
3. Remove the diffusive cap from the sample tube.
4. Slide the nut onto the open end of the sample tube and twist on the cap by 
hand.
5. Tighten the cap using one spanner to hold the base nut of the cap steady 
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whilst tightening the cap with the second spanner.
6. Please store samples in a plastic ziplock bag in a cool place (preferably the 
fridge) until they are delivered to SGS for analysis.
6 Documentation
The device measures form must be initially filled in when leaving the samples in the 
home and then completed when all the devices have been collected.  This information 
must be completed in real time.  This form includes a checklist of where to leave devices 
and documentation for drop-off and pick-up.  
7 Training 
Training in device use to be undertaken by SGS – Aneesa Vanker, Whitney Barnett and 
Masande Mbovu (fieldworker) and Barnita van Staveld (fieldworker) to be trained. Jan-
uary 2012
Each Staff member receives or has direct access to the SOP. Staff members involved in 
home visits reviews the applicable SOP’s on a three monthly basis
New staff involved in administration of in home environmental measures is trained on 
home visit SOP within 14 days of employment.
Staff members whose duties fall within this SOP scope are retrained within 14 days of the 
approval of each SOP revision.
APPENDIX A: VOC Passives Sampling Procedure
The VOC sampler consists of the following parts:
Name Image Use
VOC sampling tube Absorbs pollutants (actual sample 
which is sent for analysis) onto a resin-
like substance inside the tube.
Sample cap assembly (one 
on each side) consisting of 
nut and cap
Seals the sample from ambient air.
Diffusive cap Prevents large particles of debris or 
insects from contaminating the sample.
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Shelter Protects the sample from exposure to 
rain and other elements.
Reference number Provides a unique reference number for 
each sampler & for the lab.
General Info and considerations:
• In order to open and close the samples you will need 2 shifting spanners to hold the 
fixed end-cap assembly nut whilst the cap is loosened/tightened.
• Sample tubes will need to be re-conditioned after each exposure & analysis before 
they can be re-used. This is done at the lab after analysis but does require some time 
(i.e. samples cannot be sent back immediately for re-use).
• Individual sample tubes are engraved with a reference number and not each individ-
ual sample exposure. This number must be recorded with the start & end dates and 
times as well as the sample location since the tubes are re-used but the reference 
number remains the same. Extra caution must be exercised during reporting to en-
sure that results are not confused.
• Please do not stick any additional labels onto the tubes as this gets stuck during the 
auto-loading into the lab equipment.
• A blank cartridge should be sent with each batch of samples sent for analysis
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EDITORIAL
Tobacco smoke exposure in early life: the first African cohort
studies
TOBACCO SMOKE (TS) is a leading cause of
mortality, responsible for around 6.1 million deaths
and for morbidity that causes at least 143.5 million
disability-adjusted life years worldwide per year.1
Maternal smoking is an important risk factor for
adverse maternal and foetal outcomes, and environ-
mental TS exposure pre- and post-birth is increasingly
recognised to cause childhood illness and develop-
mental delay.2,3
In this issue of the Journal, the article by Vanker et
al. is one of the very few collaborations to report on
maternal smoking patterns in a low- to middle-
income country.4 They go further, and have enough
reliable data to relate maternal smoking to infant
birth outcomes. This setting is all the more relevant as
it is becoming a new battleground for tobacco
companies who are shifting their emphasis due to
taxation and legislation in high-income countries.
The authors are to be congratulated in several
ways; although we are not sure of the refusal rate,
they provide unique cross-sectional data comparing
two well-described local populations of mixed race
and predominantly black African communities, sug-
gesting clear differences in smoking prevalence
between the two. They are unique in comparing the
sensitivity of self-reported versus objective (validated)
smoking status using urinary cotinine in both
populations. Although relatively expensive compared
to exhaled carbon monoxide (especially on this scale),
urinary cotinine is a better validation method here as
it will not be affected by burning of domestic fossil
fuels and, of course, can be collected from newborns
without much cooperation! The authors provide
rational explanations for the discrepancies in the
sensitivity of self-reported versus validated smoking
status between the populations, and place them
within a live socio-cultural context. The study
methodology is strengthened by the fact that all
births were recruited from a single hospital so all
dyads have identical obstetric services, and, more-
over, the ethical element was maintained, as all
smokers were offered quit counselling. A member of
the study team was present at all 792 births to collect
questionnaires and maternal/newborn urine directly.
The team maintained a remarkable 91% follow-up
rate to repeat the questionnaires and urine testing at
6–10 weeks post-birth; this in itself is no mean feat in
any health system, let alone following young women
going through chaotic changes in their lives.
One important finding was that high levels of
urinary cotinine were more common in infants than
their mothers, suggesting high rates of smoking in
other household contacts. Environmental TS will be
combined in many houses with high levels of
pollution from domestic fuels which are increasingly
associated with adverse respiratory outcomes, includ-
ing later COPD.4 Finally, there was enough complete
data to properly correlate maternal smoking status
with an adverse birth outcome, which showed the
predictable association with decreased infant birth-
weight for age Z-score. The study was large enough
with enough follow-up data to allow multi-regression
to reduce the effects of confounders.
It is vital that this well-described cohort be
followed through early years to adulthood, hopefully
with longitudinal lung function and clinical out-
comes. I hope the Drakenstein Child Health Study
will continue to reveal rich data and contribute to our
understanding of public health for low- and middle-
income countries as much as landmark cohorts such
as the Lung Health Study or Framingham have done
for high-income countries. It can supply valuable
ammunition for those governments that need it in
their battlegrounds.
PROFESSOR KEIR LEWIS
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Until a couple of decades ago, air pollution did not 
feature as a major determinant of ill health among 
infants. Thus, the words “air”, “pollution”, and even 
“smoking” are conspicuously absent from the WHO’s 
1978 Declaration of Alma-Ata, a major milestone 
in the field of public health, which expressed “the 
need for urgent action…to protect and promote the 
health of all the people of the world”.1 Similarly, the 
United Nations (UN) Millennium Declaration of 2000 
remained silent with regard to clean air.2 Since then, 
things have changed and the medical community 
has become more aware that the health of children 
greatly depends on breathing clean air. Thus, the 2015 
UN resolution that defined the agenda for sustainable 
development recognises the adverse health effects 
caused by air pollution, which should be “substantially 
reduced” by 2030.3 Air pollution now also features more 
prominently than before among the risk factors that 
determine the global burden of disease.4 In particular, 
child mortality and morbidity in low-to-middle-income 
countries has been shown to be strongly associated 
with household air pollution caused by burning solid 
fuels (eg, coal, charcoal, wood, dung, and crop residues) 
for cooking and heating.5
In The Lancet Planetary Health, Aneesa Vanker and 
colleagues7 present findings from the Drakenstein 
Child Health Study,6 a birth cohort study in two poor 
peri-urban communities, some 60 km outside of Cape 
Town, South Africa. More than 1100 pregnant women 
were enrolled in this study between 2012 and 2015 to 
investigate the early-life determinants of illness in an 
African population. Vanker and colleagues7 focus on the 
effect of antenatal and postnatal exposure to indoor 
air pollution on the occurrence and severity of lower 
respiratory tract illness (LRTI) or wheezing in children 
followed up until 1 year of age. A major strength of this 
unique study,7 besides its remarkably low loss to follow-
up, is the unusually thorough assessment of individual 
exposure. This assessment included urinary cotinine 
measurements to estimate active and passive smoking, 
and more than 4500 antenatal and postnatal home 
visits, with 24-h air sampling for particulate matter of 
diameter 10 μm or less (PM10) and carbon monoxide, 
and 2 weeks’ sampling of nitrogen dioxide, sulphur 
dioxide, and volatile organic compounds. 
In brief, the study mainly found increased risks of 
LRTI (incidence rate ratio 1·62, 95% CI 1·14–2·30; 
p=0·004) and of wheezing (2·09, 1·54–2·84; p<0·0001) 
if the mother smoked during pregnancy (depressingly, 
more than half of the mothers of mixed race smoked 
during pregnancy). High antenatal indoor exposure 
to fine dust—ie, PM10 levels above 40 µg/m³, the South 
African standard for ambient air—also increased risk of 
LRTI (1·43, 1·06–1·95; p=0·008) but not of wheezing. 
Postnatal exposures were generally less associated with 
risks of LRTI or wheezing. The possible effect of traffic-
related pollution was not reported. 
In a subanalysis among children with LRTI, antenatal 
exposure to toluene above 240 µg/m³ was associated 
with significantly increased odds of hospitalisation 
(odds ratio 5·13, 95% CI 1·43–18·36; p=0·012) and 
requirement for oxygen (13·21, 1·96–89·16; p=0·008). 
An Australian case-control study8 found increased risks 
of asthma in young children with increasing toluene and 
benzene concentrations in the home, but it is unlikely 
that, at the observed concentrations, toluene (and 
similar volatile organic compounds, such as benzene) 
are causally implicated in the observed respiratory 
effects. Nevertheless, volatile organic compounds 
probably represent good markers of combustion-
related pollution and they can be measured fairly easily 
and cheaply by diffusive samplers,9 as well as in urine.10 
Another promising approach to assess exposure to 
combustion-related pollution is to measure carbon 
particles in urine.11 
Our physical-chemical environment can be envisaged 
as a series of compartments that are imbricated like 
matryoshka dolls: the innermost doll is our internal 
milieu, the next compartment is the personal milieu 
(micro-environment), the next layers are the indoor 
environment (meso-environment) and the outdoor 
environment (macro-environment), and the final layer 
is the global or planetary environment. Obviously, all 
compartments communicate with each other. Hence, 
our internal milieu is polluted by substances absorbed 
from the external environment (and, sometimes, by 
Protecting children’s lungs by providing clean air during 
pregnancy? 
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chemicals released from prostheses, dental fillings, or 
tattoos). Importantly, during pregnancy the mother’s 
internal milieu is also the external milieu of the fetus. Our 
personal micro-environment might be polluted by active 
smoking (so-called do-it-yourself air pollution), personal 
care products and cosmetics, and mobile phones, 
among other things. The meso-environment concerns 
the indoor spaces of homes, workplaces, and other 
buildings or vehicles, in which exposure to numerous 
types of pollutants can occur: cigarette smoke and other 
combustion products, substances released from building 
materials, household chemicals, and specific occupational 
agents. The outdoor environment is the one that people 
most often understand as the main environment to 
be affected by pollutants originating from industry, 
mining, power generation, agricultural activities, waste 
processing, urban traffic, among other things. In general, 
the concentrations of air pollutants are higher in indoor 
environments, especially if they are poorly ventilated, 
than in ambient urban air. Moreover, burning solid fuels 
or biomass causes not only indoor pollution, but also 
contributes substantially to ambient air pollution;12 
however, this has not been thoroughly quantified for 
Africa. Conversely, pollutants emitted by industry or 
traffic also penetrate into homes or schools, depending 
on building characteristics. Finally, at the planetary level, 
our environment is influenced by natural phenomena 
and by human activities that lead to transboundary 
transport of pollutants and climate changes. 
The Drakenstein Child Health Study is undoubtedly 
a landmark study and its findings are likely to be 
generalisable to other vulnerable populations, although 
even poorer and more polluted populations live in 
rural areas and mega-cities in sub-Saharan Africa. 
What are the study’s implications, so far, in terms of 
the prevention of LRTI? Vanker and colleagues’ rightly 
advocate effective measures to prevent smoking by 
women and limiting exposure to indoor air pollution, 
especially during the antenatal period.7 Indeed, 
as shown in their other articles,13 even excellent 
medical interventions directed at individuals, such 
as a high rates of antipneumococcal immunisation 
and successful prevention of mother-to-child HIV 
transmission, are unlikely to reduce substantially the 
incidence of childhood pneumonias in low-to-middle-
income countries. Structural interventions leading to 
decreased poverty and improved air quality are likely to 
be more effective. 
Citizens worldwide are entitled to clean air, just like 
clean water.14 
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Lower respiratory tract infections (LRTIs) are the leading cause 
of childhood morbidity and mortality in South Africa (SA). 
Despite sustained efforts to decrease this, including better access 
to vaccination and strengthening of primary healthcare services, 
childhood LRTIs continue to impact significantly on child health.[1,2]
SA, a middle-income country, has undergone much social and 
political change in the past two decades, resulting in urban migration 
and the mushrooming of peri-urban communities with subsequent 
health, education and environmental challenges.[3] Despite an increase 
in electrification, many households continue to rely on alternative 
fuel sources for cooking and heating.[4] Burning of alternative 
fuels (such as paraffin, wood, coal and other biomass substances), 
often in inadequately ventilated homes, contributes to indoor air 
pollution, a recognised risk factor for respiratory disease.[5] Further, 
environmental tobacco smoke exposure continues to be problematic 
despite anti-smoking legislation.[6]
The Drakenstein Child Health Study (DCHS), an SA birth cohort 
study of 1 000 mother-child pairs, longitudinally investigates the 
epidemiology, risk factors, aetiology and long-term outcome of 
childhood diseases, including respiratory illnesses.[7] The study site is 
in a peri-urban, poor socioeconomic community in the Drakenstein 
subdistrict, 50 km from Cape Town. Pregnant women were enrolled 
from two public primary healthcare clinics, Mbekweni (serving a 
predominantly black African population) and Newman (predominantly 
mixed-ancestry population), and all deliveries occurred at Paarl 
Hospital. Children are followed up until at least 5 years of age.
The impact of indoor air pollution (IAP) and environmental 
tobacco smoke (ETS) exposure on child health was investigated in the 
DCHS. To measure exposures comprehensively, two home visits, one 
in the antenatal period (third trimester) and the second postnatally 
(between 4 and 6 months of the infant’s life), were conducted to assess 
the home environment and to measure the most common indoor 
air pollutants and byproducts of combustion. Devices placed in 
participants’ homes measured exposure to particulate matter (PM10), 
carbon monoxide (CO), nitrogen dioxide (NO2), sulphur dioxide 
(SO2) and volatile organic compounds (VOCs).[8] Measurements 
of IAP were obtained from 863 antenatal and 723 postnatal home 
visits, providing important SA data on IAP and potential sources of 
pollution. Measured benzene (VOC) levels were significantly above 
acceptable SA ambient standards,[9] and together with CO and NO2, 
increased levels were associated with fossil fuel use.[8]
Tobacco smoking by pregnant women is often under-reported 
globally, although household ETS exposure may be high.[10,11] In the 
DCHS, urine cotinine measures were used to validate maternal self-
reported smoking and exposure.[12] Tobacco smoking and exposure 
was found to be highly prevalent, with a smoking prevalence of 
>50% in mixed-ancestry mothers. Alarmingly, 18% of infants were 
born with urine cotinine levels in keeping with active smoking, 
while a further 30% had levels indicating passive smoke expo -
sure.[12] The impact of the exposures on birth outcomes was 
significant, with antenatal maternal smoking associated with lower 
birth weight.[12]
The timing of environmental exposures on the subsequent 
development of LRTI in infancy has not been well described. Most 
interestingly, we found that antenatal exposures were the main risk 
factors associated with LRTI, with maternal smoking in pregnancy or 
PM10 exposure most strongly associated with LRTI. Further, maternal 
smoking in pregnancy or antenatal passive smoke or PM10 exposure 
was associated with wheezing in infants.[13] Interestingly, toluene, a 
volatile organic compound, was a novel exposure associated with 
severe LRTI requiring hospitalisation.[13]
Environmental exposures therefore had a substantial impact on 
child health and on LRTI. The effect on LRTI of antenatal compared 
with postnatal exposure suggests an in utero developmental lung 
effect. This study highlights antenatal and early life as a critical 
period for lung development. Urgent and effective smoking cessation 
programmes as well as public health interventions focusing on IAP 
are required. Woman of childbearing age, pregnant women and 
children in poor communities represent vulnerable populations at 
risk for long-term health effects of these exposures. Early-life LRTI 
and environmental exposures have increasingly been associated 
with the development of chronic obstructive pulmonary disease in 
adulthood. Further longitudinal study of this cohort will provide 
important information on the long-term respiratory outcomes.
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